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ABSTRACT
ESSAYS IN CAUSAL INFERENCE: ADDRESSING BIAS IN OBSERVATIONAL AND
RANDOMIZED STUDIES THROUGH ANALYSIS AND DESIGN
Raiden B. Hasegawa
Dylan S. Small
In observational studies, identifying assumptions may fail, often quietly and without notice,
leading to biased causal estimates. Although less of a concern in randomized trials where
treatment is assigned at random, bias may still enter the equation through other means.
This dissertation has three parts, each developing new methods to address a particular
pattern or source of bias in the setting being studied. In the first part, we extend the
conventional sensitivity analysis methods for observational studies to better address patterns
of heterogeneous confounding in matched-pair designs. We illustrate our method with two
sibling studies on the impact of schooling on earnings, where the presence of unmeasured,
heterogeneous ability bias is of material concern. The second part develops a modified
difference-in-difference design for comparative interrupted time series studies. The method
permits partial identification of causal effects when the parallel trends assumption is violated
by an interaction between group and history. The method is applied to a study of the repeal
of Missouri’s permit-to-purchase handgun law and its effect on firearm homicide rates. In
the final part, we present a study design to identify vaccine efficacy in randomized control
trials when there is no gold standard case definition. Our approach augments a two-arm
randomized trial with natural variation of a genetic trait to produce a factorial experiment.
The method is motivated by the inexact case definition of clinical malaria.
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CHAPTER 1
Introduction
The objective of many social science, epidemiology, and medical research studies is to iden-
tify and estimate causal relationships between treatments or exposures and outcomes of
interest. In observational studies, the absence of physical randomization and the lack of the
tightly controlled environment of a well planned experiment may lead critical observers to
call causal conclusions into question. Although less of a concern in randomized trials where
treatment is assigned at random, bias may still enter the equation through other means. For
example, outcomes attributable to a disease of interest may be aliased with outcomes caused
by other diseases when the symptoms associated with the disease are unspecific. Resulting
case definitions are usually inexact and can lead to substantial bias even in otherwise well
designed trials. Consequently, in both observational and randomized settings, anticipating
and addressing plausible patterns of unmeasured confounding should be an objective of any
research. In Chapters 2 through 5 we given four examples of how we address this objective
through developments in both statistical design and analysis.
Chapters 2 and 3 approach the issue of bias in matched-pair studies through analysis,
improving existing sensitivity analysis methods to more effectively address certain plausible
patterns of bias.
In Chapter 2, we introduce a sensitivity analysis framework that allows for the investigator
to interpret the sensitivity parameter as a bound on the average bias present in a matched-
pair study with binary outcomes (Hasegawa and Small, 2017). The new interpretation
resolves difficulties of the standard sensitivity analysis that bounds the maximal bias to
which pairs are subject, when the pattern of bias is presumed to be heterogeneous (Rosen-
baum, 1987). Specifically, when some pairs may suffer from arbitrarily large biases, but on
the average the study is more moderately biased, the average case sensitivity analysis will
be preferable to the standard approach. We motivate the method with a study of the effects
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of talking on a mobile phone on the incidence of car accidents (Tibshirani and Redelmeier,
1997).
In Chapter 3, we extend this framework using modern convex optimization tools to allow
for continuous outcomes and a simultaneous bound on both the maximal and average (or
typical) bias in a matched pair study. We call this the extended sensitivity analysis frame-
work (Fogarty and Hasegawa, 2019). In addition to bounding sample-level bias, extended
sensitivity analysis lets the investigator place bounds on the typical bias present in a su-
perpopulation from which the paired sample was drawn. This allows for calibration of a
sensitivity analysis in one study to information on confounding from another study whose
sample was generated from the same superpopulation as the first. We apply these new
methods to two sibling studies on the effects of education on future earnings. We calibrate
the extended sensitivity of one study where IQ data was not collected to an estimate of
bias introduced by differences in ability between siblings from the second study where IQ
data was collected. Empirically, the example suggests that ability bias is heterogeneous
across sibling pairs; the bias is typically modest but there is a small proportion of sibling
pairs where the differences in ability are quite large. We demonstrate that the extended
sensitivity analysis is better suited than the standard sensitivity analysis in such settings.
Through design, Chapter 3 addresses bias in comparative interrupted times series when the
parallel trends assumption of the standard difference-in-difference design fails because of an
interaction between history and the groups under comparison (Hasegawa et al., 2019). We
develop a difference-in-difference based design that allows for partial identification of causal
effects when the parallel trends assumption fails. We re-analyze a study of the repeal of
Missouri’s permit-to-purchase law and its effect on firearm homicide rates (Webster et al.,
2014) using our prosed method. The repeal occurred concurrently with the Great Recession
and there is concern that the firearm homicide trends in Missouri and the control states
may have been differentially affected by the onset of recession. Our method provides partial
identification of the repeal effect under mild assumptions about how the recession interacted
2
with the different groups.
Finally, in Chapter 5, we give another example of how improved design can mitigate con-
cerns of bias, this time in a randomized control trial to assess the efficacy of a malaria
vaccine. Symptoms of clinical malaria have significant overlap with the symptoms of other
common childhood illnesses. Furthermore, children in endemic areas are able to tolerate
varying levels of parasitemia without symptoms. Together, these facts make distinguishing
between malaria-attributable symptoms and non-malaria symptoms very challenging. In-
exact case definitions currently in use can substantially bias estimates of vaccine efficacy.
In this chapter, we leverage genetic traits that are protective against malaria but not other
childhood illnesses to identify vaccine efficacy in a randomized control trial. The sickle cell
trait is one such genetic variant that confers protection specifically against clinical malaria.
The method, which we call mendelian factorial design, is inspired by mendelian random-
ization studies that use genetic variants as instrumental variables to estimate causal effects
of non-randomized exposures. Under realistic assumption, this new study design allows for
identification of vaccine efficacy.
3
CHAPTER 2
Sensitivity Analysis for Matched Pair Analysis of Binary Data: From Worst Case to
Average Case Analysis
Abstract
In matched observational studies where treatment assignment is not randomized,
sensitivity analysis helps investigators determine how sensitive their estimated treat-
ment effect is to some unmeasured confounder. The standard approach calibrates the
sensitivity analysis according to the worst case bias in a pair. This approach will result
in a conservative sensitivity analysis if the worst case bias does not hold in every pair.
In this paper, we show that for binary data, the standard approach can be calibrated
in terms of the average bias in a pair rather than worst case bias. When the worst case
bias and average bias differ, the average bias interpretation results in a less conservative
sensitivity analysis and more power. In many studies, the average case calibration may
also carry a more natural interpretation than the worst case calibration and may also
allow researchers to incorporate additional data to establish an empirical basis with
which to calibrate a sensitivity analysis. We illustrate this with a study of the effects of
cellphone use on the incidence of automobile accidents. Finally, we extend the average
case calibration to the sensitivity analysis of confidence intervals for attributable effects.
2.1. Introduction
2.1.1. Sensitivity analysis as causal evidence
In matched-pair observational studies, causal conclusions based on usual inferential methods
(e.g., McNemar’s test for binary data) rest on the assumption that matching on observed
covariates has the same effect as randomization (i.e., that there are no unmeasured con-
founders). In other words, it is assumed that there are no unobserved covariates relevant to
both treatment assignment and outcome. A sensitivity analysis assesses the sensitivity of
results to violations of this assumption. Cornfield et al. (1959) introduced a model for sensi-
tivity analysis that was a major conceptual advance in the field of observational studies. A
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modern approach to sensitivity analysis is introduced in Rosenbaum (1987); Rosenbaum’s
approach builds on Cornfield’s model (Cornfield et al. (1959)) but incorporates uncertainty
due to sampling variance. There are other contemporary sensitivity analysis models, see
for example McCandless et al. (2007) for a Bayesian approach, but we restrict our focus to
Rosenbaum’s approach. Rosenbaum’s sensitivity analysis yields an upper limit on the mag-
nitude of bias to which the result of the researcher’s test of no treatment effect is insensitive
for a given significance level α. More specifically, Rosenbaum (1987) derives bounds on the
p-value of this test given an upper bound, Γ, on the odds ratio of treatment assignment
for a pair of subjects matched on observed covariates. Γ can be thought of as a measure
of “worst case” bias in the sense that treatment assignment probabilities in matched pairs
are allowed to vary arbitrarily as long as the odds ratio of treatment assignment for a pair
of subjects is no greater than Γ. The largest Γ for which the p-value is less than 0.05 is
denoted by Γsens. We will use Γtruth to distinguish the true unknown worst case bias. Γsens
is interpreted in Rosenbaum’s sensitivity analysis as the largest value of the worst case bias
across matched pairs that does not invalidate the finding of evidence for a treatment effect.
We refer to this as a worst case calibrated sensitivity analysis. A classic example of this type
of analysis is given in Chapter 4 of Rosenbaum (2002c). Applying the worst case sensitivity
analysis to a study of the effects of heavy smoking on lung cancer mortality (Hammond
(1964)), Rosenbaum finds that Γsens ≈ 6 and interprets this result cogently:
To attribute the higher rate of death from lung cancer to an unobserved covariate
rather than to an effect of smoking, that unobserved covariate would need to
produce a sixfold increase in the odds of smoking, and it would need to be a
near perfect predictor of lung cancer.
A brief, more formal review of Rosenbaum’s sensitivity analysis framework is in Section
2.2.2.
The worst case calibrated sensitivity analysis raises several potential questions. If we are
convinced that there is no pair in Hammond’s smoking study such that one unit is more than
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six times as likely to smoke as the other (i.e., Γtruth ≤ Γsens), then we would conclude that
our study provides convincing evidence that heavy smoking increases the rate of lung cancer
mortality. However, what if, on average, unmeasured confounders do not alter the odds of
smoking greatly but there are some subjects for whom the unmeasured confounders make
them almost certain to smoke, e.g., a subject who experiences huge peer pressure to smoke.
If such a subject ends up in our sample of matched pairs, and we condition on matched pairs
in which only one unit receives treatment, a standard practice when conducting matched
pair randomization tests, then the odds ratio of treatment assignment in the matched pair
containing that subject, and consequently Γtruth, will be infinite. In such a case, since
Γsens is generally finite, we’d expect it to be smaller than Γtruth. Now, suppose that there
are such pairs in the Hammond study but that for most pairs the odds ratio of smoking
between the units is much smaller than six. Using the worst case calibrated sensitivity
analysis, we would conclude that the study is sensitive to bias. Is there potentially some
natural quantification of average bias over the sample of matched pairs, say, Γ′truth, that
isn’t infinite and perhaps is smaller than six? And if we calibrate our sensitivity analysis to
this measure of bias rather than the worst case measure, will the sensitivity analysis be valid
in the sense that the inference is conservative at level α for any Γ ≥ Γ′truth? If it is valid,
are there other advantages to using the average case calibrated sensitivity analysis over the
worst case calibrated sensitivity analysis? In what follows, we attempt to answer these
motivating questions in the context of a matched pair analysis of the association between
cellphone use and car accidents.
2.1.2. Outline
In this paper we demonstrate that interpreting sensitivity analysis results in terms of average
case rather than worst case hidden bias is both valid and conceptually more natural in many
common scenarios. To illustrate our claim that the average case analysis is more natural
we will perform a causal analysis of a study by Tibshirani and Redelmeier (1997) that asks
if there is an association between cellphone use and motor-vehicle collisions. The study is
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described in the following section. In section 2.2 we review the model for sensitivity analysis
of tests of no treatment effect and sensitivity intervals for attributable effects for binary data.
In section 2.3 we discuss the theory behind the validity of average case sensitivity analysis.
Finally, the Tibshirani and Redelmeier (1997) study is examined in this new light in section
2.4. In particular, we see how the average case sensitivity analysis makes it possible to use
additional information from the problem to empirically calibrate our sensitivity analysis in
Section 2.4.1 and we extend the average case sensitivity analysis to the study of sensitivity
intervals for attributable effects in Section 2.4.3.
2.1.3. Motivating Example: Effects of cellphone use on the incidence of motor-vehicle col-
lisions
Tibshirani and Redelmeier (1997) conducted a case-crossover study of the effects of cellphone
use on the incidence of car collisions. In a case-crossover study each subject acts as her own
control which has the benefit of controlling for potential confounders that are time-invariant,
even if they are unobserved. Data collection took place at a collision reporting center in
Toronto between July 1, 1994 and August 31, 1995 during weekday peak hours (10 AM to 6
PM). Consenting drivers who reported having been in a collision with substantial property
damage and who owned a cellphone were included in the study. Drivers involved in collisions
that involved injury, criminal activity, or transport of dangerous goods were excluded. The
resulting study population included 699 individuals who gave permission to review their
cellphone records and filled out a brief questionnaire about their personal characteristics
and the features of the collision. The matched pair analysis compared cellphone usage in
the 10-minute hazard window prior to the crash with a 10-minute control window on a
chosen day prior to the crash. We will denote the time of the crash as t and the hazard
window as t− 10 to t− 1 minutes. The authors examined several different control windows:
1. Previous day : time t− 10 to t− 1 minutes on the previous day.
2. Previous weekday/weekend : time t− 10 to t− 1 minutes on the previous weekday if the
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crash took place on a weekday and similarly if the crash took place on a weekend.
3. One week prior : time t− 10 to t− 1 minutes one week prior to the collision.
4. Busiest cellphone day of previous three days: time t − 10 to t − 1 minutes on the one
day among the prior three to the collision with the most cellphone calls.
For each choice of control window, Tibshirani and Redelmeier (1997) found that there was
a significant positive association between cellphone usage and traffic collision incidence.
The 2 x 2 contingency tables shown in Table 1 summarize the data using the four different
control windows.
Control
On phone Not on phone
Previous Weekday/end
Hazard
On phone 12 158
Not on phone 23 506
One Week Prior
Hazard
On phone 6 164
Not on phone 21 508
Previous Driving Day
Hazard
On phone 18 119
Not on phone 20 171
Most Active Cellphone Day
Hazard
On phone 17 135
Not on phone 43 504
Table 1: One Week Prior: results for one week prior control window versus hazard
window;Previous Weekday/end: results for previous weekday/weekend control window
versus hazard window; Previous Driving Day: results for previous driving day control
window versus hazard window;Most Active Cellphone Day: results for most active
cellphone day in previous 3 days control window versus hazard window.
2.1.4. Sensitivity of results to hidden bias
As this was an observational study, the associations cannot be assumed to be causal. We
would like to quantify how large a hidden bias would have to be to explain the observed
association between cellphone use and car accidents without it being causal. A sensitivity
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analysis seems appropriate and is a straightforward exercise (see Chapter 4, Rosenbaum
(2002c) for example). Table 2 shows the results of a standard worst case sensitivity analysis
for each control window. Here, Γsens is the largest value of Γ such that the result are still
significant at the α = 0.05 level. In our analysis of the case-crossover study from Tibshirani
and Redelmeier (1997) we condition on subjects who were on a cellphone in exactly one of
the control and hazard windows (i.e., discordant case-crossover pairs). Thus, the odds ratio
of treatment assignment for the two windows observed for any case-crossover subject can
be viewed as the conditional odds that treatment occurs in a particular window. Hence,
we can interpret Γ as the maximum (and 1/Γ as the minimum) over all study subjects of
the odds that a driver is using a cellphone during the hazard window and not during the
control window.
Control Window Γsens
previous weekday/weekend 4.92
one week prior 5.53
previous driving day 4.15
most active cellphone day 2.40
Table 2: Sensitivity analysis for (marginal) α = 0.05.
The sensitivity analysis suggests that the most active cellphone day control window was the
most conservative analysis. This is unsurprising since we would expect that the treatment
assignment (cellphone use) would be biased toward the control window on a day when you
used a cellphone relatively often. We can interpret these results as follows: the observed
ostensible effect is insensitive to hidden bias that increases the odds that a driver was on
a cellphone in the hazard window and not the control window on the most active cellphone
day by at most a factor of 2.4. In many observational studies this type of statement is
very useful. However, it may be plausible that some study participants are exposed to
infinite (or at least very large) hidden bias. For example, this happens if a subject was not
driving during the control window and (almost) always uses her landline rather than her
cellphone when she is not driving. When we condition on case-crossover pairs where the
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treatment is received in exactly one of the windows – a standard practice when conducting a
matched pair randomization test – such a driver is always on a cellphone during the hazard
window. When this happens, the observed ostensible effect is (almost) always sensitive to
hidden bias, no matter how strong the observed association. Implicitly, in the worst case
sensitivity analysis, the investigator is supremely skeptical; she assumes that it could be that
all study participants suffer from the worst case hidden bias which, when it is possible that
some study participant suffers from unbounded hidden bias, renders sensitivity analysis
under the standard worst case interpretation uninformative. Yet in many studies where
unbounded hidden bias in some matched pairs is plausible, as in our motivating example,
we still want to examine the sensitivity of our results to potential hidden bias. If we
could perform a valid, average case calibrated sensitivity analysis then we could (1) make
sensitivity analysis informative even in the presence of pairs subject to unbounded hidden
bias and (2) make the interpretation of sensitivity analysis results far less conservative. It
turns out that there is a measure of the sample average bias that is generally finite in the
presence of pairs subject to unbounded bias for data with binary treatment and outcome.
Moreover, the sensitivity analysis calibrated to this measure of average bias is valid when
using McNemar’s statistic to test the null hypothesis of no treatment effect against the
alternative of a positive treatment effect (i.e., that talking on a cellphone while driving
increases the rate of automobile accidents).
2.2. Notation and Review
2.2.1. Notation
Our study sample consists of S matched pairs where each pair s = 1, 2, . . . , S is matched on a
set of observed relevant covariates xs1 = xs2 = xs. Units in each pair are indexed by i = 1, 2.
We let Zsi and Rsi denote the treatment assignment and outcome, respectively, of the i-th
unit of the s-th pair. The potential outcomes under treatment and control are denoted
as rTsi and rCsi, respectively. Hence, we can write Rsi = ZsirTsi + (1 − Zsi)rCsi. Under
Fisher’s sharp null hypothesis of no treatment effect, i.e., rTsi = rCsi for all i, we have that
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Rsi = rCsi. Hereafter, we will work under the null hypothesis and under the assumption that
each pair was matched on some set of observed covariates xs. Additionally, we assume that
there is some unobserved covariate Usi that is associated with both treatment assignment
and outcome and let usi be the realization of Usi for the i-th unit of the s-th pair. Within pair
differences in treatment and outcome will be denoted as Vs = Zs1−Zs2 and ys = rCs1−rCs2.
It will be convenient to define the following vector quantities: Z = (Z11, Z12, . . . , ZS2)
T ,
r = (rC11, rC12, . . . , rCS2)
T ,U = (U11, U12, . . . , US2)
T , and A = (|y1|, |y2|, . . . , |yS |)T .
To be very clear about the information on which we are conditioning we will define some
important information sets. Let F = {(xs, usi, rCsi, rTsi) : s = 1, 2 . . . , S, i = 1, 2} be the
set of fixed observed and unobserved covariates for all units. Let Z = {Z : |Vs| = 1, s =
1, . . . , S} be the set of matched pairs such that only one unit receives treatment. We assume
that R is binary and we define A1 = {A : |ys| = 1, s = 1, . . . , S}. So Z ∩ A1 is the set of
discordant matched pairs. In the analysis that follows, we will condition on F , Z ∩A1.
2.2.2. Review: sensitivity analysis for binary data
Under the assumption that all variables that confound treatment assignment are observed,
Zsi⊥⊥(rCsi, rTsi) |Xs (Ignorability)
our matched observational study should closely resemble a randomized study and thus
P(Z = z| F , Z ∩A1) = 1/2S for z ∈ Z. In practice, this assumption is rarely valid and the
probability of treatment assignment depends materially on the unobserved covariates U.
A second assumption made in the causal framework introduced in Rosenbaum and Rubin
(1983) is the Positivity assumption – 0 < P(Zsi = 1|Xs) < 1 for all s = 1, 2, . . . , S and
i = 1, 2 – which says that all units have a chance of receiving treatment. In our case-
crossover study, however, this may not be an appropriate assumption. We introduce an
example of how our case-crossover study might violate the positivity assumption in Section
2.4.1 and how our average case sensitivity analysis framework is able to handle violations
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of positivity.
When both Z and r are binary it is common to use McNemar’s statistic to test for treatment
effect:
Definition 1. For a matched pair study with binary treatment and outcome we define
McNemar’s statistic to be
T (Z, r) =
S∑
s=1
1{VsYs = 1} . (2.1)
Under the null distribution of no treatment effect T (Z, r) follows a Poisson-Binomial dis-
tribution with probabilities {p1, p2, . . . , pS} where ps = P((Zs1 − Zs2)(rs1 − rs2) = 1) is the
probability that the unit with positive outcome, i.e., r = 1, receives treatment in pair s. If
we consider only discordant pairs and we assume, without loss of generality, that the first
unit in each pair is the unit with positive outcome we may write
ps = P(Zs1 = 1|F , Z ∩A1) . (2.2)
Recall that the Poisson-Binomial distribution is the sum of independent, not necessarily
identical Bernoulli trials. If Xs contains the complete set of relevant covariates then ps
equals 1/2 for all pairs and we can conduct inference using B(1/2, S) as our null distri-
bution, effectively treating our data as being the outcome of a randomized study. As we
mentioned earlier in this section, if there is some unobserved characteristic U that is relevant
to treatment assignment and outcome then {p1, . . . , pS} are unknown and consequently the
exact null distribution is no longer available to the investigator. When this is the case,
a sensitivity analysis like the one conducted informally in Section 2.1.4 can be used to
determine how sensitive the investigator’s conclusions are to departures from the ideal ran-
domized design. Following Chapter 4 of Rosenbaum (2002c) we can formalize the notion of
a sensitivity analysis introduced in Sections 2.1.1 and 2.1.4 with a simple sensitivity model
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where
1
1 + Γ
≤ P(Zs1 = 1|F , Z ∩A1) ≤ Γ
1 + Γ
(2.3)
for all s = 1, . . . , S and where Γ ≥ 1 is the sensitivity parameter that bounds the extent
of departure from a randomized study. Proposition 12 in Chapter 4 of Rosenbaum (2002c)
states that (2.3) is equivalent to the existence of the following model
log
(
ps
1− ps
)
= γ (us1 − us2) , s = 1, . . . , S (2.4)
where exp(γ) = Γ, γ ≥ 0, and usi ∈ [0, 1] for s = 1, . . . , S and i = 1, 2. The restriction of
the unobserved confounder to the unit interval in this equivalent representation preserves
the non-technical interpretation of Γ used in section 2.1.4 as a bound on the odds that the
driver was talking on a cellphone in the hazard window. Henceforth, we assume that Usi
and its realization usi belongs to the unit interval for s = 1, . . . , S and i = 1, 2. However,
the distribution of Usi on the unit interval may be arbitrary.
Under this sensitivity model, if we let T+ be binomial with success probability Γ/(1+Γ) and
T− be binomial with success probability 1/(1+Γ) it follows from Theorem 2 of Rosenbaum
(1987) that
P
(
T− ≥ k) ≤ P(T ≥ k|F , Z ∩A1) ≤ P(T+ ≥ k) (2.5)
for all k = 1, . . . , S. This inequality is tight in the sense that it holds for any realization u of
U. For conducting a hypothesis test, the stochastic ordering in (2.5) gives us bounds on the
p-value of our test for a given magnitude of bias Γ. If Γ ≥ Γtruth, then T+ yields a valid,
albeit conservative, reference distribution for testing the null hypothesis of no treatment
effect against the alternative of a positive treatment effect.
2.2.3. Attributable effects for binary outcomes: hypothesis tests and confidence intervals
Attributable effects are a way to measure the magnitude of a treatment effect on a binary
outcome. The number of attributable effects is the number of positive outcomes among
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treated subjects that would not have occurred if the subject was not exposed to treatment.
In this section, we review Rosenbaum (2002a)’s procedure to construct one-sided confidence
statements about attributable effects in the context of the cellphone case-crossover study.
Let S˜ be the number of all pairs in the study, discordant or not, and let the first S be the
discordant pairs. If we assume that rTsi ≥ rCsi, that talking on a cellphone cannot prevent
an accident, then we can write the attributed effect as
A =
S˜∑
s=1
2∑
i=1
Zsi(rTsi − rCsi) =
S˜∑
s=1
Zs1(rTs1 − rCs1) (2.6)
where the first unit of s-th pair is the observation from the hazard window. Why does the
second equality hold? If the subject was talking on a cellphone in the control window, that
is Zs2 = 1, then we observe rTs2 = 0 which by our assumption that talking on a cellphone
cannot prevent an accident implies that rCs2 = 0. So attributable effects can only occur
among discordant pairs where the subject was talking on a cellphone in the hazard window
or concordant pairs where the subject was talking on a cellphone in both windows. The
following table characterizes the four types of possible pairs in our case-crossover study,
Zs1 Zs2 Rs1 Rs2 rTs1 rCs1
D(+,−) 1 0 1 0 1 -
D(−,+) 0 1 1 0 1 1
C(−,−) 0 0 1 0 1 1
C(+,+) 1 1 1 0 1 -
Table 3: The four possible types of pairs in our case-crossover study. D and C indicate
discordant and concordant pairs, respectively, and the + and − indicate if a unit in the pair
was treated or not, respectively.
D and C indicate discordant and concordant pairs, respectively. D(+,−) is the set of
discordant pairs where the subject was on a cellphone in the hazard window, D(−,+) is
the set of discordant pairs where the subject was on a cellphone in the control window,
C(+,+) is the set of concordant pairs where the subject was on a cellphone in both hazard
and control windows, and C(−,−) is the set of concordant pairs where the subject was not
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on a cellphone in either window. If there are no attributable effects then we know that
rCs1 = 1 in D(+,−) and C(+,+) and we have that Rs1 = rCs1 for all pairs s, concordant
or discordant. We can write the probability that the subject was talking on a cellphone at
the time of accident for each type of pair as (1) P(Zs1Rs1 = 1|D(+,−) ∪D(−,+)) = ps,
where ps here is equivalent to the ps defined in Section 2.2.2 when there are no attributable
effects; (2) P(Zs1Rs1 = 1|C(−,−)) = 0; and (3) P(Zs1Rs1 = 1|C(+,+)) = 1. Now let
c+ = |C(+,+)| denote the cardinality of the set of concordant pairs where the subject was
on a cellphone in both windows and let s = S + 1, . . . , S + c+ be the pairs belonging to
C(+,+). Then if A = 0 we can define the standardized deviate for McNemar’s statistic T
as
T˜ =
∑S
s=1 Zs1rCs1 −
∑S
s=1 ps{∑S
s=1 ps(1− ps)
}1/2
=
∑S+c+
s=1 Zs1Rs1 −
(∑S
s=1 ps + c
+
)
{∑S
s=1 ps(1− ps)
}1/2 . (2.7)
T˜ defines a normal reference distribution for
∑S
s=1 Zs1rCs1 that we can use to conduct
approximate inference. If A = a > 0, then Zs˜1Rs˜1 = Zs˜1rT s˜1 = Zs˜1(rCs˜1 + 1) for pair s˜
belonging to the set of a pairs with attributable accidents and the second equality above
does not hold. When this equality fails to hold, the standard normal deviate T˜ cannot
be computed from the observed data conditional on F . How then can we adjust T˜ for
attributable accidents so that it can be computed from the observed data? Because we’ve
assumed talking on a cellphone cannot prevent an accident, we only need to consider two
cases. If pair s˜ belongs to D(+,−) then we subtract Zs˜1(rT s˜1−rCs˜1) = 1 from
∑S˜
s=1 Zs1Rs1,
ps˜ from the expectation, and ps˜(1− ps˜) from the variance term. If s˜ belongs to C(+,+) we
again subtract 1 from
∑S˜
s=1 Zs1Rs1 and subtract 1 from the |C(+,+)| in the expectation
while leaving the variance term unchanged.
Let δ = (δ11, δ12, . . . , δS˜1, δS˜2)
T be defined as δsj = rTsj − rCsj . We say that δ is compatible
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if δsj = 0 whenever Zsj = 1 and Rsj = 0 or Zsj = 0 and Rsj = 1. Under this definition, we
can express the number of attributable effects as A = ZTδ. For a compatible δ such that
ZTδ = a we denote T˜−δ to be T˜ adjusted for the a attributable effects. T˜−δ defines a new
reference distribution for
∑S
s=1 Zs1rCs1 under the null hypothesis that potential accidents
indicated by δ are attributable to talking on a cellphone while driving. We can write T˜−δ
as
T˜−δ =
∑S+c+
s=1 Zs1Rs1(1− δs1)−
(∑S
s=1(1− δs1)ps +
∑S+c+
s=S+1(1− δs1)
)
{∑S
s=1(1− δs1)ps(1− ps)
}1/2 . (2.8)
Using the notion of asymptotic separability (Gastwirth et al. (2000)), Rosenbaum (2002a)
show that choosing a compatible δ∗ ≡ δ∗(a) with ZTδ∗(a) = a that maximizes the expecta-
tion, and when there are ties to maximize the variance term, yields a reference distribution
that, asymptotically, has the largest upper tail area among compatible δ(a). Thus, we can
use T−δ∗ to test the plausibility that there are at most a attributable effects. Since A is a
random variable we refrain from calling this a hypothesis test, a term usually reserved for
unknown parameters. From equation (2.8) we see that δ∗(a) includes the a pairs in D(+,−)
with the smallest values of ps.
It is possible to invert the one-sided “plausibility tests” introduced above using T−δ∗ that
we just introduced in order to construct a confidence interval for attributable effects of the
form {A : A > a}. It turns out that if it is plausible that there are a attributable effects
then it is also plausible that there are a+ 1 attributable effects (Rosenbaum (2002c)). This
monotonicity property leads to a very simple procedure to construct a one-sided confidence
interval in the absence of hidden bias. First, if ps = 1/2 for all s = 1, 2, . . . , S˜ then for any
a ≥ 0 we can compute T˜−δ∗ = {T − a− (S − a)/2}/{(S − a)1/2/2}.
Next, starting with a = 0 we check if T˜−δ∗ < Φ−1(1 − α), incrementing a by one if it
isn’t and stopping if it is. Finally, let a∗ be equal to one less the value of a at which we
terminate the procedure. Using the monotonicity result above we have that {A : A > a∗}
is a one-sided 100× (1− α)% confidence interval.
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If we bound the worst case calibrated bias above by Γ then we can construct a one-sided
100× (1−α)% confidence interval following the same procedure but instead using T˜−δ∗,Γ =
{T−a−(S−a)pγ}/{(S−a)pγ(1−pγ)}1/2 as our standard deviate where pγ = Γ/(1+Γ). The
resulting one-sided 100× (1−α)% confidence interval is referred to as a sensitivity interval
(See Chapter 4, Rosenbaum (2002c)). For a detailed illustration of these procedures we
refer the reader to Sections 3-6 of Rosenbaum (2002a).
2.3. From Worst Case to Average Case Sensitivity Analysis
2.3.1. Valid average case analysis: binary outcome
An investigator conducting a sensitivity analysis tries to determine a test statistic whose
null distribution is known conditional on the presence of hypothetical bias Γ. Since the
distribution of Usi is unknown, traditionally, the investigator assumes the worst. That is,
the null distribution is constructed assuming that in each pair us1 = 1 and us2 = 0. As
noted in Section 2.2.2, T+ yields a valid reference distribution for testing the null of no-
treatment effect when Γ ≥ Γtruth. However, such a test is inherently conservative because it
is designed to be valid for any realization of U since U and thus since p = (p1, . . . , pS)
T are
generally unknown. This is why we resort to a sensitivity analysis where we allow ps to vary
arbitrarily as long as ps/(1 − ps) ≤ Γ. In Section 2.1.1 we asked whether there was some
natural quantification of average bias to which we could calibrate our sensitivity analysis
which would lead to a less conservative analysis than the worst case calibration. One such
quantification is Γ′truth = p/(1−p) where p is the sample average of ps. In what follows, we
show that if we calibrate our sensitivity analysis to Γ′truth it will be valid and less conservative
than the worst case calibration. To prove this, we show that T ′ ∼ B(Γ′truth/(1 + Γ′truth), S)
yields a valid reference distribution for testing the null of no treatment effect against the
alternative of a positive treatment effect. In Theorem (2) below, we prove that the upper
tail probability for McNemar’s statistic T is bounded above by the upper tail probability
for T ′.
Theorem 2. Set p =
(∑S
s=1 ps
)
/S and Γ′truth = p/(1−p) and let Vs
iid∼ Bern(Γ′truth/(1 +
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Γ′truth)) for all s = 1, 2, . . . , S. Define T
′ = V1 + · · ·+ VS. Then
Pr(T ≥ a|F , Z ∩A1) ≤ Pr
(
T ′ ≥ a) for all a ≥ Sp .
Proof. Observe that p majorizes p · 1 and note that if a function f(p) is Schur-convex in
p then f(p) ≥ f(p1). What remains to be shown is that the distribution function for a
Poisson-Binomial is Schur-convex in p. See Gleser (1975) for this approach and Hoeffding
(1956) for the original proof. The theorem as stated is an immediate corollary of Theorem
4 in Hoeffding (1956). Gleser (1975) presents a more general version of this result which
holds when the success probabilities of T majorize those of T ′.
Remark 1. Theorem (2) is a finite sample result whose proofs we refer to are both rather
technical. An analogous asymptotic result follows from much simpler arguments. The vari-
ance of a Bernoulli random variable with success p can be written as f(p) = p(1− p). f is
clearly concave and thus by Jensen’s Inequality, Var(T ) ≤ Var(T ′). Since the expectation
of T and T ′ are equal, using a normal approximation to the exact permutation test will
asymptotically yield the same stochastic ordering as in Theorem (2).
Remark 2. It is important to note that Γ′truth ≤ Γtruth since ps/(1 − ps) ≤ Γtruth for
s = 1, . . . , S. Consequently, we have that Pr(T ′ ≥ a) ≤ Pr(T+ ≥ a) which implies that
sensitivity analysis with respect to Γ′, the average case calibrated sensitivity analysis, is less
conservative than the worst case calibrated sensitivity analysis with respect to Γ.
The implication of this theorem is that it is safe to interpret a sensitivity analysis in terms
of Γ′, an upper bound on the sample average hidden bias (p/(1− p)). For example, when
using the most active cellphone day control window we have Γsens = 2.4. Previously, we
would say that if no case-crossover pair was subject to hidden bias larger than 2.4, then the
data would still provide evidence that talking on a cellphone increases the risk of getting in
a car accident. Now, some case-crossover pairs may be subject to hidden bias (much) larger
than 2.4, as long as the sample average hidden bias is no larger than 2.4. It is important to
note that this interpretation is only valid for binary outcomes. The proof relies on Schur-
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convexity of the distribution function of our test statistic with respect to p which requires
that it be symmetric in p. For more general tests, such as the sign-rank test, this is not the
case.
Some additional applications of Theorem 2 can be found in the Appendices. Appendix A
considers the case when Us1 and Us1 measure some time-varying propensity of subject s to
use his cellphone. Using Theorem 2 we develop a little theory and a numerical example.
Appendix B provides details on how Theorem 2 can be applied when U is not restricted to
the unit interval.
2.4. The Effect of Cellphone Use on Motor-vehicle Collisions
In this section we return to our motivating example to see how our average case theory can
provide interpretive assistance to our standard sensitivity analysis we carried out in Section
2.1.4 and allow us to incorporate additional information to empirically calibrate our average
case sensitivity analysis.
2.4.1. Driving intermittency
The study conducted in Tibshirani and Redelmeier (1997) did not have access to direct
information on whether an individual was driving during the control window. The authors
examine the effect of driving intermittency during the control window on their relative-risk
estimate by bootstrapping the estimate using an intermittency rate of ρ̂ = 0.65. In other
words, they correct for bias due to the possibility that a subject was not driving during the
control window. The intermittency rate was estimated using a survey asking 100 people
who reported car crashes whether they were driving at the same time the previous day.
Alternatively, one may ask a related question in the context of a sensitivity analysis - does
the bias due to driving intermittency explain the observed association between cellphone
usage and traffic incidents? Given that the study took place in the early 1990s when, for
some cellphones and carphones were synonymous, it would not be surprising if many study
participants (almost) always used their landlines rather than their cellphones when not
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driving, violating the positivity assumption. Therefore, the only plausible Γtruth is infinite
(or at least very large) when conditioning on case-crossover pairs where the subject is on her
cellphone in only one of the two windows. This renders the worst case sensitivity analysis
uninformative. No magnitude of association between cellphone use and car accidents would
convince us that the relationship was causal if we stuck to the worst case calibration of the
sensitivity analysis. The average case calibration, on the other hand, still has a chance. We
can use our estimate ρ̂ to approximate a plausible value of p, p = (1− ρ̂) ·1+ ρ̂ ·0.5 = 0.675,
and a corresponding plausible value of Γ′truth, Γ
′
truth = p/(1 − p) = 2.1 . Theorem (2)
circumvents the conceptual hurdle of unbounded Γtruth and allows us to confidently use a
sensitivity analysis to quantitatively assess the causal evidence. Moreover, it allows us to
incorporate information about ρ into our analysis. If the association between cellphone use
and motor vehicle collisions is causal in nature, our empirical calibration suggests that our
test for treatment effect should be insensitive to unobserved biases with magnitude Γ′ ≈ 2.1.
2.4.2. An alternative approach to handling pairs with unbounded bias
There are other approaches to dealing with the example of infinite bias we just presented.
For instance, the investigator may be more confident in specifying an upper bound on the
worst case bias to be finite, Γ <∞, for a proportion 1−β of the matched pair sample than
he is in working in terms of the average case bias. If he has a good sense of what proportion
β of the pairs is exposed to unbounded bias he may drop β × S pairs where the treated
unit had positive outcome and perform the standard worst case sensitivity analysis on the
remaining (1 − β) × S pairs. Rosenbaum (1987) proved that this method yields a valid
sensitivity analysis. This strategy would be particularly suited for the example of driver
intermittency discussed above. However, this approach assumes this particular pattern of
unmeasured confounding is present and driver intermittency is just one of many sources of
potential bias. On the other hand, the average case analysis accomodates arbitrary patterns
of bias that may lead to large differences in average and worst case biases.
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2.4.3. Average case sensitivity analysis for attributable effects
How many of the recorded accidents in our study can be attributed to the driver talking on
a cellphone? Recall from Section 2.2.3 that the set indicated by δ∗ includes the a pairs in
D(+,−) with the smallest values of ps. Although we cannot compute T˜−δ∗ and thus cannot
use it directly to conduct inference, we can compute a lower bound that we will show can
be used to perform an average case sensitivity analysis:
T˜−δ∗ =
∑S
s=1 Zs1rCs1 −
∑S
s=1(1− δ∗s1)ps{∑S
s=1(1− δ∗s1)ps(1− ps)
}1/2
=
∑S
s=1 Zs1Rs1(1− δ∗s1)−
∑S
s=1(1− δ∗s1)ps{∑S
s=1(1− δ∗s1)ps(1− ps)
}1/2
=
T − a− (S − a)p(a){∑S
s=1(1− δ∗s1)ps(1− ps)
}1/2
≥ T − a− (S − a)p(a)
{(S − a)p(a)(1− p(a))}1/2
= T˜ (p(a)) (2.9)
where p(a) =
∑S
s=1(1− δ∗s1)ps/(S−a). The last inequality follows from Jensen’s inequality
applied to the variance term in the denominator. Notice that instead of applying Theorem
(2) in order to derive a sensitivity analysis in terms of the average bias we use the simpler
argument in Remark (1). Now note that if ps ≥ p∗ for all s = 1, . . . , S then we can relate
the trimmed average probability, p(a), to p as follows
p ≥ (S − a)p(a) + a·∗
S
= q(a) . (2.10)
We can use this relationship to construct a simple procedure – mirroring that of Section
2.2.3 – to perform an average case calibrated sensitivity analysis for one-sided confidence
intervals of the form {A : A > a} that yields average case calibrated sensitivity intervals.
The procedure can be summarized as follows,
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1. Choose a desired average calibrated sensitivity parameter Γ′.
2. For a = 0 solve q(a) = Γ′/(1 + Γ′) for p(a) and denote the solution p(a, γ′). Compute
T˜ (p(a, γ′)).
3. If T˜ (p(a, γ′)) < Φ−1(1− α) then conclude it is plausible that none of the accidents can
be attributed to talking on a cellphone.
4. Else, repeat steps (2) and (3) for a = 1, . . . , S stopping when T˜ (p(a, γ′)) < Φ−1(1−α).
Let a∗ = a− 1.
5. Return the 100 × (1 − α)% sensitivity interval {A : A > a∗} and conclude that it is
plausible that more than a∗ of the accidents are attributable to talking on a cellphone
when exposed to an average bias of at most Γ′.
Just as in the simple test for no treatment effect, we see that we have a nearly identical
procedure to the worst case sensitivity analysis with an average interpretation of the bias
parameter. In fact, the procedure also yields a corresponding worst case calibration for
the computed sensitivity interval. Under the worst case calibration, the sensitivity interval
from step (5) would correspond to a worst case bias Γ = p(a∗, γ′)/(1− p(a∗, γ′)).
How might we apply this procedure to our example? For a given control window we would
like to make confidence statements such as, at the 95% level it is plausible that there are a∗
or more accidents attributable to talking on a cellphone. Recall the empirically calibrated
average case bias from Section 2.4.1, Γ′ ≈ 2.1. We may also be interested making sensitivity
statements such as, if the average probability of talking on a cellphone during the hazard
window is at most 2.1 times that of talking on a cellphone in the control window for drivers
in our study, Γ′ = 2.1, it is plausible at the 95% level that there are a∗ or more accidents
attributable to talking on a cellphone. Table 4 summarizes the plausible range of attributable
accidents for each of the four different control windows. For all four control windows we
set Γ′ = 2.1. The first column is the number of discordant pairs in which the driver was on
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a cellphone during the control window. The second column reports the lower bound a∗ of
the one-sided sensitivity intervals for α = 0.05 We also report the corresponding worst case
calibrated bias in the last column of Table 4. In the cellphone study we have no convincing
reason to believe that p∗ > 0 but in other examples, it may make sense that ps is bounded
from below, which has the effect of making the procedure less conservative.
Control Window |D(+,−)| a∗ Γ′ Γ
previous weekday/weekend 158 28 2.1 4.04
one week prior 164 31 2.1 4.37
previous driving day 119 18 2.1 3.51
most active cellphone day 134 5 2.1 2.3
Table 4: Sensitivity analysis for 95% one-sided confidence intervals for attributable effects
of the form {A : A > a∗}. Γ′ indicates the average calibration bias that we specify for the
procedure and Γ is the implied worst case calibration that corresponds to the computed
interval. We assume that p∗ = 0 .
We find that even if the average probability of talking on a cellphone during the hazard
window was at most 2.1 times that of talking on a cellphone on the same day one week prior,
it is plausible that there are 31 or more accidents attributable to talking on a cellphone. The
implied worst case bias associated with this statement is Γ = 4.37. What this means is that
we would arrive at the same conclusion about the number of plausible attributable accidents
if we put an upper bound on the worst case bias of Γ = 4.37 and followed the standard
confidence interval procedure for attributable effects outlined in Section 2.2.3 and Gastwirth
et al. (2000). Unlike the sensitivity analysis for the simple test for no treatment effect, the
average case calibrated sensitivity analysis for attributable effects is not guaranteed to be less
conservative than the worst case calibration. For a 95% sensitivity interval for attributable
effects generated by our procedure where a∗ > 0, the corresponding upper bound on the
average case bias Γ′ is less than the corresponding upper bound on the worst case bias Γ.
This occurs since we do not know which pairs contain attributable effects nor do we know
each pair’s particular exposure to hidden bias. Without any further assumptions, the best
lower bound for Γ′ assumes that all the a pairs with attributable effects have arbitrarily
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small probability of being on a cellphone in the hazard window and not the control window.
This is expressed mathematically in equation (2.10) by setting p∗ = 0. If Γ′truth < Γtruth
– which is a reasonable assumption in most circumstances – then using the average case
calibration may still result in a less conservative analysis. However, if all case-crossover pairs
are exposed to the same magnitude of bias such that Γ′truth = Γtruth then we are guaranteed
to be less conservative by using the worst case calibration. A reasonable solution would be
to simply supply both the Γ′ and Γ when reporting a sensitivity interval, as we do in Table
4. The investigator may then present an argument based on subject matter expertise as to
which calibration is likely to be less conservative.
2.5. Discussion
The theorem presented in 2.3.1 can be thought of as an interpretive aid: For the same
standard sensitivity analysis we now have an additional, often more natural, way to interpret
the results. This new average case interpretation may also allow researchers to make use of
additional information about the problem to empirically calibrate their sensitivity analysis.
As we saw in Section 2.4.1, we used the estimate of driver intermittency rate to determine
an approximate lower bound on Γ′truth, providing us with some empirical guidance when
conducting our sensitivity analysis. In the worst case setting, such an empirical calibration
would not be possible. The investigator performs a sensitivity analysis in anticipation
of critics who might claim the association is due to some unobserved confounder. The
average case analysis makes the protection that the sensitivity analysis provides against such
criticism more robust. As the title of the article makes clear, the results we present are for
binary data. As we illustrated in Section 2.4.3, the notion of attributable effects allows us to
construct interpretable confidence intervals for binary outcomes. We show that our average
case calibration can be extended to the sensitivity analysis of such confidence intervals and
in most cases will yield a less conservative conclusions. It may then be interesting to apply
the results here to the sensitivity analysis of displacement effects, the continuous analog of
attributable effects for non-binary outcomes. Rosenbaum (2002a) show that displacement
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effects can be analyzed in the attributable effect framework for binary response, providing
a potential avenue to extend average case calibrated sensitivity analysis to a study with
non-binary outcomes.
2.6. Appendix
2.6.1. Appendix A
Time-varying propensity for cellphone use
After conditioning on the time-invariant driver characteristics X, it may be natural to
model Usi as a time-varying propensity quantile for using a cellphone in the hazard window
(i = 1) and in the control window (i = 2). Usi could summarize an arbitrary number of
confounding variables that vary between control and hazard windows for driver s. As a
quantile, we can think of Usi as coming from a uniform distribution on [0, 1]. Us1 and Us2
can conceivably be considered independent since by design a case-crossover study controls
for all individual, time-invariant confounders. Now, suppose that we conduct a sensitivity
analysis that returns Γsens. If we interpret this as an average case hidden bias we may
want to ask how large we would expect the corresponding worst case hidden bias to be.
If we assume the the Usi are propensity quantiles that are iid uniformly distributed we
can compute a lower bound for the expected worst case hidden bias corresponding to the
average case calibrated Γsens. Let Σ be the set of all permutations of {11, 12, . . . , S1, S2}
and let σ ∈ Σ be an element in the set. Now define γ∗(U) to be the solution to
Γsens/(1 + Γsens) = sup
σ∈Σ
{
1
S
S∑
s=1
exp(γ(Uσ(s1) − Uσ(s2)))
1 + exp(γ(Uσ(s1) − Uσ(s2)))
}
. (2.11)
The right hand side of this equation inside the supremum operator is an expression for p¯
under the sensitivity model defined in Section 2.2. The following proposition and corollary
show that Γ∗ = exp(γ∗(U)) is a lower bound for the worst case calibrated hidden bias
corresponding to the average case calibrated Γsens given U.
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Proposition 1. With probability one γ∗(U) is the unique solution of (2.11) and the smallest
γ that satisfies
Γsens/(1 + Γsens) =
1
S
S∑
s=1
exp(γ(Uσ(s1) − Uσ(s2)))
1 + exp(γ(Uσ(s1) − Uσ(s2)))
for some σ ∈ Σ.
Proof. It suffices to show that the right hand side of (2.11) is strictly increasing in γ with
probability one. Consider 0 ≤ γ1 < γ2 and let σ1 be the permutation that maximizes
f(σ, γ1,U) =
1
S
S∑
s=1
exp(γ1(Uσ(s1) − Uσ(s2)))
1 + exp(γ1(Uσ(s1) − Uσ(s2)))
.
Assuming that the Usi are iid uniform, U is nonconstant with probability one. If U is
nonconstant then f(σ1, γ1,U) < f(σ1, γ2,U) since Uσ(s1) − Uσ(s2) > 0 for at least one
s = 1, . . . , S. If we let σ2 be the permutation that maximizes f(σ, γ2,U) then we have that
f(σ1, γ1,U) < f(σ2, γ2,U), completing the proof.
Corollary 3. Under the sensitivity model defined in Section 2.2, Γ∗ = exp(γ∗(U)) is a
lower bound for the worst case calibrated hidden bias corresponding to the average case
calibrated Γsens given U.
Using Corollary 3 we can determine the expected lower bound on the worst case hidden
bias corresponding to the average case calibrated Γsens by computing E[Γ∗] via Monte
Carlo estimation. The expectation here is taken over U ∼ U [0, 1]2S . Under this propensity
quantile model for the unobserved confounders, this procedure can give us a sense of how
much less conservative the average case calibration is than the worst case calibration. In
the table below we give Monte Carlo estimates and standard errors for E[Γ∗] corresponding
to the average case calibrated Γsens for each of the four control windows.
For each control window we find that the average case interpretation is significantly less
conservative than the worst case interpretation. For example, using the worst case calibrated
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Control Window Γsens E[Γ∗]
previous weekday/weekend 4.92 24.76 (0.08)
one week prior 5.53 31.42 (0.11)
previous driving day 4.15 17.66 (0.06)
most active telephone day 2.40 5.81 (0.01)
Table 5: Sensitivity analysis for (marginal) α = 0.05 and the expected lower bound on
corresponding worst case calibrated bias E[Γ∗]. Standard errors for Monte Carlo estimates
are in parentheses.
sensitivity analysis we can conclude that if no case-crossover pair was subject to hidden bias
larger than 4.15, there is still significant evidence at level α = 0.05 that talking on the phone
increases the risk of getting in a car accident. In contrast, using the average case calibration
we can say there is significant evidence of a treatment effect even if we expect that the worst
case bias in any case-crossover pair to be greater than 17.66. Notice that for larger values
of Γsens the benefit from using the average case calibration increases. This exercise is not
necessarily meant to be a general purpose procedure but rather a numerical illustration of
the gain in power that comes from using the average case calibration even under relatively
innocuous assumptions about U.
2.6.2. Appendix B
Simultaneous sensitivity analysis
The one-parameter sensitivity model introduced in Section 2.2 is often referred to as the
primary sensitivity analysis. In this model, the association between Usi and Zsi is con-
trolled by Γ and the stochastic ordering in Equation (5) of the main paper were derived by
Rosenbaum (1987) assuming that Usi and rCsi have a near perfect relationship but this is
not always a plausible assumption – for example, if Usi is continuous propensity score for
treatment and the outcome is binary. A more general two-parameter sensitivity model was
first introduced by Gastwirth et al. (1998) where ∆ controls the association between Usi
and rCsi and Λ controls the association between Usi and Zsi. For example, if Us1 = 1 and
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Us2 = 0 then the first unit of the pair is Λ times more likely to receive treatment and ∆
times more likely to have the positive outcome. This model is known as the simultaneous
sensitivity analysis and is particularly useful when it is not plausible that Usi and rCsi are
perfectly correlated. When the outcome is binary – and more generally if ys, the difference
in outcomes in pair s, come from a distribution belonging to Wolfe’s semiparametric family
(see Wolfe (1974)) – Rosenbaum and Silber (2009) show that Γ can be amplified to the
two-parameter model (Λ,∆) by the identity Γ = (Λ∆ + 1)/(Λ + ∆) which we refer to as the
amplification curve. The simultaneous sensitivity model acts as an interpretive aid to the
standard one-parameter procedure; We may consider how usi affects the odds of treatment
and the odds of positive outcome separately and then use the amplification curve to deter-
mine the corresponding Γ with which we can perform a standard one-parameter sensitivity
analysis. Like the one-parameter sensitivity model, the simultaneous sensitivity model does
not require that the investigator specifies the distribution of Usi, only that Usi ∈ [0, 1] for
s = 1, 2, . . . , S and i = 1, 2.
When U is not bounded
Theorem 1 in the main paper is free from any modeling decision of the underlying causal
mechanism. In that sense, it is very general and allows us to relax the restriction that U lie
in the unit interval. This provides flexibility in modeling the unobserved confounders but
for Γ, or ∆ and Λ in the amplified setting, to retain meaning we will have to standardize
the distribution of U in some fashion. For example, we may scale U such that the post
matching variance of Us1 − Us2 is equal to 1. Now suppose that Us1 − Us2 = ±1. Then the
odds that the treated unit has positive outcome in pair s is
Γ =
1 + Λ∆
(1 + Λ)(1 + ∆)
, (2.12)
which is equivalent to the worst case bias when U was taken to lie on the unit interval.
We will refer to this as the one standard deviation (1SD) worst case bias. Related work
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by Wang and Krieger (2006) considers arbitrary distributions of Ws = Us1 − Us2 with
mean 0 and variance 1 after matching. They show that for any such distribution of W =
(W1,W2, . . . ,WS)
T , the population mean of ps, E[ps], is maximized whenWs takes values±1
with equal probability. The implication of this result is that when U is scaled appropriately
the 1SD worst case bias is asymptotically more conservative than Γ′ even when U is not
restricted to the unit interval.
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CHAPTER 3
Extended Sensitivity Analysis for Heterogeneous Unmeasured Confounding with an
Application to Sibling Studies of Returns to Education
Abstract
The conventional model for assessing insensitivity to hidden bias in paired obser-
vational studies constructs a worst-case distribution for treatment assignments subject
to bounds on the maximal bias to which any given pair is subjected. In studies where
rare cases of extreme hidden bias are suspected, the maximal bias may be substantially
larger than the typical bias across pairs, such that a correctly specified bound on the
maximal bias would yield an unduly pessimistic perception of the study’s robustness
to hidden bias. We present an extended sensitivity analysis which allows researchers to
simultaneously bound the maximal and typical bias perturbing the pairs under investi-
gation while maintaining the desired Type I error rate. We motivate and illustrate our
method with two sibling studies on the impact of schooling on earnings, one containing
information of cognitive ability of siblings and the other not. Cognitive ability, clearly
influential of both earnings and degree of schooling, is likely similar between members
of most sibling pairs yet could, conceivably, vary drastically for some siblings. The
method is straightforward to implement, simply requiring the solution to a quadratic
program.
3.1. Introduction
3.1.1. A motivating example: Returns to schooling
Is educational attainment a determining factor for success in the labor market? Initial
interest among economists in addressing this question is attributed to the observation in
the late 1950s that increases in education levels could account for much of the produc-
tivity growth in post-war US (Becker, 2009; Griliches, 1970; Card, 1999). With strong
evidence of a positive association between education and earnings in a variety of political
and geographic environments but little to no experimental data, a recurring theme in the
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subsequent pursuit of a causal relationship between education and income is that of the
presence of “ability bias” (Card, 1999). After controlling for family background, or consid-
ering within-family estimates of the causal effect using sibling or twin studies, can latent
differences in ability influence both differences in schooling choice and earnings? A notable
twin study by Ashenfelter and Rouse (1998), which we re-examine in this paper, argued
cogently, albeit with limited statistical evidence, that identical twins can be regarded as
truly identical in all dimensions relevant to schooling choices and future income, including
latent ability. In a survey of contemporary economic investigations of returns to education,
Card (1999, p.1852) addresses this hypothesis:
Despite this evidence, and the strong intuitive appeal of the “equal abilities”
assumption for identical twins, however, I suspect that observers with a strong
a priori belief in the importance of ability bias will remain unconvinced.
Perhaps latent ability is truly identical for many twin pairs but markedly different in a
few pairs; what would happen then? That exogeneity is not testable leaves even the most
compelling observational evidence susceptible to the warranted, though often non-specific,
criticism, “what if bias remains?” Should the totality of evidence assume the absence of
hidden bias, the critic need merely suggest the existence of bias to cast doubt upon the
posited causal mechanism. It is thus incumbent upon researchers not only to anticipate
such criticism, but also to arm themselves with a suitable rejoinder. Rather than arguing
for or against the presence of ability bias or any other unobserved confounding factor, in this
paper we assess the sensitivity of causal conclusions to departures from truly randomized
assignment while allowing for patterns of ability bias that may be highly heterogeneous
across sibling pairs.
3.1.2. Assessing returns to schooling with sibling comparison designs
Sibling comparison studies are a special case of stratified designs where natural blocks are
formed by family membership. These studies automatically control for genetic, socioeco-
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nomic, cultural, and child-rearing characteristics to the extent that they are shared between
siblings; however, instability of familial characteristics over time for sibling pairs of differ-
ent ages and non-shared genetic makeup are among threats to this premise (Donovan and
Susser, 2011). Due to their natural and automatic control of stable familial factors, both
observed and unobserved, sibling comparison designs have long been a popular tool for
studying causal effects in both epidemiological and economic settings; see Griliches (1979)
and Donovan and Susser (2011) for surveys of past and current sibling comparison studies
in economics and epidemiology, respectively.
Sibling comparison designs have been particularly fruitful in the study of returns to school-
ing, where genetic and family background are deemed essential to both schooling choices and
future income; see for example Hauser et al. (1999), Stanek et al. (2011), and Ashenfelter
and Rouse (1998). Hauser et al. (1999) study sibling pairs from the Wisconsin Longitudi-
nal Study (WLS), a random sample (n = 10, 317) of men and women born between 1938
and 1940 who graduated from Wisconsin high schools in 1957. The size of the sample was
set to be approximately a third of all Wisconsin high school graduates in 1957. Random
siblings of those in the study (n = 7, 928), born between 1930 and 1948, were also se-
lected and interviewed. The WLS contains a rich set of baseline covariates and endpoints,
including physical, cognitive, social, and occupational outcomes collected over nearly 60
years following graduation. Uniquely, the WLS dataset contains intelligence quotient (IQ)
scores recorded while a given individual was in high school – a covariate rarely measured in
longitudinal cohort studies.
In other sibling studies of the returns to schooling, such as that of Ashenfelter and Rouse
(1998), baseline intelligence measures such as IQ are not available, making it plausible that
the siblings being compared differ in cognitive ability in unobserved ways. Furthermore,
the IQ data from the WLS study suggests that, when considering same-sex sibling pairs
where one sibling attended college and the other did not (n = 171), intellectual ability is not
balanced sufficiently by shared genetics alone. The boxplots of differences in IQ between
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Figure 1: Boxplots of differences in IQ scores between same-sex siblings where one attended
college and the other did not. (top panel): Male same-sex sibling pairs (n = 128). (bottom
panel): Female same-sex sibling pairs (n = 43).
the college-attending siblings and their counterparts in Figure 1 exhibit a prominent shift
in the IQ distribution between the two groups for both male and female same-sex sibling
pairs. The mean (sd) is 107.1 (14.7) in the college-attending group and 97.4 (14.4) in the
high school-only group for male same-sex sibling pairs. In female same-sex sibling pairs,
these values are 108.1 (14.0) and 101.4 (14.2) for the college-attending and high school-only
attending groups respectively. Details on the construction of the 171 same-sex sibling pairs
can be found in Appendix 3.8.2. An important inclusion criterion was that both siblings
were employed when income data was collected.
3.1.3. Potential for rare but extreme unmeasured biases
Despite their analytical strengths and convenient, automatic stratification, sibling com-
parison designs for estimating causal effects are subject to biases arising from differences
in subject-level confounders. For example, latent ability, as measured by IQ, may differ
substantially within twin pairs in Ashenfelter and Rouse’s twin study. This concern is mag-
nified in sibling studies where discordant within-pair treatment assignment may actually
exacerbate differences in covariates that are related to both the intervention and outcome
of interest (Frisell et al., 2012). When pairs do not arise naturally, as in paired sibling
studies, matching algorithms designed to minimize disparities in observed covariates may
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be used to construct pairs of “comparable” subjects; see, for example, Hansen and Klopfer
(2006) and Stuart (2010) for discussion on various approaches to matching. Matched pairs
constructed in this fashion may be comparable along observed covariates, but they are still
vulnerable to unmeasured bias arising from differences in covariates not available to the
matching algorithm.
While agnostic covariate adjustment within sibling sets as suggested in Rosenbaum (2002b)
can help mitigate the impact of discrepancies in observed individual-specific covariates, bias
arising from differences in unobserved confounders may remain and imperil the conclusions
of the study. An additional inferential step known as a sensitivity analysis assesses the
robustness of the conclusions of a study to these unmeasured biases. Sensitivity analysis was
first introduced by Cornfield et al. (1959) and refined to accommodate continuous outcomes
in Rosenbaum (1987). The resulting sensitivity analysis for paired studies considers the
worst-case bias to which any pair may be subject and asks whether the study conclusions
might change if we assumed that all pairs were exposed to the maximal bias in a manner
adverse to the desired inference. We refer to this as the conventional sensitivity analysis.
See Cornfield et al. (1959), Marcus (1997), Imbens (2003), Yu and Gastwirth (2005), Wang
and Krieger (2006), Egleston et al. (2009), Hosman et al. (2010), Zubizarreta et al. (2013),
Liu et al. (2013), and VanderWeele and Ding (2017) for additional perspectives on and
worked examples of sensitivity analysis.
In many paired studies, sibling or otherwise, hidden biases may strongly influence the re-
sults observed for some pairs and more modestly affect others. If the impact of unmeasured
confounding were truly heterogeneous in this manner, the conventional sensitivity analysis
would be conspicuously conservative. Consider, for example, discrepancies in IQ scores
within sibling pairs measured in the WLS where one sibling attended college for at least
two years and the other received at most a high school diploma. While existing longitudinal
cohort studies rarely contain measures of intelligence (Herd et al., 2014), existing evidence
suggests that discrepancies in IQ between sibling pairs are strongly predictive of both dif-
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Figure 2: (left panel): Histogram of between-sibling IQ disparities of same-sex male sibling
pairs in the WLS study where one sibling attended college and the other did not (n = 128).
(right panel): Histogram of between-sibling IQ disparities of same-sex female sibling pairs in
the WLS study where one sibling attended college and the other did not (n = 43). (bottom
panel): Table of the estimated increase in pairwise bias due to IQ disparities between siblings
measured as an odds ratio.
ferences in educational attainment and differences in future income (Stanek et al., 2011).
In the WLS data, the between-sibling disparity in IQ scores is quite variable across sibling
pairs where one sibling attended college and the other did not. The histogram of these
college-minus-high school differences is shown in the left panel of Figure 2 for male sibling
pairs and the right panel for female sibling pairs. Most IQ differences are modest, but a
few sibling pairs have large imbalances (e.g. > 40).
In a sibling study on the returns of schooling where IQ was not recorded, such as Ashenfelter
and Rouse’s twin study, the maximal bias to which any pair is subject could be materially
larger than the typical bias for any sibling pair. Evidence of this pattern’s plausibility
can be seen in the bottom table of Figure 2. The table shows the distribution of the
estimated increase in pairwise bias due to IQ disparities between siblings measured as an
odds ratio. The numerator of the odds ratio is the predicted maximum odds that the sibling
who reported higher income attended college given the reported disparities in IQ while the
denominator corresponds to the maximum odds had both siblings had the same IQ. (the
method for estimating these odds ratios is described in Appendices 3.8.3-3.8.4). While the
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odds ratio in most pairs is close to one, there are a handful of pairs with odds ratios near 2
and two rare cases of odds ratios greater than 6. As far as the ‘typical’ or ‘expected’ pairwise
bias is as interpretable a quantity as the worst-case pairwise bias, an extended sensitivity
analysis of both maximal and expected bias may alleviate concerns that the conventional
approach is overly pessimistic while providing a more flexible handling of unobserved bias.
3.1.4. Accommodating varying degrees of unmeasured confounding
We present an extended sensitivity analysis bounding both the maximal and expected bias
for paired studies. The concept of expected bias is made precise in §3.3.1. The theoretical
foundations and implementation of the extended sensitivity analysis are developed in §§3.2-
3.4, while supporting Type I error control and power simulations are presented in §3.5. The
procedure involves two interpretable parameters, Γ and Γ¯ ≤ Γ, bounding the maximal and
expected bias, respectively. At one extreme, setting Γ¯ = Γ recovers the conventional sensi-
tivity analysis for paired studies proposed in Rosenbaum (1987, §2). At the other, setting
Γ =∞ for a fixed value of Γ¯ allows one to bound the average bias while leaving the maximal
bias in any given pair unbounded, subsuming the extension presented in Rosenbaum (1987,
§4) where the investigator specifies a fraction β of the pairs that satisfy a constraint on the
maximal bias and allows the remaining pairs to be exposed to potentially unbounded bias.
The procedure builds on recent work by Hasegawa and Small (2017) that established an
exact sensitivity analysis for the sample average bias for paired studies with binary out-
comes in two important ways. First, our procedure accommodates continuous outcomes
while providing an asymptotically valid testing procedure for sharp null hypotheses for a
large class of test statistics. While generalizing to continuous outcomes corrupts properties
unique to McNemar’s test statistic utilized in Hasegawa and Small (2017), these difficulties
are overcome through a new formulation of the optimization problem necessitated by the
sensitivity analysis as a quadratic program. Second, our procedure allows the researcher to
bound the expected bias at the level of a superpopulation, rather than the average of the
bias at the level of the observed study population, if a superpopulation model is deemed ap-
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propriate. This facilitates consonance between superpopulation and finite-sample modes of
inference to which the researcher is automatically entitled when only bounding the maximal
bias. Actualizing this harmony requires the combination of concentration inequalities with
the technique presented in Berger and Boos (1994) for yielding valid p-values by maximizing
over a confidence set for nuisance parameters.
To demonstrate the practical consequences of our procedure we return in §3.6 to the moti-
vating example of returns to schooling. Using the availability of IQ measures in the WLS
sibling data, we follow Hsu and Small (2013) to estimate the maximal and expected bias
under the assumption that inherent cognitive ability is the overwhelming unobserved con-
founding factor in sibling studies of returns to schooling when IQ measures are not available.
We compare standard and extended sensitivity analyses calibrated to these estimates of the
sensitivity parameters for Ashenfelter and Rouse’s twin study where IQ was not observed.
3.2. Sensitivity analysis for paired studies
3.2.1. An idealized construction of a paired observational study
There are I pairs of individuals. In the ith matched pair one individual receives the treat-
ment, Zij = 1, and the other receives the control, Zij′ = 0, such that Zi1 + Zi2 = 1 for
each i. In practice, the I pairs come into being by minimizing a metric reflective of the
within-pair discrepancies between the observed covariates xij for the treated and control
individuals in a candidate pairing, such that xi1 ≈ xi2 in the resulting pairs. As an ideal-
ization of this practice, we follow Rosenbaum (1987) and imagine a generative model where
the pairs are constructed, for i = 1, ..., I, by initially drawing, without replacement from an
infinite population of treated individuals (that is, conditional upon Z = 1), an individual
who has an observed covariate Xi = xi. For each i, we then sample a control individual
from the population of controls with the same value for the observed covariate, i.e. given
Z = 0, X = xi. Finally, randomly assign indices (i, 1) and (i, 2) to the two individuals in
pair i, and let Xi be a random variable denoting the shared value Xi1 = Xi2. Despite having
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a shared value Xi, it may be the case that Ui1 6= Ui2 in any pair i for some unobserved
covariate U . In §3.3.3, we describe the extent to which the following methodology applies
to finite-sample inference in the absence of a superpopulation.
Under the stable unit-treatment value assumption (Rubin, 1980), individual j in matched
set i has a potential outcome under treatment, RT ij , and under control, RCij which does not
depend on the treatment received by other individuals in the population. The fundamental
problem of causal inference is that vector (RT ij , RCij) is not jointly observable. Instead, we
observe the response Rij = RT ijZij +RCij(1−Zij), and the observed treated-minus-control
paired differences Yi = (Zi1 − Zi2)(Ri1 − Ri2). Lowercase letters denote realizations of
random variables. Let FI = {(xij , uij , rT ij , rCij), 1 ≤ i ≤ I, j = 1, 2} be the values of the
potential outcomes, measured covariates, and unmeasured covariates for the 2I individuals
in the observational study at hand. At times it will be convenient to use boldface for
vector-valued constants and random variables after the assignment of indices. For example,
Z represents a vector of length 2I with elements Z = (Z11, Z12, ..., ZI2), while Ri is a vector
of length two with elements Ri = (Ri1, Ri2).
3.2.2. Randomization inference under strong ignorability
The expectation of each paired difference Yi in the infinite population model of the preceding
section is E(Yi | Xij = x) = E(RT ij | Zij = 1, Xij = x) − E(RCij | Zij = 0, Xij = x) which
need not equal τ(x) := E(RT ij − RCij | Xij = x) without further assumptions on the
relationship between the potential outcomes, the observed covariates, and the treatment
indicators. A sufficient condition for equality of these expectations, strong ignorability,
entails that for any point x,
(RT , RC) ⊥⊥ Z | X, 0 < P(Z = 1 | X = x) < 1. (3.1)
Strong ignorability facilitates far more than equality between E(Yi | Xij = x) and τ(x);
indeed, it entitles the researcher to use randomization tests akin to those justified in ran-
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domized experiments. We consider general hypotheses of the form
H0 : FT (RT ij) = FC(RCij) ∀i, j
for pre-specified functions FT (·) and FC(·). While this form accommodates flexible models
for treatment effects, perhaps the most classical specification is the additive treatment
effect model where the treatment effect is constant at τ for all individuals. Under this
model RT ij = RCij + τ , which can be expressed by setting FT (RT ij) = RT ij − τ and
FC(RCij) = RCij . From our data alone we observe Fij = FT (RT ij)Zij +FC(RCij)(1−Zij);
let F = [F11, ..., FI2]. Under H0, the vectors FC = [FC(RC11), ..., FC(RCI2)] and FT =
[FT (RT11), ..., FT (RTI2)] are known to be equal, and hence are entirely specified by the
vector of observed responses R.
Let t(Z,F) be an arbitrary test statistic that is a function of the treatment indicators Zij
and the observed values Fij , and let ΩI = {z : zi1 + zi2 = 1, 1 ≤ i ≤ I} be the set of 2I
possible assignments of individuals to treatment and control in a paired design. Further let
fC be the realized value of the random variable FC . When H0 holds, fC is fully observed.
Under the idealized model in §3.2.1 and under (3.1), Theorem 1 of Rosenbaum (1984)
demonstrates that under the null hypothesis H0,
P{t(Z,F) ≥ a | FI , H0} = 1
2I
∑
z∈ΩI
χ{t(z, fC) ≥ a}, (3.2)
where χ{A} is an indicator that the event A occurred. Importantly, under H0, the random-
ization distribution (3.2) is free of unknown parameters through conditioning on FI , and
hence can be used directly to facilitate inference on H0.
3.2.3. Sensitivity analysis bounding the supremum
In paired randomized experiments, the physical act of randomization breaks the association
between potential outcomes and the intervention and thus justifies both the assumption
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of strong ignorability and randomization inference through the conditional distribution in
(3.2). Paired observational studies aim to mimic an idealized randomized experiment by
creating pairs where individuals are similar on the basis of their observed covariates, X,
which would similarly facilitate randomization inference through (3.2) if strong ignorability
held. In observational studies, strong ignorability, and in turn belief in (3.2), turns a
statement of fact into a leap of faith due to the potential presence of unobserved factor
U . That treatment assignment is rarely known to be strongly ignorable given observed
covariates X alone necessitates a sensitvity analysis which assesses the robustness of a
study’s conclusions to factors not included in X. A sensitivity analysis operates under the
premise that strong ignorability would have been satisfied if an additional pretreatment
covariate U had been used in constructing the pairs, that is if for any x and u
(RT , RC) ⊥⊥ Z | (X,U), 0 < P(Z = 1 | X = x, U = u) < 1. (3.3)
A simple model parameterizing the impact of hidden bias presented in Rosenbaum (1987,
§2) relates U to the assignment mechanism through a parameter Γ = exp(γ) ≥ 1, which
constrains the degree to which U can affect the odds of receiving the intervention through
a logit model,
logit(P(Z = 1 | X = x, U = u)) = κ(x) + γu, 0 ≤ u ≤ 1. (3.4)
The bounds on u in (3.4) may be viewed as a restriction on the scale of the unobserved
covariate that is required for the numerical value of γ to have meaning (Rosenbaum, 2002c,
Chapter 4). Letting pii = P(Zi1 = 1 | FI), (3.3) and (3.4) then imply pii = expit(γ(ui1−ui2))
and 1 − pii = expit(γ(ui2 − ui1)). As a result, the model requires that the bound pi∗i =
max{pii, 1 − pii} = expit(γ|ui1 − ui2|) ≤ Γ/(1 + Γ) holds uniformly for all i, but imposes
no additional constraints on pi, and imposes no constraint on the relationship between
the unobserved covariate and the potential outcomes. Theorem 1 of Rosenbaum (1987)
illustrates that (3.3), (3.4) and the generative model described in §3.2.1 imply that under
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a sharp null H0, the distribution t(Z,F) given FI takes on the modified form
P{t(Z,F) ≥ a | FI , H0} =
∑
z∈ΩI
[
χ{t(z, fC) ≥ a}
×
I∏
i=1
expit(γ(ui1 − ui2))zi1expit(γ(ui2 − ui1))zi2
]
. (3.5)
At Γ = 1⇔ γ = 0, (3.5) recovers (3.2), hence representing strong ignorability on the basis
of X alone. For Γ > 1, (3.5) depends on the unknown values of u. A sensitivity analysis
proceeds by, for a given value of Γ, finding bounds on (3.5) by optimizing over the nuisance
parameters u ∈ [0, 1]2I (or equivalently, optimizing over pii subject to pi∗i ≤ Γ/(1 + Γ)).
We consider test statistics of the form t(Z,F) = ZTq for some function q = q(F), commonly
referred to as sum statistics. Examples of sum statistics in paired observational studies in-
clude Wilcoxon’s signed rank test and McNemar’s test among many others; see Rosenbaum
(2002c, Chapter 2) for more on sum statistics. For example, were we to test the null that the
treatment effect was constant at zero for all individuals (commonly referred to as Fisher’s
sharp null hypothesis), then a choice of qij = (Rij−Rij′)/I = (rCij−rCij′)/I would amount
to a choice of the average of the treated-minus-control paired differences in outcomes as the
test statistic. In paired studies, arguments parallel to those in Rosenbaum (2002c, Chapter
4) yield that a tight lower bound on (3.5) is found by setting ui1−ui2 = −sign(qi1− qi2) for
each pair i, where sign(a) is the sign of the scalar a. Similarly, a tight upper bound on (3.5)
is found by setting ui1−ui2 = sign(qi1− qi2) for each i. As a further illustration, if one uses
the difference in means as the test statistic, the lower (upper) bound is attained through
a perfect negative (positive) correlation between the differences in unmeasured covariates
and the signs of the treated-minus-control paired differences.
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3.3. An extended sensitivity analysis
3.3.1. Average-case unmeasured confounding in paired studies
In §§1.1-1.2, it was argued that large discrepancies in IQ within pairs of siblings, while likely
uncommon, would have a large impact on both likelihood of attaining more than a high
school degree and on an individual’s expected earnings. Were this the only unmeasured
confounder, we would then expect most of the values for pi∗, the maximal probabilities of
assignment to treatment within a pair, to not deviate substantially from 0.5, while a few
pairs would likely have values for pi∗i substantially larger than 0.5. The conventional model
for a sensitivity analysis presented in §3.2.3 bounds pi∗i by Γ/(1 + Γ) for all pairs. Despite
typical discrepancies in IQ likely being small, the smallest value of Γ for which (3.4) and
(3.5) hold would be large due to the small number of extremely biased pairs. When utilized
in its original form, the sensitivity analysis in §2.3 may then paint an overly pessimistic
picture of the robustness of the study’s findings to unmeasured confounding under this
belief, as it cannot account for the ‘typical’ level of unmeasured confounding being different
from the worst-case level.
We consider an extension of the conventional sensitivity analysis summarized in §2.3 in-
volving two sensitivity parameters, Γ and Γ¯. The first, Γ, plays a role identical to that
of Γ in the conventional sensitivity analysis by bounding the supremum of the biased as-
signment probabilities within a pair. Explicitly, we bound the probabilities of receiving the
intervention through a logit form,
logit(P(Z = 1 | X,U)) = κ(X) + γU, 0 ≤ U ≤ 1. (3.6)
That 0 ≤ U ≤ 1 trivially implies that for any pair i
1/2 ≤ expit(γ|Ui1 − Ui2|) ≤ Γ
1 + Γ
. (3.7)
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Under (3.3) and the setup of §3.2.1, (3.6) yields that Π∗i = max{Πi, 1−Πi} = expit(γ|Ui1−
Ui2|) ≤ Γ/(1 + Γ), where Πi = P(Zi1 = 1 | Xi,Ui,RT i,RCi) = P(Zi1 = 1 | Xi,Ui). We
capitalize Uij and Π
∗
i to emphasize that they themselves are random variables with respect
to the superpopulation model in §2.1, which would become deterministic by conditioning
in FI .
The second sensitivity parameter, Γ¯, serves to bound the expectation of the biased proba-
bilities. We define µpi∗ = E[Π∗i ] = E[expit(γ|Ui1 − Ui2|)], and impose that for some value Γ¯
such that 1 ≤ Γ¯ ≤ Γ,
1/2 ≤ µpi∗ ≤ Γ¯
1 + Γ¯
. (3.8)
Again, this expectation is taken over repeated samples in the idealized setting in §3.2.1,
within which the fixed but unknown values pi∗i in our observational study can be modeled as
iid realizations of the random variables Π∗i . As with the conventional sensitivity analysis,
our model makes no assumption about the relationship between the unobserved covariates
and the potential outcomes.
Like the conventional sensitivity analysis, our extended procedure solves an optimization
problem over a set of nuisance parameters pi that satisfy the typical and maximal bias
bounds specified in (3.7) and (3.8). Although the population-level bound Π∗i ≤ Γ/(1 + Γ)
implies the corresponding sample level bound pi∗i ≤ Γ/(1+Γ), the same cannot be said about
the corresponding bound on µ∗pi. If µ∗pi ≤ Γ¯/(1 + Γ¯), a sample realization p¯i∗ arbitrarily close
to Γ/(1 + Γ) is still possible, however unlikely. To address this, we translate the bound on
µ∗pi to a stochastic bound on Π¯∗.
In order to construct this stochastic bound, we consider properties of the random variable
Π∗i across draws from the idealized setting in §3.2.1. From (3.7) and (3.8), we have that
for all i Π∗i is bounded above by Γ/(1 + Γ), bounded below by 1/2, and has expectation
µpi∗ which is itself bounded above by Γ¯/(1 + Γ¯). The Bhatia-Davis inequality (Bhatia and
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Davis, 2000) provides the variance upper bound
var(Π∗i ) ≤ (Γ/(1 + Γ)− µpi∗) (µpi∗ − 1/2) = ν2(Γ, µpi∗).
As the Π∗i can further be modeled as iid random variables under the setting being considered,
defining Π¯∗ = I−1
∑I
i=1 Π
∗
i , it follows that
E[Π¯∗] = µpi∗ , var(Π¯∗) ≤ ν2(Γ, µpi∗)/I.
If var(Π∗i ) > 0 the Central Limit Theorem applies to Π¯
∗, indicating that for any 0 < β ≤ 0.5
lim
I→∞
P(Π¯∗ ∈ Cβ(Γ, µpi∗)) ≥ 1− β, (3.9)
where, because Π¯∗ ≥ 1/2 by definition of Π∗i
Cβ(Γ, µpi∗) =
[
1/2, µpi∗ + I
−1/2Φ−1(1− β)ν(Γ, µpi∗)
]
, (3.10)
and Φ−1(p) is the p-quantile of the standard normal distribution. Further, (3.9) is trivially
true if var(Π∗i ) = 0, as the upper bound of Cβ(Γ, µpi∗) is no smaller than µpi∗ when β ≤ 0.5.
That is, knowledge of µpi∗ alone enables the construction of asymptotically valid uncertainty
sets for Π¯∗.
3.3.2. Sensitivity analysis bounding the supremum and expectation
Conditional upon FI , attention returns to the unmeasured confounders for the individuals
in our study population, u, and the corresponding assignment probabilities pi. For any
value of u and value for Γ, we have that
P{t(Z,F) ≥ a | FI , H0} =
∑
z∈ΩI
χ{t(z, fC) ≥ a}
I∏
i=1
pizi1i (1− pii)zi2 , (3.11)
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where pii = expit(γ(ui1−ui2)). As the shared notation seeks to emphasize, (3.11) is precisely
the null distribution utilized in (3.5). Here as well as in (3.5), the unmeasured confounders
u, and hence the conditional assignment probabilities pi, are unknown constants, hindering
the desired inference through their presence as nuisance parameters. The approach taken
in §3.2.3 was to maximize or minimize (3.11) over u ∈ [0, 1]2I for a given value Γ, or
equivalently over pi∗i ≤ Γ/(1 + Γ). In what follows, we replace this optimization with one
over a subset informed by both Γ and Γ¯ while providing an asymptotically valid level-α
test.
Suppose without loss of generality that we are considering a one-sided, greater than alter-
native. Let Pβ(Γ, µpi∗) = {pi : p¯i∗ ∈ Cβ(Γ, µpi∗), pi∗i ≤ Γ/(1 + Γ), 1 ≤ i ≤ I}, and consider
the following optimization problem:
maximize
pi,µpi∗
p(pi, µpi∗) =
∑
z∈ΩI
χ{t(z, fC) ≥ t(Z,F)}
I∏
i=1
pizi1i (1− pii)zi2 (3.12)
subject to pi ∈ Pβ(Γ, µpi∗)
µpi∗ ≤ Γ¯/(1 + Γ¯).
Let Uβ(Γ, Γ¯) be the set of feasible solutions to (3.12). Let pisup,β and µsup,β be the arg max
of (3.12), such that p(pisup,β, µsup,β) is the tail probability at the solution to (3.12). If Γ¯ < Γ,
let pβ = p(pisup,β, µsup,β) + β; otherwise, let pβ = p(pisup,β, µsup,β).
Proposition 2. Suppose we sample I pairs from an infinite population through the procedure
in §2.1, that treatment assignment is strongly ignorable given (X,U), and that (3.7) and
(3.8) hold at Γ and Γ¯ ≤ Γ respectively. Then, if H0 is true, for 0 < β ≤ 0.5,
lim
I→∞
P(pβ ≤ α | H0) ≤ α
That is, pβ is an asymptotically valid p-value for an extended sensitivity analysis testing H0
with parameters (Γ, Γ¯).
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Proof. We first prove the result for Γ¯ < Γ. The proof is similar to that of Lemma 1 in
Berger and Boos (1994), differing primarily in that the nuisance parameters given FI , pi,
are themselves realizations of random variables in the setting of §3.2.1. Suppose the null
hypothesis is true, and let µ0 be the true value for µpi∗ . Further, for any set FI let pi0 be
the true value of pi. and let p(pi0, µ0) be the value of (3.11) evaluated at pi0 and µ0.
P(pβ ≤ α) = E[P(pβ ≤ α, p¯i∗0 ∈ Cβ(Γ, µ0) | FI)] + E[P(pβ ≤ α, p¯i∗0 /∈ Cβ(Γ, µ0) | FI)]
≤ E[P(p(pi0, µ0) + β ≤ α | FI)] + E[P(p¯i∗0 /∈ Cβ(Γ, µ0) | FI)]
= E[P(p(pi0, µ0) ≤ α− β | FI)] + P(Π¯∗ /∈ Cβ(Γ, µ0))
The second line follows from p(pi0, µ0) ≤ suppi∈Pβ(Γ,µ0) p(pi, µ0) ≤ pβ − β if p¯i∗0 ∈ Cβ(Γ, µ0).
By validity of (3.11) at pi0 given FI , the first term in the third line is less than or equal to
α − β, while (3.9) illustrates that limI→∞P(Π¯∗ /∈ Cβ(Γ, µ0)) ≤ β for 0 < β ≤ 0.5, proving
the result for Γ¯ < Γ.
If Γ¯ = Γ, a solution pi ∈ U(Γ,Γ) is pii = Γ/(1+Γ) if (qi1 > qi2) and pii = 1/(1+Γ) otherwise,
which recovers the sensitivity analysis of §2.3. Call this solution piΓ. By arguments in
Rosenbaum (2002c, Chapter 4), this solution yields a tight upper bound for the probability
in (3.11) under the constraint that pi∗i ≤ Γ/(1 + Γ). Hence, p(pisup,β, µsup,β) = p(piΓ,Γ/(1 +
Γ)) for any β. At Γ¯ = Γ, we simply employ the conventional sensitivity analysis which
produces valid p-values without an additive increase by β.
Prior to conducting an extended sensitivity analysis, the practitioner needs to choose a value
for β. A compromise must be made, as β acts as a lower bound on the p-value reported
by the extended sensitivity analysis but larger values of β correspond to tighter constraints
on p¯i∗. Accordingly, we recommend that β be chosen to be smaller than the precision with
which p-values are typically reported, but not by much. This recommendation is similar to
the guidance given in Berger and Boos (1994).
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pβ yields an asymptotically valid p-value for an extended sensitivity analysis with parame-
ters (Γ, Γ¯) because the uncertainty set Cβ(Γ, µpi∗) defined in (3.10) utilizes the Central Limit
Theorem. As our random variables Π∗i are bounded, we are entitled to certain distribution-
free uncertainty sets based on concentration inequalities which have the desired coverage for
all sample sizes I; see Appendix 3.8.1 for two approaches using Hoeffding’s inequality and
Bennett’s inequality. These sets, used in place of Cβ(Γ, µpi∗) when constructing Pβ(Γ, µpi∗),
would provide valid p-values for the extended sensitivity analysis through the solution of
(3.12) for all values of I. Unfortunately, exact computation of pβ through (3.12) is itself
generally intractable, with the additional constraints imposed on the value of p¯i destroying
the properties of the optimization problem solved by the conventional sensitivity analysis
which facilitate an exact solution. In §3.4, we provide an implementation of our sensitivity
analysis valid in large samples by approximating (3.11) with an appropriate normal dis-
tribution, justified under mild conditions. As we employ a normal approximation through
our implementation, already implying a large-sample regime, we proceed illustrating the
method using the asymptotically valid uncertainty set Cβ(Γ, µpi∗).
3.3.3. On extended sensitivity analyses for observed study populations
Under the superpopulation model described in §3.2.1, Π∗i is itself a random variable with
expectation E[Π¯∗]. In randomized experiments and observational studies, the assumption
that the individuals in the study arose as a sample from some larger target population is
often specious. Such an assumption is not required for inferential statements, as the act
of random assignment to intervention itself can form the basis for probabilistic statements
and hypothesis tests, endowing randomized experiments with what Fisher referred to as a
“reasoned basis for inference” (Fisher, 1935). Rosenbaum (1999) further argues that the
most compelling observational studies are not those which are representative of a larger
population, but rather those arrived upon through an active choice of the conditions of
observation, seeking the “rare circumstances in which tangible evidence may be obtained to
distinguish treatment effects from the most plausible biases” (Rosenbaum, 1999, p. 259).
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As (3.5) indicates through conditioning on the study population, FI , the classical sensitiv-
ity analysis in §3.2.3 yields a null distribution for finite-sample inference whose nuisance
parameters are the unknown assignment probabilities pi for the individuals in the study at
hand. The parameter Γ, which originally served to bound the supremum of the random
variables Π∗i , also bounds the supremum of the observed values pi
∗
i . This yields harmony
between inference conducted for the finite study population and inference assuming an in-
finite population into existence when interest is in the hypothesis H0. Inference given FI is
valid on its own, but if a superpopulation model is deemed appropriate, inference given FI
yields valid unconditional inference within that framework.
The motivation for formulating the extended sensitivity analysis with explicit reference to
a superpopulation is that while bounds on the supremum of a random variable bound the
random variable’s realizations, bounds on the expectation of a random variable do not afford
bounds in the sample average. The idealized model is used to formulate probabilistic bounds
for the sample average Π¯∗, which then entitle us to a further bound on the average of the
realized vector pi∗. Proposition 2 indicates that the price to be paid for implementing this
bound is the addition of an extra β term to the p-value, necessitated by the view of pi∗ as a
realization of a random variable. Should a superpopulation model be deemed unreasonable,
our model could instead be interpreted as placing a bound on the sample average of the
parameters pi∗, p¯i∗, in the particular observational study being analyzed. This interpretation
eliminates the need for both the uncertainty set Cβ(Γ, µpi∗) and the increase in the p-value by
β, and an option to consider study population inference is available within our R function.
In our particular case study we proceed using superpopulation bounds, as in calibrating
the sensitivity parameters in one observational study by means of another one must assume
comparability of biases in the two studies.
3.3.4. A special case: Binary outcomes
Although exact computation of pβ is generally intractable, in one special but common
setting it is not. When the outcomes being studied are binary and t(Z,F) is chosen to be
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McNemar’s test statistic, computing pβ exactly under Fisher’s sharp null H0 : RT ij = RCij
becomes a straightforward exercise. Recall that McNemar’s test statistic counts the number
of pairs where the subject under treatment has a positive outcome and the control subject
does not; that is, t(Z,F) =
∑I
i=1(Zi1−Zi2)(RCi1−RCi2)/2 + 1/2 when Fisher’s sharp null
is true. Since pairs that are not discordant in treatment and outcome do not contribute to
McNemar’s statistic it is natural to distinguish pairs that are discordant in outcome and
those that are not. Let the first Id pairs be the discordant pairs and the last Ic be the
concordant pairs so that I = Id + Ic. Furthermore, let the first unit of each discordant pair
be the unit with positive outcome, that is Ri1 = 1 for i = 1, . . . , Id.
For the special case of McNemar’s test, let µm be the value of µpi∗ ≤ Γ¯/(1+Γ¯) that maximizes
the upper bound of Cβ(Γ, µpi∗) and let p¯im be the maximized upper bound. Define p¯ic = 1/2,
p¯id = min {(Ip¯im − Icp¯ic)/Id,Γ/(1 + Γ)} ,
and pim = ([p¯id · 1d, p¯ic · 1c]), where 1k is a vector of Ik ones. (pim, µm) is then a feasible
solution to (3.12) that is designed to put as much bias on the discordant pairs as is allowed
by the constraints of the optimization problem. Furthermore, since the concordant pairs do
not contribute to the test statistic we have that p(pim, µm) = P(B(Id, p¯id) ≥ t(Z,F)), where
B(Id, p¯id) is a Binomial random variable with success probability p¯id and Id trials. Now, let
pβ = p(pim, µm) + β when Γ¯ < Γ and let pβ = p(piΓ,Γ/(1 + Γ)) otherwise. In the following
proposition we show that, in this special setting, an exact solution to (3.12) simply requires
computing this Binomial tail probability.
Proposition 3. Consider a test of H0 : RT ij = RCij with binary outcomes, and let t(Z,F)
be McNemar’s test statistic. Further, let Cβ(Γ, µpi∗) be an exact, distribution-free 1 − β
uncertainty set. Then under the same conditions as Proposition 2,
P(pβ ≤ α | H0) ≤ α
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for any I if t(Z,F) ≥ Idp¯id. In other words, for any value of I, computing a valid p-value
for an extended sensitivity analysis testing H0 with parameters (Γ, Γ¯) reduces to computing
the Binomial tail probability P(B(Id, p¯id) ≥ t(Z,F)).
Proof. When Γ¯ = Γ, the proof follows immediately from the proof of this case in Proposition
2. Hence, we restrict our attention to the case when Γ¯ < Γ. As noted in §3.3.2, if we replace
Cβ(Γ, µpi∗) with a distribution-free uncertainty set the optimal solution to (3.12) yields a
valid p-value for an extended sensitivity analysis for all values of I. All that remains to be
shown is that (pim, µm) is the argmax of (3.12).
Without loss of generality, suppose once again that the first subject of each discordant pair
is the unit with a positive outcome, Ri1 = 1 for all i = 1, . . . , Id. Let (pi
′, µ′) be a feasible
solution of (3.12) and define p¯i′d and p¯i
′
c to be the sample average of the maximal assignment
probabilities for the discordant and concordant pairs, respectively. ([p¯i′d · 1d, p¯i′c · 1c], µ′) is
clearly also a feasible solution. Then, Theorem 1 in Hasegawa and Small (2017) implies
that p([p¯i′d · 1d, p¯i′c · 1c], µ′) ≥ p(pi′, µ′) when t(Z,F) ≥ Id · p¯i′d. Hence, we need only consider
feasible solutions of the form ([p¯i′d · 1d, p¯i′c · 1c], µ′). An elementary fact about Binomial
random variables is that B(Id, p1) stochastically dominates B(Id, p2) when p1 ≥ p2. By
construction, (pim, µm) yields a feasible solution such that p¯id ≥ p¯i′d for all feasible solutions
of the form ([p¯i′d ·1d, p¯i′c ·1c], µ′). Consequently, p(pim, µm) ≥ p([p¯i′d ·1d, p¯i′c ·1c], µ′) ≥ p(pi′, µ′)
for all feasible solutions (pi′, µ′) which proves the result for Γ¯ < Γ.
For McNemar’s test, the extended sensitivity analysis exhibits an interesting behavior when
p¯id = Γ/(1 + Γ): the procedure returns a p-value equal to the p-value returned by the
conventional sensitivity analysis at Γ plus the extra β term. We still pay the cost of
specifying a bound on E[Π∗i ] but do not receive the benefit of a tighter constraint on the
realization of pi∗ for discordant pairs. What, exactly, explains this phenomenon? A plausible
scenario that may give rise to this behavior is when Ic >> Id, i.e. there are many concordant
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pairs in the sample of I pairs. In throwing out concordant pairs when using McNemar’s
statistic, the uncertainty set for Π¯∗, the average of Π∗i over all pairs, tells us relatively little
about the realized average p¯i∗d over discordant pairs, reflecting the cost of bounding the
marginal expectation E[Π∗i ] instead of the conditional expectation E[Π∗i | RT i,RCi].
Although this behavior indicates that the extended sensitivity analysis is, in some sense,
suboptimal compared to the conventional sensitivity analysis when Ic >> Id, the practical
implications are mostly negligible as β is chosen to be smaller than the precision with which
p-values are generally reported. Furthermore, given a choice of Γ and conditional on (Id, Ic),
we can a priori determine the value of Γ¯ above which the conventional analysis is superior
to the extended analysis. Because (Id, Ic) are known conditional on FI , we are not at
risk of using the data twice – once to choose the best test and once to perform that test.
Consequently, the resulting sensitivity analyses will still have the appropriate level.
3.4. Implementation through quadratic programming
The test statistics described in §3.2.3 can be represented as the sum of I independent
random variables, ZTq =
∑I
i=1 Ti, where Ti = (qi1 + qi2)/2 + (Zi1 − Zi2)(qi1 − qi2)/2. This
suggests that, under mild regularity conditions, a central limit theorem would be applicable
to the distribution of ZTq for any value of pi in (3.11) for almost every sample path FI .
One sufficient condition proposed in the special central limit theorem of Ha´jek et al. (1999,
§6.1.2) is that, almost surely,
∑I
i=1(qi1 − qi2)2
max
1≤i≤I
(qi1 − qi2)2 →∞,
which requires that no one term (qi1 − qi2)2 dominates the sum as the number of pairs
increases. (An aside: the central limit theorem in Ha´jek et al. (1999, §6.1.2) as originally
stated applies to sums of the form
∑I
i=1 aiXi where Xi are iid random variables; however,
the proof can readily be extended to settings where Iσ2 ≤ ∑Ii=1 var(Xi) ≤ Icσ2 for c > 1
while dropping the requirement of identical distribution, which encompasses the setting of
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our extended sensitivity analysis). Under a normal approximation, the problem of finding
the worst-case p-value is equivalent to finding the worst-case deviate.
Recall that a sensitivity analysis is typically conducted only if the null hypothesis is rejected
under the assumption of no unmeasured confounding (Γ = Γ¯ = 1), and then proceeds by it-
eratively increasing the sensitivity parameters until the test fails to reject. Having proceeded
to sensitivity analysis only after rejecting the null under no unmeasured confounding, even
with one-sided alternatives we can safely consider rejection or failure to reject for sequen-
tially larger values of Γ and Γ¯ based on the minimal squared deviate, an objective function
which is preferred for computational reasons alluded to below. Recalling that under (3.11)
we condition on FI and hence treat the vector q as fixed, minimizing the squared deviate
can be expressed as an optimization problem over the unknown probabilities pi as
min
pi∈Uβ(Γ,Γ¯)
(t− Epi[ZTq | FI ])2
varpi(ZTq | FI) , (3.13)
where t is the observed value of the statistic t(Z,F), and the expectation and variance are
for the test statistic t(Z,F) under the randomization distribution (3.11) for a given vector
pi. Under a normal approximation for t(Z,F), the squared deviate follows a χ21 distribution.
By the argument of the previous section, we then reject the null at level α if (3.13) is greater
than or equal to G−1(1−2(α−β)) for one-sided alternatives or G−1(1−(α−β)) for two-sided
alternatives, where G−1(p) is the p quantile of a χ21 distribution.
The expectation and variance of the contribution of Ti can be expressed as a function of
the unknown vector pi as
Epi[Ti | FI ] = qTi pii (3.14)
varpi(Ti | FI) = pii(1− pii)(qi1 − qi2)2 (3.15)
= (q2i )
Tpii − (qTi pii)2
where pii and qi are vectors of length two with elements pii = (pii1, pii2) and qi = (qi1, qi2),
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respectively. Suppose without loss of generality that we are considering a one-sided, greater
than alternative and that we rejected the null at (Γ, Γ¯) = (1, 1), which implies that t ≥
(2I)−1
∑I
i=1
∑2
j=1 qij (i.e. that the observed value of t exceeded its null expectation). Sort
each vector qi in descending order such that qi1 ≥ qi2. Then, varpi(Ti | FI) = varpi∗(Ti | FI)
from (3.15), while from (3.14) Epi[Ti | FI ] ≤ Epi∗ [Ti | FI ] = qTi pi∗i and (qi1 + qi2)/2 ≤
Epi∗ [Ti | FI ]. Hence, any feasible solution pi′ to (3.13) has an objective value that is no
smaller than that of (pi∗)′, as the variance will be the same while, recalling the iterative
nature of a sensitivity analysis, the distance (t − E(pi∗)′ [ZTq′ | FI ])2 will be smaller than
(t − Epi′ [ZTq′ | FI ])2. Maintaining this ordering of the vectors qi, we can express our
optimization problem as a function of the maximal probabilities pi∗i .
For any candidate pi∗, we reject under a normal approximation with a one-sided, greater
than alternative at level α−β if the corresponding squared deviate exceeds its critical value,
G−1(1−2(α−β)) i.e. if ζ(pi∗, α−β) = (t−Epi∗ [ZTq | FI ])2−G−1(1−2(α−β))varpi∗(ZTq |
FI) ≥ 0. We write ζ(pi∗, α− β) explicitly as a function of pi∗ as
ζ(pi∗, α− β) = (t− qTpi∗)2 −G−1(1− 2(α− β))
I∑
i=1
(
(q2i )
Tpi∗i − (qTi pi∗i )2
)
If we find that ζ(pi∗, α − β) ≥ 0 for all feasible pi∗ ∈ Uβ(Γ, Γ¯), we can reject the null while
asymptotically controlling the size of the extended sensitivity analysis with parameters
(Γ, Γ¯) at α. The function ζ(pi∗, α − β) is convex and quadratic in pi∗. Meanwhile, we
explicitly write the constraints determining membership in Uβ(Γ, Γ¯) as
1/2 ≤ pi∗i ≤ Γ/(1 + Γ), 1 ≤ i ≤ I (3.16)
I−1
I∑
i=1
pi∗i ≤ µpi∗ + I−1/2Φ−1(1− β) {(Γ/(1 + Γ)− µpi∗) (µpi∗ − 1/2)}1/2 (3.17)
µpi∗ ≤ Γ¯/(1 + Γ¯). (3.18)
For a fixed value of µpi∗ ≤ Γ¯/(1 + Γ¯) the constraints are linear in the unknown maximal
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probabilites pi∗i . Hence, for fixed µpi∗ , the problem minpi∗ ζ(pi
∗, α− β) subject to (3.16) and
(3.17) can be written as a quadratic program. With a one-sided alternative, an asymptot-
ically level-α extended sensitivity analysis with parameters (Γ¯,Γ) simply requires checking
whether the solution to that quadratic program is greater than or equal to zero, rejecting
the null if so and failing to reject otherwise. For a two-sided alternative, simply replace
ζ(pi∗, α − β) with ζ(pi∗, (α − β)/2) to control the level of the procedure at α. See Rosen-
baum (1992) and Fogarty and Small (2016) for similar formulations of sensitivity analyses
as convex programs.
A minor complication is that for small values of I or for small values for β, the right-hand
side of (3.17) need not be monotone increasing in µpi∗ if 2Γ¯/(1 + Γ¯) ≥ Γ/(1 + Γ) + 1/2, as
decreasing µpi∗ may lead to an increase in the component dependent on the variance bound
which exceeds the corresponding decrease in the additive term µpi∗ . To remedy this, one
can simply find the value for µpi∗ over the range [(Γ/(1 + Γ) + 1/2)/2, Γ¯/(1 + Γ¯)] which
maximizes the right-hand side of (3.17) through a bisection algorithm, and then proceed
with the quadratic program using this single value. If 2Γ¯/(1+Γ¯) < Γ/(1+Γ)+1/2, the right-
hand side of (3.17) is, subject to (3.18), maximized at µpi∗ = Γ¯/(1 + Γ¯), so one can proceed
by replacing µpi∗ with Γ¯/(1 + Γ¯) and solving the required quadratic program. Importantly,
the method only requires solving a single quadratic program. Quadratic programs can be
solved by many free and commercially available solvers; we provide code implementing our
method using the R package for the solver Gurobi, which is free for academic use, at the
author’s website http://www.raidenhasegawa.com. We also provide options to replace
the constraint (3.17), justified by the Central Limit Theorem, with bounds described in
Appendix 3.8.1 which are valid for any I through distribution-free concentration inequalities.
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3.5. Simulations
3.5.1. Type I error control
In the following simulations, we demonstrate that the extended sensitivity analysis intro-
duced in §3.3 has the correct level. We consider two important cases: (1) when no unmea-
sured bias is present and (2) when the there is unmeasured bias but the sensitivity analysis
is conducted at the true values of Γ and Γ¯. In both settings we test Fisher’s sharp null
that τ = 0 using the difference in means test with desired Type I error control at α = 0.05.
We set β = α/10 = 0.005 for conducting the extended sensitivity analysis. The following
treatment model, outcome model, and simulation settings were used to conduct the Type I
error control simulations:
1. Treatment model: Π∗i = 1/2 with probability p = 2(Γ − Γ¯)/{(Γ − 1)(Γ¯ + 1)} and
Π∗i = Γ/(1 + Γ) with probability 1− p.
2. Outcome model:
- unbiased: Yi = τ · (Zi1 − Zi2) + i where i iid∼ N (0, 1),
- biased: Yi = τ · (Zi1 − Zi2) + {2 · χ(pii > 1− pii)− 1} · |i| where i iid∼ N (0, 1).
3. Sensitivity parameters:
- Γ ∈ {1, 1.1, 1.25, 1.5, 2},
- Γ¯ ∈ {1, 1.05, 1.1, 1.15, 1.2, 1.25, 1.3, 1.35,
1.4, 1.45, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0},
- Γ¯ ≤ Γ.
4. Study and simulation size: I = 100 pairs, Nsim = 5000 simulations.
In the biased setting, the unit with higher potential outcome under control has higher
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probability of receiving treatment. When Γ = Γ¯ = 1 we use the convention that p = 0/0 = 0.
The value of p = P(Π∗i = 1/2) was chosen so that the population treatment model satisfies
E[Π¯∗] = Γ¯/(1 + Γ¯). The results of the simulation study for the biased and unbiased settings
are shown in Table 6 and the Table 9 in §3.8.5 of the Appendix, respectively. The extended
sensitivity procedure correctly controls the Type I error rate for all pairs of sensitivity
parameters (Γ, Γ¯) tested. The first row of each table, where Γ¯ = 1, corresponds to tests
under the absence of unmeasured confounding. The pairs where Γ = Γ¯ correspond to
the conventional worst-case sensitivity analysis. Under the unbiased treatment model, the
extended sensitivity analysis is typically more conservative as we increase Γ or Γ¯. In the
biased setting, we observe the same pattern as we vary Γ, but as Γ¯ approaches Γ, the level
of the extended sensitivity analysis does not decrease monotonically. In fact, at a certain
value of Γ¯, the extended sensitivity analysis becomes less conservative as we approach Γ.
In short, the solution pisup,β to the optimization problem in (3.12) tends to more closely
approximate the true allocation pi0 when Γ¯ is close to either 1 or Γ in the biased setting.
When Γ¯ is close to 1, the feasible set of pi’s is closely bounded around pi0 ≈ 1 · 1/2. When
Γ¯ is close to Γ the true allocation is pi0 ≈ piΓ and the extended sensitivity analysis behaves
like the conventional sensitivity analysis, where pisup,β = piΓ yields a tight upper bound on
the probability in (3.11). In between these edge cases, when the feasible set of pi is relatively
large and the trade-off between maximizing expectation and variance is more nuanced, (3.12)
may produce solutions pisup,β that yield appreciably more conservative inference than if had
we known the true pi0.
3.5.2. The power of an extended sensitivity analysis
The power of a sensitivity analysis quantifies the ability of an observational study design
to distinguish treatment effects from unmeasured bias. Formally, it reports for a given
study design the probability of rejecting a false null hypothesis for a chosen level α and
sensitivity parameter Γ under ‘favorable’ conditions, defined in Rosenbaum (2010, Chapter
14), as the presence of a treatment effect that causes meaningful effects and absence of
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Γ
Γ¯ 1 1.1 1.25 1.5 2
1 0.047 0.047 0.045 0.046 0.044
1.05 0.022 0.011 0.007 0.005
1.1 0.032 0.010 0.004 0.003
1.15 0.012 0.002 0.002
1.2 0.017 0.004 0.001
1.25 0.025 0.004 0.001
1.3 0.006 0.000
1.35 0.009 0.001
1.4 0.011 0.001
1.45 0.014 0.001
1.5 0.025 0.001
1.6 0.003
1.7 0.004
1.8 0.006
1.9 0.011
2 0.021
Table 6: Rejection probability of the true null hypothesis, H0 : τ = 0, under the biased
setting with target Type I error control at α = 0.05. The Monte Carlo standard error
of these probability estimates is bounded above by
√
0.05× 0.95/5000 ≈ 0.003 if the true
Type I error rate is 0.05.
unmeasured biases. The investigator cannot determine from observable data alone whether
or not such favorable conditions hold. An attractive study design would be highly insensitive
to unmeasured confounding if she was lucky enough to find herself in this favorable setting.
The power of an extended sensitivity analysis extends this formalism to the triplet (α,Γ, Γ¯).
Power simulations for α = 0.05 and several pairs of (Γ, Γ¯) are reported in Table 7 and Table
10 in §3.8.5 of the Appendix for τ = 0.5 and τ = 0.25, respectively. Other than the presence
of a ‘meaningful’ treatment effect τ , the simulation settings are identical to the unbiased
setting in §3.5.1.
Unsurprisingly, the power of the extended sensitivity analysis decreases as Γ¯ approaches Γ.
If the investigator has reason to believe that unmeasured confounding is heterogeneous and
that extreme pairwise unmeasured confounding is possible but relatively rare, the conven-
tional sensitivity analysis is likely unduly conservative. Further, the extended sensitivity
analysis allows the investigator to compare the power of competing study designs under
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different assumptions about the maximal and expected degree of unmeasured confounding.
Γ
Γ¯ 1 1.1 1.25 1.5 2
1 0.998 0.999 0.998 0.999 0.999
1.05 0.994 0.990 0.984 0.978
1.1 0.996 0.984 0.965 0.941
1.15 0.977 0.947 0.896
1.2 0.978 0.928 0.833
1.25 0.979 0.907 0.759
1.3 0.890 0.719
1.35 0.884 0.664
1.4 0.879 0.626
1.45 0.874 0.578
1.5 0.882 0.541
1.6 0.505
1.7 0.478
1.8 0.463
1.9 0.472
2 0.486
Table 7: Rejection probability of the false null hypothesis, H0 : τ = 0, under the unbiased
setting with true alternative hypothesis H1 : τ = 0.5. The Monte Carlo standard error of
these probability estimates is bounded above by
√
0.5× 0.5/5000 ≈ 0.007.
3.6. Extended sensitivity analysis for returns to schooling
3.6.1. A model for returns to schooling
How does going to college affect job earnings? The question and the implications of the
many putative answers are important to education policy experts and parents alike. It has
been empirically demonstrated that log earnings are nearly a linear function of schooling
(see, for instance, Card and Krueger, 1992). In the idealized paired observational setting
introduced in §§3.2.1-3.2.2 where the treatment condition is attending college for at least two
years and the control condition is receiving at most a high school diploma, a hypothesized
treatment effect τ × 100 would describe the percentage increase in earnings associated
with attending at least two years of college, the minimum number of years to receive an
associates degree. Formally, we consider the multiplicative treatment effect hypothesis
Hτ : RT ij = τRCij where (RT ij , RCij) are potential earnings after attending college or not.
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Choosing t(Z,F) = ZTq to be the adjusted difference-in-means test comparing log earnings,
qij would take the form qij = (logRT ij − logRCij′)− log(τ) and qij′ = −qij under Hτ .
Let X = [Xf , Xs] where Xf and Xs are familial and subject level covariates. In an idealized
sibling comparison design, the strong ignorability condition in (3.1) would hold with respect
to Xf ; that is, if for all xf ,
(RT , RC) ⊥⊥ Z | Xf , 0 < P(Z = 1 | Xf = xf ) < 1. (3.19)
If Xs does not affect treatment assignment but does predict potential outcomes, this sibling
version of strong ignorability will still hold. For example, in the sibling pairs from the WLS
data that we consider in the following section, the age at which income is measured (AGE)
is different between siblings. If Xs = AGE, then it is conceivable that Xs does not affect
whether a sibling went to college or not. This would not be the case for people who went
to college later in life or whose family characteristics may have changed over time, in which
case AGE would be a proxy for those changes. Regardless, model-agnostic adjustment
for Xs and Xf can improve the power of the resulting sensitivity analysis (Rosenbaum,
2002b). For example, we can use simple linear regression to adjust for X by replacing q
with (I −HXs)q where HXs is the orthogonal projection onto Xs without an intercept.
3.6.2. Ashenfelter: Conventional versus extended sensitivity analysis
To illustrate the differences between the conventional and extended sensitivity analyses, we
return to the twin study of Ashenfelter and Rouse (1998) (AR). AR collected survey data on
680 monozygotic twins (340 pairs) attending the Twinsburg Twins Festival in Twinsburg,
Ohio during the summers of 1991, 1992, and 1993. We consider the 40 pairs of twins where
one twin attend at least two years of college and the other had no more than a high school
education, and where both twins were employed at the time of data collection. Assuming
no unmeasured confounding, testing Fisher’s sharp null H0 yields a p-value of ≈ 0.0001.
We obtain a 95% confidence interval for log(τ) of [0.16,0.43] by inverting Hτ for τ ∈ R+ at
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α = 0.05 with a two-sided alternative. Exponentiating the endpoints, attending at least two
years of college versus receiving at most a high school diploma increased wages by between
17% and 53% with 95% confidence.
Being a retrospective study neither baseline IQ nor any other intelligence scores were col-
lected, and a critical reader may point to the possible presence of ability bias as a basis to
call the conclusions of the study into question. Conducting a sensitivity analysis produces
a quantitative rejoinder to this type of criticism in the form of a sensitivity value Γ∗ for
the conventional analysis and a sensitivity curve (Γ∗, Γ¯∗) for the extended analysis. The
sensitivity value is the largest bound on the maximal bias such that the qualitative conclu-
sions of the study do not change (i.e., such that we reject H0). The sensitivity curve is the
two-dimensional analog of the sensitivity value and can be seen as the threshold between
the gray region (reject H0) and the white region (retain H0) in Figure 3. At the limits of
the sensitivity curve, we recover two separate single-parameter sensitivity analyses. The
sensitivity value returned by the conventional analysis corresponds to the point where the
sensitivity curve intersects the y = x line (Γ∗ ≈ 2.36). The limit of the sensitivity curve as
Γ → ∞ is the sensitivity value of a single-parameter sensitivity analysis that bounds the
typical bias (Γ¯ ≈ 1.22).
3.6.3. Ability Bias: Cross-study sensitivity analysis calibration
Without context, the sensitivity curve and values from the Ashenfelter analysis may be
difficult to interpret. In response to the critic of the “equal abilities” hypothesis for twins,
we would ideally like to report whether or not the Ashenfelter study is sensitive to plausible
patterns of ability bias. One strategy for addressing this is to estimate the bias due to
ability from a calibration study that has a comparable design and information on baseline
ability such as IQ. We can then calibrate the sensitivity analysis to these estimates of Γ and
Γ¯. To implement this cross-study calibration, we modify the procedure established in Hsu
and Small (2013) to calibrate sensitivity parameters to observed covariates. In brief, one fits
ostensible treatment and outcome models – for instance, via linear and logistic regression
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Figure 3: Extended sensitivity curve from the AR study calibrated to the estimates of ability
bias from the WLS study (cross). The gray region indicates the sensitivty parameter pairs
(Γ, Γ¯) for which H0 can still be rejected. The point where the sensitivity curve intersects the
y = x line corresponds to the sensitivity value returned by conventional sensitivity analysis
(Γ∗ ≈ 2.36). The limit of the curve as Γ→∞ corresponds to the sensitivity value returned
by the single-parameter sensitivity analysis that bounds the typical bias (Γ¯∗ ≈ 1.22).
– and uses the resulting model fits to estimate pi∗, Γ¯, and Γ. The details of this step can
be found in Appendix 3.8.3. Calibrating the sensitivity analysis to estimates of ability bias
provides the context relevant to the critic’s concerns.
To assess the robustness of the AR study to ability bias, we use the sibling data from the
WLS study introduced in §3.1.2 to design a calibration study. We constructed a set of 171
same-sex, full-sibling pairs that received discordant treatment. We let Zij = 0 if sibling j
in pair i received 12 or fewer years of education and Zij = 1 if he or she received 14 or more
years of education (at least two years of college). Log income for the previous year was
collected for WLS participants and their siblings in 1975 and 1977, respectively. To more
closely approximate the superpopulation from which the AR twins came, we only consider
siblings where both had non-zero income at the time of collection (i.e. were employed). As
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outlined in the previous section, we let Xs = AGE and use regression to adjust q for the age
at which income was collected. This calibration analysis is stylized to some extent to avoid
obscuring the primary contribution of our method. Many other subject-level covariates are
available for adjustment via regression. A detailed analysis including treatment modification
with respect to gender and more thorough covariate adjustment would not preclude the use
nor usefulness of our method.
Using the 171 WLS sibling pairs, we estimate that Γ ≈ 9.3 and Γ¯ ≈ 1.1, summarizing the in-
formation we have about maximal and typical biases due to IQ disparities. Heterogeneneity
of ability bias can explain the considerable difference between these two measures of con-
founding. The histogram of the estimated pi∗ in Figure 4 indicates that most sibling pairs
have modest differences in intelligence in high school but in a few rare cases the disparity
in sibling IQ exposes pairs to high levels of bias. Calibrating the conventional sensitivity
analysis of AR to the WLS study would suggest that our conclusions are likely not robust
to plausible patterns of ability bias since Γ∗ < 9.3. However, calibration of the extended
sensitivity analysis suggests otherwise. In Figure 3, the WLS IQ calibration point (9.3, 1.1)
is indicated by the blue cross and falls below the sensitivity curve. The single-parameter
sensitivity analysis that bounds the typical bias agrees with the extended analysis that the
conclusions are robust to plausible patterns of ability bias (Γ¯∗ ≥ 1.1 ). Incorporating infor-
mation about the heterogeneity of ability bias by bounding both the maximal and typical
biases promotes a less pessimistic assessment of an observational study’s robustness to un-
measured confounding. When information on the heterogeneity of potential confounders is
available, as in the above cross-study calibration analysis, the extended sensitivity analysis
provides a richer picture of the study’s robustness to hidden bias.
3.6.4. Sensitivity intervals: Interval estimates with hidden bias
For a fixed bound on the worst-case bias, incorporating heterogeneous bias through the
extended sensitivity can also produce narrower sensitivity intervals than those attained
through the conventional analysis. Representing a natural extension of confidence intervals
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Figure 4: Histogram of pi∗ estimated for 171 same-sex, full-sibling pairs from the WLS
study.
to inference in the presence of unmeasured confounding, a 100(1−α)% sensitivity interval is
constructed by inverting a level-α extended sensitivity analysis with a two-sided alternative
at a given pair of values (Γ, Γ¯). Explicitly, let pβ(Γ, Γ¯, τ) be the two-sided p-value bound
returned by the extended sensitivity analysis in (3.12) for particular values of Γ and Γ¯.
Then, a 100(1− α)% sensitivity interval can be written as I({τ : pβ(Γ, Γ¯, τ) ≤ α}), where
I(A) is the smallest interval containing the set A. At Γ = Γ¯ = 1, the sensitivity interval is
simply the corresponding confidence interval found by inverting Hτ using the randomization
p-value given in (3.2) as would be justified in a paired experiment. Setting Γ = Γ¯ > 1
returns sensitivity intervals produced through the conventional sensitivity analysis, while
setting Γ > Γ¯ > 1 employs the extended sensitivity analysis in constructing the sensitivity
intervals.
Table 8 illustrates the potential for reduced interval lengths through accommodating het-
erogeneity in unmeasured confounding. It reports 95% sensitivity intervals for log(τ) in the
AR study with three pairs of values for Γ and Γ¯. The first, denoted by Irand, is the 95%
sensitivity interval assuming no unmeasured confounding previously reported in §6.2. The
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second, Isup, is the 95% sensitivity interval derived by setting Γ = Γ¯ = 9.3, the calibrated
value of the maximal bias parameter from the WLS study. This is precisely the sensitivity
interval that the conventional sensitivity analysis bounding only the worst-case confounding
would return. The final interval, Iext, is the 95% sensitivity interval setting Γ = 9.3, Γ¯ = 1.1
in accord with the calibrated values of the maximal and typical bias from the WLS study.
We see that Iext is more than 80% shorter than Isup. Further, both Irand and Iext exclude
zero while Isup does not. The positive finding in the unconfounded setting can be explained
away by bias calibrated to the WLS study using the conventional sensitivity model, but not
when using the extended sensitivity model. Once again, we see that when it is plausible
that the typical bias to which pairs are subject is materially smaller than the worst-case
bias, the conventional analysis may be overly pessimistic about how informative the data
is.
Interval Type 95% Sensitivity Interval
Irand [0.16,0.43]
Isup [-0.88,1.63]
Iext [0.06,0.53]
100× (1− |Iext|/|Isup|) 81%
Table 8: 95% sensitivity intervals for log(τ) in the AR study constructed by inverting
Hτ for different values of Γ and Γ¯. Irand is the 95% confidence interval for log(τ) in the
unconfounded setting, Γ = Γ¯ = 1. Isup and Iext are 95% sensitivity intervals derived
from the conventional sensitivity analysis and the extended sensitivity analysis respectively.
These intervals are formed using the sensitivity parameters calibrated from the WLS data,
(Γ, Γ¯) = (9.3, 1.1). The percentage reduction in interval length from accommodating het-
erogeneous unmeasured confounding, 100× (1− |Iext|/|Isup|), is reported in the last row.
3.7. Concluding remarks
While convenient for ease of calculation, the low-dimensional sensitivity analysis bounding
the supremum may fail to address specific concerns with unmeasured confounding in cer-
tain contexts. Rosenbaum and Silber (2009) present an amplification of the conventional
sensitivity analysis, where the one-dimensional analysis based on Γ is mapped to a curve
of two-dimensional analyses which simultaneously bound the extent to which differences
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in unobserved covariates can influence the odds of being treated and the odds of having a
higher potential outcome under control by the pair (Λ,∆). This amplificiation provides an
aid to interpretation, allowing the researcher to posit bounds on the extent to which unmea-
sured confounding can affect treatment decisions and the outcome variable. Rather than
amplifying the conventional sensitivity analysis, the extended sensitivity analysis provides
the researcher a way to further control the distribution of the unmeasured confounders
beyond bounding the supremum. In fact, amplification and extension can be viewed as
complementary tools available to the researcher. It is straightforward to employ both: the
conventional supremum bound Γ that appears in the extended sensitivity analysis may be
amplified yielding yet an even richer analysis, with Γ¯ bounding the typical probability that
the treated individual in a pair has the larger (smaller) potential outcome under control for
greater-than (less-than) alternatives.
Framing sensitivity analysis in terms of the typical bias is not a new idea, but has been
largely unaddressed in the literature; the idea of expected bias appears briefly in Wang
and Krieger (2006) in the context of population-level inference for binary outcomes but
is not the focus of the paper. In a particular sense, Cornfield et al. (1959) anticipated
the duality of both amplified and extended sensitivity analyses in their seminal work on
sensitivity analysis. In their smoking and lung cancer example, the authors considered a
hypothetical hormone X which increases the probability of developing lung cancer among
those exposed from r2 to r1 and due to a positive correlation between exposure to X and
smoking, appears in a higher proportion among smokers than non-smokers (i.e p1 > p2). At
once, Cornfield et al. (1959) captures the spirit of an amplified analysis in specifying how
X is related to both treatment assignment and outcome and that of an extended analysis
by imagining that hormone X is not completely absent among non-smokers and completely
present among smokers, leading to exposure to bias that is heterogeneous across subjects
within both groups.
The concept of heterogeneous unmeasured confounding appeared naturally, if not intention-
65
ally, in Cornfield’s original example. The extended sensitivity analysis introduced in this
paper brings this idea into a modern light and provides the researcher with a way to con-
duct a sensitivity analysis while bounding both maximal and typical biases in matched pair
studies. Using two sibling studies on the returns of schooling to income, we demonstrated
that a sensitivity analysis bounding the maximal and typical bias is both natural and less
susceptible to an overly pessimistic view of the study’s robustness to hidden bias. When a
researcher believes that most, if not all, pairs are exposed to the worst-case bias, our pro-
cedure can recover the conventional analysis by setting Γ¯ = Γ. If however, the researcher is
worried that some, though few, pairs may be exposed to arbitrarily large biases all is not
lost; by letting Γ tend to ∞ the extended sensitivity analysis recovers a single-parameter
sensitivity analysis that bounds the typical bias.
3.8. Appendix
3.8.1. Construction of Valid Finite-Sample Uncertainty Sets
We now describe the construction of two 100(1− α)% uncertainty sets for Π∗ valid for any
number of pairs I. The first is based on Hoeffding’s inequality, which implies that the set
Hβ(Γ, µpi∗) = (−∞, µpi∗ + I−1/2
{
1/2 log(1/β)(Γ/(1 + Γ)− 1/2)2}1/2]
satisfies P(Π¯ ∈ Hβ(Γ, µpi∗)) > 1 − β for all values of I. The second combines Bennett’s
inequality and the Bhatia-Davis inequality to create the set
Bβ(Γ, µpi∗) = (−∞, µ¯pi∗ + bβ(Γ, µpi∗ , I)]
bβ(Γ, µpi∗ , I) = SOLVE{a : I−1 log(1/β)(Γ/(1 + Γ)− 1/2)2/ν2(Γ, µpi∗) =
h
(
a(Γ/(1 + Γ)− 1/2)/ν2(Γ, µpi∗)
)},
where h(x) = (1 + x) log(1 + x)− x. Bβ(Γ, µpi∗). This set also satisfies P(Π¯ ∈ Bβ(Γ, µpi∗)) >
1− β for any I if E[Π¯∗] = µpi∗ .
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In practice, the upper bound of the set based on Bennett’s inequality is smaller than that
based on Hoeffding’s inequality when µpi∗ is far from (Γ/(1+Γ)+1/2)/2, while the ordering
reverses when µpi∗ is close to the midpoint. The price paid for this exactness for any I is that
the upper bounds for both intervals are larger than those of Cβ(Γ, µpi∗), the asymptotically
valid uncertainty set based on the Central Limit Theorem.
As noted in the manuscript, the general reliance of our implementation on asymptotic
normality reduces the attractiveness of these finite sample uncertainty sets; however, in the
case of McNemar’s test with binary data, employing either Hβ or Bβ yields an extended
sensitivity analysis for Fisher’s sharp null valid for any sample size. R functions to compute
these uncertainty set can be found in the file multipliers.R at the author’s website http:
//www.raidenhasegawa.com.
3.8.2. Constructing the WLS same-sex sibling sample
Of the 10,317 individuals in the WLS sample, 7,928 had a randomly chosen sibling who was
surveyed. Of those 7,928 subjects with sibling data, 2,106 had information about sibling
status (i.e. full, half or step siblings) of which 2,004 were full siblings. 1,486 of these sibling
pairs were same-sex siblings of which 49.3% were men. Of the same-sex sibling pairs, there
were 749 (40.6% men) where both had no more than a high school education, 265 (64.9%
men) where both had at least two years of college education, and 323 (58.8% men) where one
had at most a high school degree and the other had at least two years of college education.
Of the same-sex pairs discordant in educational attainment, 171 (74.9% men) had complete
IQ data and non-zero reported income. There were 149 (45.0% men) same-sex sibling pairs
of the 1,486 for which the treatment and control conditions were not well defined – at least
one sibling had only one year of college education.
3.8.3. Calibrating Sensitivity Parameters to Disparities in IQ in the WLS Study
We follow a modified version of the calibration strategy introduced in Hsu and Small (2013)
which involves estimating putative treatment and outcome models as a function of (X,U)
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under H0 via maximum likelihood where the likelihood is marginalized over the unknown
confounder U . Our modification is as follows: instead of marginalizing over the unobserved
covariate we suppose that the only unobserved confounder in the Ashenfelter study is intelli-
gence, which is measured via baseline IQ scores in the WLS study. Consequently, estimating
the bias due to IQ disparities using the WLS data permits a cross-study calibration of the
Ashenfelter and Rouse sensitivity analysis.
By definition, Xf is controlled automatically between siblings. We make the stylized as-
sumption that Xs = AGE. Further, we assume that AGE does not affect treatment
assignment. Finally, we assume that intelligence is the only unmeasured confounder in the
Ashenfelter and Rouse study (i.e. U = IQ). Under these assumptions, a possible model for
treatment assignment is
P(Zij = 1 | Xf,i, Xs,ij , Uij) = exp(αZ,i + βZ,IQ · IQij)
1 + exp(αZ,i + βZ,IQ · IQij) . (3.20)
The pair specific intercept αZ,i captures the Xf,i effects. We estimate the treatment model
using conditional likelihood maximization using the R function clogit in order to avoid
bias arising from the fact that the number of αi to be estimated grows with the sample size.
We consider a Gaussian linear model for the outcome
Yij = αY,i + βY,AGE ·AGEij + βY,IQ · IQij + ij such that ij iid∼ N (0, σ2) . (3.21)
We estimate the treatment assignment and outcome models using the 171 discordant sibling
pairs that we analyze from the WLS study in the paper.
In the Ashenfelter and Rouse twins study, AGE is controlled within twin pairs so we
are interested in calibrating the sensitivity parameters to the estimated bias due to IQ
disparities alone. Following Hsu and Small (2013) we estimate that, controlling for age and
assuming that IQ is the only confounding factor, the probability that the sibling that went
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to college reported a higher income in pair i to be
pii(IQ) =
exp{βˆZ,IQ(IQi1 − IQi2)} exp{(βˆY,IQ/σˆ2)(Yi(2) − Yi(1))(IQi1 − IQi2)}+ 1
[1 + exp{βˆZ,IQ(IQi1 − IQi2)}][1 + exp{(βˆY,IQ/σˆ2)(Yi(2) − Yi(1))(IQi1 − IQi2)}]
where Yi(1) = min{Yi1, Yi2} and Yi(2) = max{Yi1, Yi2}. Define pi(IQ) to be the 171×1 vector
of pii(IQ). Letting pi
∗(IQ) = pi(IQ) when βˆZ,IQβˆY,IQ ≥ 0 and 1−pi(IQ) otherwise, one rea-
sonable set of estimates for (Γ, Γ¯) is (pimax/(1+pimax), p¯i/(1+p¯i)) where pimax = supi pi
∗
i (IQ)
and p¯i = (1/171)
∑171
i=1 pi
∗
i (IQ). It may concern some that pimax/(1+pimax) is a downwardly-
biased estimator of Γ, but due to sampling variability and possible misspecification of the
treatment and outcome models, the calibration is inherently approximate and meant only
to act as a guide for the researcher conducting a sensitivity analysis of the Ashenfelter
and Rouse study. It should also be noted that since higher IQ does not perfectly predict
higher earnings, we find ourselves in a simultaneous sensitivity framework where we simul-
taneously bound the dependence between IQ and education and between IQ and earnings
(see Gastwirth et al. (1998) for further details). This explains the slightly different defini-
tion of pi∗i used here than the one found in the paper. Simultaneous sensitivity analysis is
closely related to amplified sensitivity analysis, which we discuss briefly in §3.7 of the paper
(see Rosenbaum and Silber (2009) for more details). For our purposes, the simultaneous
framework suffices to calibrate Γ and Γ¯ in the Ashenfelter and Rouse study to the WLS
study.
3.8.4. Details of Histogram in Right Panel of Figure 2
The figure in the right panel of Figure 2 in the paper is described as the [h]istogram of the
estimated increase in pairwise bias due to IQ disparities between siblings measured as an
odds ratio. To be specific, and using the notation introduced in Appendix 3.8.3, this is a
histogram of
pi∗i (IQ)
1− pi∗i (IQ)
/
pi∗i (0)
1− pi∗i (0)
(3.22)
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for i = 1, . . . , 171 where pi∗i (0) = (1/2) is pi
∗
i computed for the sibling pair i had they had
same IQ scores.
3.8.5. Additional Simulation Results
Table 9 shows the rejection probability of the true null hypothesis, H0 : τ = 0, under the
unbiased setting with target Type I error control at α = 0.05. Table 10 shows the power to
reject the false null hypothesis, H0 : τ = 0, under the unbiased setting with true alternative
hypothesis H1 : τ = 0.25 and target Type I error control at α = 0.05.
Γ
Γ¯ 1 1.1 1.25 1.5 2
1 0.049 0.044 0.042 0.050 0.045
1.05 0.018 0.010 0.008 0.004
1.1 0.016 0.007 0.002 0.001
1.15 0.005 0.000 0.000
1.2 0.003 0.000 0.000
1.25 0.004 0.001 0.000
1.3 0.000 0.000
1.35 0.000 0.000
1.4 0.001 0.000
1.45 0.000 0.000
1.5 0.000 0.000
1.6 0.000
1.7 0.000
1.8 0.000
1.9 0.000
2 0.000
Table 9: Rejection probability of the true null hypothesis, H0 : τ = 0, under the unbiased
setting with target Type I error control at α = 0.05. The Monte Carlo standard error
of these probability estimates is bounded above by
√
0.05× 0.95/5000 ≈ 0.003 if the true
Type I error rate is 0.05.
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Γ
Γ¯ 1 1.1 1.25 1.5 2
1 0.694 0.677 0.677 0.694 0.683
1.05 0.544 0.462 0.391 0.338
1.1 0.528 0.363 0.282 0.188
1.15 0.340 0.202 0.123
1.2 0.322 0.160 0.072
1.25 0.333 0.132 0.046
1.3 0.121 0.031
1.35 0.111 0.024
1.4 0.110 0.019
1.45 0.107 0.017
1.5 0.119 0.015
1.6 0.012
1.7 0.006
1.8 0.009
1.9 0.008
2 0.010
Table 10: Rejection probability of the false null hypothesis, H0 : τ = 0, under the unbiased
setting with true alternative hypothesis H1 : τ = 0.25 and target Type I error control at
α = 0.05. The Monte Carlo standard error of these probability estimates is bounded above
by
√
0.5× 0.5/5000 ≈ 0.007.
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CHAPTER 4
Evaluating Missouri’s Handgun Purchaser Law: A Bracketing Method for
Addressing Concerns about History Interacting with Group
Abstract
In the comparative interrupted time series design (also called the method of difference-
in-differences), the change in outcome in a group exposed to treatment in the periods
before and after the exposure is compared to the change in outcome in a control group
not exposed to treatment in either period. The standard difference-in-difference esti-
mator for a comparative interrupted time series design will be biased for estimating
the causal effect of the treatment if there is an interaction between history in the after
period and the groups; for example, there is a historical event besides the start of the
treatment in the after period that benefits the treated group more than the control
group. We present a bracketing method for bounding the effect of an interaction be-
tween history and the groups that arises from a time-invariant unmeasured confounder
having a different effect in the after period than the before period. The method is
applied to a study of the effect of the repeal of Missouri’s permit-to-purchase handgun
law on its firearm homicide rate. We estimate that the effect of the permit-to-purchase
repeal on Missouri’s firearm homicide rate is bracketed between 0.9 and 1.3 homicides
per 100,000 people, corresponding to a percentage increase of 17% to 27% (95% con-
fidence interval: [0.6,1.7] or [11%,35%]). A placebo study provides additional support
for the hypothesis that the repeal has a causal effect of increasing the rate of state-wide
firearm homicides.
4.1. Comparative Interrupted Time Series Design and Potential Biases
The interrupted time series design is an observational study design for estimating the causal
effect of a treatment on a group when data is available before the group was treated. In
the simplest interrupted time series design, the before and after treatment outcomes are
compared. This before-after design does not account for confounding factors that co-occur
with treatment such as historical events or maturation (Cook et al., 2002). To strengthen
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the before-after design, it is common to add time series data from a control group that
never received the treatment over the same period – the comparative interrupted time
series design (Cook et al., 2002; Meyer, 1995; Bernal et al., 2017; Wing et al., 2018), also
called the nonequivalent control group design or method of difference-in-differences. The
latter name derives from the concept that the simplest comparative interrupted time series
analysis is to take the difference between the difference of the after and before outcomes
for the treated group and the difference of the after and before outcomes for the control
group. This difference-in-differences estimate is an unbiased estimator of the causal effect
of treatment if the treatment and control groups would have exhibited parallel trends in
the counterfactual absence of treatment (Meyer, 1995); see Figure 5. The parallel trends
Figure 5: Stylized plot of data from a comparative interrupted time series design. The
dotted line shows the assumption that the difference-in-difference (DiD) estimate makes
about the treatment group’s counterfactual mean in the absence of treatment.
Before After
Control Group
Treated Group
Counterfactual Treated Group w/o Treatment
DiD Estimate
assumption can be partially assessed if there is more than one time point in the before
period by assessing whether the groups exhibit parallel trends in the before period (Meyer,
1995). However, even if the trends are parallel in the before period, there could be historical
events in the after period that affect the two groups differently, i.e., history interacts with
group (other reasons that parallel trends could be violated include differences in maturation,
instrumentation or statistical regression between the groups) (Cook and Campbell, 1979;
Reynolds and West, 1987). For example, the outcome measures poor health, country A
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(treated group) enacts a policy reform, country B (control group) does not enact the reform,
and a worldwide economic recession occurs after the reform that has a greater impact on
people starting out in poorer health. If country B started out with poorer health, then
parallel trends would be violated because country B’s poor health would have increased
more than country A in the after period in the counterfactual absence of the reform because
of the worldwide economic recession. This violation of parallel trends would not happen if
A and B started with the same level of poor health in the before period. However, it is
often difficult to find a control group that has outcomes close to the treated group in the
before period.
When there is no control group completely comparable to the treated group, Campbell
(1969) proposed bracketing to distinguish treatment effects from plausible biases (Rosen-
baum, 1987). Consider the study design of comparing treatment and control at one time
point and suppose that there is concern about an unmeasured confounder U . Bracketing
uses two control groups such that, in the first group U tends to be higher than in the
treated group and in the second group, U tends to be lower. The effect of U on the treated
group is bracketed by its effect on the two control groups. When there is bracketing, if the
treated group has a notably higher outcome than both control groups, then this association
between treatment and outcome cannot plausibly be explained away as being bias from U .
In this paper, we show how bracketing can be applied to the comparative interrupted time
series to distinguish treatment effects from plausible biases due to history interacting with
group. The basic idea is to consider one control group that has a lower expected outcome
than the treated group in the before period and another control group that has a higher
expected outcome than the treated group in the before period; we show under certain
assumptions that the expectations of the two difference-in-difference estimators using the
lower control group and higher control group respectively bracket the causal effect of the
treatment. Bracketing for the comparative interrupted time series has been mentioned
informally (Meyer, 1995) but the idea of choosing the bracketing control groups based on
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expected before period outcomes was not mentioned. We present assumptions and results
for our bracketing method in §4.2 and then apply the method to study the effect of the
repeal of Missouri’s permit-to-purchase handgun law on its firearm homicide rate in §4.3.
4.2. Methods: Bracketing
4.2.1. Notation and Model
Let Y denote outcome and D dose of exposure, D = 1 for treatment and D = 0 for
control. Let Y
(d)
ip denote the counterfactual outcome that would have been observed for
unit i in period p, p = 0 for before period and p = 1 for after period, had the unit received
exposure dose d, i.e., Y
(1)
ip is the counterfactual outcome under treatment and Y
(0)
ip is the
counterfactual outcome under control. Let Ui be a vector of time invariant unmeasured
confounders for unit i. Let G denote group where the groups are t = treated group, lc =
lower control group (control group with expected outcomes lower than treated group in
before period) and uc = upper control group (control group with expected outcomes higher
than treated group in before period). Finally, let S be an indicator of whether or not a unit
belonging to a particular group is in the study population in a given period. Specifically,
Sip = 1 or 0 when unit i is in the population or not in period p: Si0 = Si1 = 1 for a
unit in the population both before and after treatment, Si0 = 1, Si1 = 0 for a unit in the
population only before treatment (unit might have moved away or died in after period) and
Si0 = 0, Si1 = 1 for a unit in the population only after treatment (unit might have moved
into study area or been born in after period).
We consider the following model which generalizes the standard difference-in-difference
model and changes-in-changes model. (Athey and Imbens, 2006) Let Ui be time-invariant
unmeasured confounders and ip be an error term that captures additional sources of vari-
ation for unit i in period p. Then our model can be expressed as
Y
(d)
ip = h(Ui, p) + βd+ ip (4.1)
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where the function h(Ui, p) is the unobserved expected outcome under control of subject i
in period p. We drop the subscript i to refer to a randomly drawn unit from the population
of all units in either period, where Y
(d)
p , d = 0, 1, and p are undefined if Sp = 0. We make
the following assumptions:
Increasingness of h in U: h(U, p) bounded and increasing in U for p = 0, 1. (4.2)
((h(U, p) ≥ h(U′ , p) whenever all coordinates of U ≥ all coordinates of U′)
Time Invariance of U Within Groups: U conditionally independent of (4.3)
{S0, S1} given group G.
Independence of  with Time and Group: Distributions of p|Sp = 1, G = g for (4.4)
p = 0, 1, g = lc, uc, tc all have mean zero and are the same.
Assumptions (4.2) and (4.3) match assumptions in the changes-in-changes model. Assump-
tion (4.2) requires that higher levels of unmeasured confounders correspond to higher levels
of outcomes. Such increasingness is natural when the unmeasured confounder is an individ-
ual characteristic such as health or ability (Athey and Imbens, 2006) and Y is a measure of
some positive outcome, for example, income. Negative confounders – where higher levels of
the confounder correspond to lower levels of the outcome – are not precluded by Assump-
tion (4.2) as the corresponding coordinates of U may simply be replaced by their negation.
Assumption (4.3) says that the distribution of confounders in the population of units for a
given group remains the same over time. Assumption (4.4) says that time-varying factors
have the same distribution in each group and over time. It would be sufficient for subsequent
developments to just assume the distributions of p|Sp = 1, G = g for p = 0, 1, g = lc, uc, tc
all have mean zero rather than the stronger assumption of identical distributions. We can
further relax this assumption by assuming zero mean only for components of p that are
true confounders, that is, factors whose distributions depend on the interaction of time and
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group. Assumption (4.4) is weaker than the changes-in-changes model assumption that ip
is always zero which rules out classical measurement error in the outcome when h is non-
linear (Athey and Imbens, 2006). Our model contains the standard difference-in-difference
model, which can be represented in our model by h(U, p) = k(U) + τp for some bounded
and increasing function k, where k(U) can be viewed as a group fixed effect.
We make two further assumptions about the distribution of U in groups and how its effect
over time changes among the groups. First, we assume the distribution of U within groups
can be stochastically ordered so that U is lowest in the lower control group, intermediate
in the treated group and highest in the upper control group:
U|G = lc  U|G = t  U|G = uc (4.5)
where two random vectors A,B are stochastically ordered, A  B, if E[f(A)] ≤ E[f(B)]
for all bounded increasing functions f (Shaked and Shanthikumar, 1994). For example, if
U is normally distributed with common variance and group means µlc, µt, and µuc, then
µlc ≤ µt ≤ µuc would imply (4.5). Second, we assume that higher values of U either have a
bigger effect over time over the whole range of U or a smaller effect over the whole range:
Either (i) h(U, 1)− h(U, 0) ≥ h(U′ , 1)− h(U′ , 0) for all U ≥ U′ , U,U′ ∈ U or
(ii) h(U, 1)− h(U, 0) ≤ h(U′ , 1)− h(U′ , 0) for all U ≥ U′ , U,U′ ∈ U (4.6)
An example of this pattern of U confounding could occur in a study of the effect of a regional
policy on average income where the policy change occurred contemporaneously with an
easing of trade restrictions. A potential unmeasured confounder for such a study would be
U = share of skilled workers in a region, as a higher share of skilled workers is associated
with higher average income. There is considerable evidence that trade liberalization leads
to an increase in the skill premium – the relative wage of skilled to unskilled workers – at
both the regional and country level (Dix-Carneiro and Kovak, 2017; Burstein and Vogel,
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2017). Thus, we might expect (i) in (4.6) to hold if there was an easing of trade restrictions
in the after period.
We assume units are randomly sampled from each group in each time period. The data
could be obtained from repeated cross sections or a longitudinal study. Inferences under
different sampling assumptions are discussed in Appendix 4.5.1.
4.2.2. Bracketing Result
The standard moment difference-in-difference estimator using control condition c can be
written as βˆdd.c = (Y 1|G=t−Y 0|G=t)−(Y 1|G=c−Y 0|G=c) where Y p|G=g indicates the sample
average of units observed in group g and time period p, Yp|G = g, Sp = 1. This estimate is
equivalent to the coefficient on the treatment indicator in a fixed effects regression with full
time and group indicator variables. When using data already aggregated at some level, for
example by state-year, a fixed effects regression using weights proportional to population
will return this estimate. In the following, we show that the expectation of the two standard
difference-in-difference estimators computed with the upper and lower controls can be used
to bound the treatment effect.
The expected value of the standard difference-in-difference estimator comparing the treated
group to the lower control group, βˆdd.lc, is
E[βˆdd.lc] = {E[Y1|G = t, S1 = 1]− E[Y0|G = t, S0 = 1]}
−{E[Y1|G = lc, S1 = 1]− E[Y0|G = lc, S0 = 1]}
= {β + E[h(U, 1)|G = t, S1 = 1]− E[h(U, 0)|G = t, S0 = 1]}
−{E[h(U, 1)|G = lc, S1 = 1]− E[h(U, 0)|G = lc, S0 = 1]},
where Y1, Y0 denote observed outcomes in after period (p = 1) and before period (p = 0)
respectively. Under the time invariance of U within groups assumption (4.3), we have
E[βˆdd.lc] = β + {E[h(U, 1)− h(U, 0)|G = t]} − {E[h(U, 1)− h(U, 0)|G = lc]}; (4.7)
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similarly, the expected value of the difference-in-difference estimator comparing the treated
group to the upper control group, βˆdd.uc, is
E[βˆdd.uc] = β + {E[h(U, 1)− h(U, 0)|G = t]} − {E[h(U, 1)− h(U, 0)|G = uc]}. (4.8)
The difference-in-difference estimators βˆdd.lc and βˆdd.uc are unbiased if h(U, 1) − h(U, 0)
is constant for all U, i.e., the time effect between periods is the same for all levels of
U, or equivalently, the effect of the unmeasured confounders is the same in both time
periods. If the effect of the unmeasured confounders changes between periods, then because
of assumptions (4.5) and (4.6), we conclude from (4.7) and (4.8) that
min{E[βˆdd.lc], E[βˆdd.uc]} ≤ β ≤ max{E[βˆdd.lc], E[βˆdd.uc]}, (4.9)
i.e., the expected values of the difference-in-difference estimators using the upper control
group and lower control group bracket the causal effect (proof in Appendix 4.5.2). The
tightness of the bracketing bounds in (4.9) and, to some extent, the width of the corre-
sponding confidence interval developed in following section depend on the magnitude of
the group-by-time interaction. For example, if urban poverty concentration varied notably
between groups and its effect on firearm homicides were modulated by the Great Recession,
one would expect looser bracketing bounds.
4.2.3. Inference
We would like to make inferences for the causal effect β under the assumption (4.6) that
h(U, 1) − h(U, 0) is either an increasing or decreasing function of U (we do not want to
specify which a priori). Let θlc.t = E[βˆdd.lc] and θuc.t = E[βˆdd.uc], i.e., the expected values
of the difference-in-difference estimators using the lower control group and upper control
group, respectively. From the bracketing results (4.9), we have
min(θlc.t, θuc.t) ≤ β ≤ max(θlc.t, θuc.t).
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and the following interval, where CI means two-sided confidence interval,
[min(lower bound of 1− α CI for θlc.t, lower bound of 1− α CI for θuc.t),
max(upper bound of 1− α CI for θlc.t, upper bound of 1− α CI for θuc.t)], (4.10)
has probability ≥ 1− α of containing both min(θlc.t, θuc.t) and max(θlc.t, θuc.t), and thus β,
where it assumed that the two-sided CIs are constructed by taking the intersection of two
one-sided 1− (α/2) confidence intervals (proof in Appendix 4.5.3).
4.2.4. Constructing the Lower and Upper Control Groups
The results in §4.2.2-4.2.3 assume the lower and upper control groups have been constructed
before looking at the data. If the lower control group was constructed by looking at the
before period data by choosing units with lower outcomes than the treated in the before
period, then the sample average of Y0|G = lc, S0 = 1 may tend to be lower than E(Y0|G =
lc, S0 = 1). Consequently, the difference-in-difference estimate using the lower control group
may be downward biased even if the parallel trends assumption holds because of regression
to the mean (Cook et al., 2002); similarly, the difference-in-difference estimated using the
upper control group may be upward biased. This may invalidate the bracketing result (4.9).
To avoid bias arising from regression to the mean, we propose first selecting a “pre-study”
time period prior to the before period. Then, the lower control group can be constructed
from units with lower outcomes than the treated in this pre-study period and the upper
control group from units with higher outcomes. It should then be tested whether the
constructed lower control group has smaller expected outcomes than the constructed upper
control group in the before period; see §4.3 for example.
4.2.5. Role of Examining the Groups’ Relative Trends in the Before Period
In the standard difference-in-difference analysis that assumes parallel trends, when the be-
fore period contains multiple time points, it is good practice to test for parallel trends in the
before period (Meyer, 1995; Volpp et al., 2007). In our bracketing approach, we do not need
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the parallel trend assumption to hold, but examining the relative trends of the groups in
the before period is still useful for assessing model plausibility and assumptions. Our model
(4.1)-(4.4) along with assumptions (4.5)-(4.6) implies that if we had counterfactual data on
the treatment group in the after period in the absence of treatment, then, without sampling
variance, we would see either: (i) the differences between the upper control and counterfac-
tual treated groups and the difference between the counterfactual treated and lower control
groups in the after period would be at least as large as their respective differences in the
before period or (ii) the difference between the upper control and counterfactual treated
groups and the difference between the counterfactual treated and lower control groups in
the after period would be no larger and possibly smaller than their respective differences
in the before period. The following two patterns would violate the model/assumptions:
(iii) the difference between the upper control and counterfactual treated groups is larger
after than before and the difference between the counterfactual treated and lower control
groups is smaller after than before or (iv) the difference between the upper control and
counterfactual treated groups is smaller after than before and the difference between the
counterfactual treated and lower control groups is larger after than before. Although we
do not have the counterfactual treatment group’s data in the absence of treatment in the
after period, we have the treatment group’s data in the absence of treatment in the before
period. We can split the before period into two (or more) periods and test whether the
pattern in the before period is consistent with the model. Visual inspection of the relative
trends of the counterfactual treated group and the upper and lower control groups during
the before period can provide additional evidence for or against the model assumptions.
4.2.6. Time-Varying Confounders
Our bracketing method addresses an interaction between history and groups that arises
because the time-invariant unmeasured confounders that differ between the groups in the
before period (U) become more (or less) important in the after period (assumption (4.6)).
When there are time-varying confounders, the bracketing method still works under certain
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assumptions. Time-varying confounders can be represented in model (4.1) by letting U
contain all variables that differ in distribution between the groups in the before period, i0
be the effect of factors that do not differ in distribution between the groups in the before
period and i1 be the effect of the same factors in i0 in the after period as well as factors
not contained in U that differ in distribution between the groups in the after period (details
on time-varying model in Appendix 4.5.4. If this last set of factors is present, then (4.4)
may not hold. However, the bracketing result (4.9) still holds as long as (i) in (4.6) holds,
E[i1|G = uc] ≥ E[i1|G = t] ≥ E[i1|G = lc], (4.11)
or when (ii) in (4.6) holds,
E[i1|G = uc] ≤ E[i1|G = t] ≤ E[i1|G = lc]; (4.12)
Appendix 4.5.4 contains a proof and sufficient conditions for (4.11) or (4.12) to hold. One
of these sufficient conditions (condition (c) in Appendix 4.5.4 is analogous to (i) in (4.6) in
that effects on the outcome, be they time effects or those due to contemporaneous shocks
to confounders, are amplified at larger values of U.
One type of time-varying confounder is a variable that largely stays the same between
time periods but may change modestly. For example, in our study of Missouri’s repeal of
their permit-to-purchase law in §4.3, urban concentration of poverty might be a confounder
and U contain urban concentration of poverty in the before period. Urban concentration
of poverty may stay mostly the same over time but change modestly, where the changes
are reflected in 1. If the effect of urban concentration of poverty on firearm homicides
increased in the after period, then the bracketing result would still hold (with respect to
the confounding from urban concentration of poverty) as long as the impact of changes in
urban concentration of poverty on firearm homicides were at least as great in the upper
control group as Missouri and at least as great in Missouri as the lower control group.
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4.3. Application: Effect of the Repeal of Missouri’s Handgun Purchaser Licensing
Law on Firearm Homicides
American federal gun law requires background checks and record keeping for gun sales by
federally licensed firearm dealers but exempts these regulations for private sales. However,
some states have laws requiring all purchasers of handguns from licensed dealers and pri-
vate sellers to acquire a permit-to-purchase license that verifies the purchaser has passed
a background check. Missouri passed a permit-to-purchase law in 1921, requiring handgun
purchasers to obtain a license from the local sheriff’s office that facilitated the background
check, but repealed the law on August 28, 2007. Webster et al. (2014) examined the effect
of Missouri’s repeal on firearm homicide rates (the rate of homicides committed using a
firearm). One of their analyses used a comparative interrupted time series design, compar-
ing Missouri to the eight states bordering Missouri using a before-period of 1999-2007 and
after-period of 2008-2010 (the only available post-repeal data at the time of their analy-
sis), finding evidence that the repeal of Missouri’s permit-to-purchase law increased firearm
homicide rates (see their Table 1). None of the border states introduced new or made
changes to existing permit-to-purchase laws during the study period. Using a fixed effect
regression and adjusting for several background crime and economic covariates, they esti-
mated that the Missouri permit-to-purchase repeal was associated with an increase in the
firearm homicide rate by 1.1 per 100,000 persons (95% confidence interval [CI]: 0.8,1.4) ,
a 22% (95% CI: 16 %, 29%) increase. Non-gun related homicides remained virtually un-
changed. In what follows, we re-examine the effect of Missouri’s repeal using bracketing
and the now available after-period data from 2008-2016 to address possible biases arising
from unobserved state-by-time interactions.
Figure 6 shows the age-adjusted firearm homicide rates in Missouri and the border states
over the study period using data from the Centers for Disease Control and Prevention (CDC)
Wide-ranging Online Data for Epidemiologic Research (WONDER) system (http://wonder.cdc.gov,
2018). The standard difference-in-difference estimate using all neighboring control states,
83
shown in the top row of Table 12, is that Missouri’s permit-to-purchase repeal increased
firearm homicides by 1.2 per 100,000 persons (95% CI: 1.0,1.4), corresponding to a 24%
increase (95% CI: 18%,31%). In the before-period, Missouri had generally higher firearm
Figure 6: Age-adjusted firearm homicide rates in Missouri and states bordering Missouri
(population-weighted averages), 1999-2016.
homicide rates than the control border states, suggesting a lack of comparability between
the groups. One concern is that the start of the after period coincided with the beginning
of the Great Recession. The economic downturn was followed by a decline in homicide
rates. Possible reasons for the effect of the downturn on homicide rates and violence gener-
ally include changing alcohol affordability, disposable income, unemployment, and income
inequality (Matthews et al., 2006; Wolf et al., 2014; Shepherd and Page, 2015). The effects
of the economic downturn on firearm homicides might interact with the starting level of
firearm homicides in a state. To address this concern, we constructed upper and lower
control groups that bracket Missouri’s firearm homicide rate in the before period. To avoid
regression to the mean in §4.2.4, we use data from 1994-1998, the five years prior to our be-
fore period, to choose the upper and lower control groups; see Table 11 for data. The lower
control group is Iowa, Kansas, Kentucky, Nebraska, and Oklahoma and the upper control
group is Arkansas, Illinois, and Tennessee. The population-weighted firearm homicide rate
in the before period of 1999-2007 is 5.2 in the upper control states, 4.7 in Missouri, and
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2.7 in the lower control states (95% CI for difference between upper control and Missouri:
0.2,0.8; 95% CI for difference between Missouri and lower controls: 1.8,2.2).
Table 11: Age-adjusted firearm homicide rates per 100,000 persons from periods 1994-1998
(pre-study period used to construct lower and upper control groups), 1999-2007 (before re-
peal period where repeal refers to repeal of Missouri’s permit-to-purchase handgun licensing
law) and 2008-2016 (after repeal period).
1994-1998 1999-2007 2008-2016
Missouri 6.1 4.7 6.1
Arkansas 7.3 5.1 5.5
Illinois 7.1 5.1 5.2
Iowa 1.2 0.9 1.2
Kansas 4.2 3.0 3.0
Kentucky 4.1 3.3 3.7
Nebraska 2.2 1.8 2.4
Oklahoma 4.8 3.8 4.8
Tennessee 6.9 5.5 5.4
Population-weighted 5.6 4.2 4.4
All Controls
Population-weighted 7.1 5.2 5.3
Upper Controls
Population-weighted 3.5 2.7 3.2
Lower Controls
Figure 7 shows firearm homicides rates (age-adjusted and population-weighted) in the brack-
eted control groups compared to Missouri. The bottom two rows of Table 12 show the
difference-in-difference estimates using the lower and upper control groups and 95% CIs.
Both the lower and upper control groups provide evidence that Missouri’s repeal of its
permit-to-purchase handgun law increased firearm homicides, bracketing the effect of the
repeal between 0.9 and 1.3 homicides per 100,000 people, corresponding to a percentage
increase of 17% to 27%. The interval (4.10) that has a ≥ 95% chance of containing the
effect of the repeal on the firearm homicide rate is [0.6, 1.7], corresponding to an 11% to
35% increase in firearm homicides, providing evidence that the repeal increased firearm
homicides.
4.3.1. Assessing Model Assumptions: Time-Varying Confounders and Relative Trends
A type of time-varying confounder that is relevant to the Missouri permit-to-purchase study
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Figure 7: Age-adjusted gun homicide rates per 100,000 persons in Missouri, lower control
states bordering Missouri (population-weighted averages) and upper control states bordering
Missouri, 1999-2016.
Table 12: Difference-in-difference estimates of effect of repeal of Missouri’s permit-to-
purchase handgun licensing requirement on firearm homicide rates per 100,000 persons.
CI indicates confidence interval.
Control Group Estimate 95% CI % Change Estimate 95% CI
All Controls 1.2 [0.9, 1.5] 24% [18% ,31%]
Upper Controls 1.3 [0.9, 1.7] 27% [19% ,35%]
Lower Controls 0.9 [0.6, 1.2] 17% [11% ,23%]
is a factor that only arises in the after period. The Ferguson unrest in 2014 might have led to
less effective policing (spikes in violence typically follow social unrest) in Missouri compared
to other states. Such a time-varying confounder would be unlikely to satisfy (4.11) or (4.12)
because it arises only in the treated group (Missouri) in the after period. However, this
confounder alone does not change our finding that the repeal increased firearm homicides.
If we limit the study to 2008-2013, Missouri still has larger increases in firearm homicide
rates than both the upper and lower control groups; see Appendix 4.5.6.
To assess the plausibility of our model (4.1)-(4.4) and assumptions (4.5)-(4.6), we apply
the relative trends test described in §4.2.5. Applying the test to our study of the repeal
of Missouri’s permit-to-purchase law, we do not find evidence that our model assumptions
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are violated. Visual inspection of the relative trends of counterfactual Missouri and the
upper and lower controls in the before period further supports the plausibility of our model
assumptions; see Figure 9 in Appendix 4.5.5.
4.3.2. Standard Error Estimates: A Poisson Model for Death Counts
The standard errors used for inference in the previous section come directly from the CDC
WONDER system. Vital statistics that derive from complete counts of deaths (by cause)
are not subject to sampling error. Nonetheless, a stochastic model of vital statistics may
be justified by the presence of biological, environmental, sociological, and other natural
sources of variability (Brillinger, 1986). For inferential purposes, a census may be viewed
as a realization from such a stochastic process under similar conditions to those observed
(Keyfitz, 1966). In particular, the observed firearm homicide death rate in any state-year
may be viewed as one of a large series of possible Poisson distributed outcomes under
similar conditions (US Department of Health and Human Services, 2004). The standard
errors reported by the CDC are computed under this Poisson model.
4.3.3. A Placebo Study: Assessing Alternative Sources of Uncertainty
There may be other sources of uncertainty unaccounted for by the natural variability of a
Poisson model for yearly state-level firearm homicides. Several recent papers suggest that
such sources of uncertainty, if ignored, may yield substantially different inferential conclu-
sions. Serially correlated data (Bertrand et al., 2004), yearly state-level shocks (Donald
and Lang, 2007), and small numbers of policy changes (Conley and Taber, 2011) can cause
the standard errors returned by a fixed effects regression to be downwardly biased. We
conduct a placebo study (Abadie et al., 2010; Bertrand et al., 2004) to address inferential
challenges that arise from the presence of possibly dependent, yearly state-level shocks to
the conditions that generate these Poisson realizations.
Akin to permutation inference, a placebo study in the context of the Missouri permit-to-
purchase repeal analysis applies the bracketing method to every state to create a placebo
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intervention effect distribution. Specifically, for each state where there was no permit-to-
purchase repeal we construct lower and upper control groups of neighboring states, when
available, in exactly the same way we did so for Missouri. We then compute the difference-
in-difference estimates using both control groups for a placebo “repeal” on August 28,
2007. This results in two exact distributions for the placebo intervention effect estimate,
one estimated using lower controls and the other using upper controls. If the permit-to-
purchase repeal effect in Missouri is not spurious, we would expect to see few placebo
effects greater than the ones reported in our study using either control condition. The
Figure 8: Histograms of placebo “repeal” effects using different control states. (Left Panel):
Histogram of placebo difference-in-difference estimates using lower control states (n = 38
states with lower control neighbors – includes Missouri). Two states (Oklahoma and
Delaware) had a larger estimate than Missouri (dashed line).(Right Panel): Histogram
of placebo difference-in-difference estimates using upper control states (n = 37 states with
upper control neighbors – includes Missouri). One state (Delaware) had a larger estimate
than Missouri (dashed line).
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histograms of the placebo effects in Figure 8 suggest that the Missouri bracketing study is
relatively robust to these alternative sources of variability. Of the 38 states that had lower
control neighbors, only two (Oklahoma and Delaware) had placebo effect estimates using
lower controls that were larger than Missouri (dashed line, left panel). Of the 37 states
that had upper control neighbors, only one (Delaware) had a placebo effect estimate using
upper controls that was larger than Missouri (dashed line, right panel). Alaska, Hawaii, the
District of Columbia and three states with missing data in either the pre-study, before or
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after period were excluded from the analysis.
4.4. Conclusion and Discussion
We developed a bracketing method for comparative interrupted time series to account for
concerns that history may interact with groups. In a study of the repeal of Missouri’s permit-
to-purchase handgun law, the method addressed a concern that on average, control states
started out with lower firearm homicide rates than Missouri before the repeal. Comparing
both to states that started with higher firearm homicide rates than Missouri and states that
started with lower rates, the repeal was associated with a significant increase in firearm
homicides, thus strengthening the evidence that the repeal had a causal effect of increasing
firearm homicides.
A limitation of our estimated impact of the repeal of Missouri’s permit-to-purchase law is
that a Stand Your Ground law was simultaneously adopted in Missouri. However, in the
original study by Webster et al. (2014), the inclusion of a Stand Your Ground indicator
in the regression did not dramatically change the estimated effect. Additionally, a recent
comparative interrupted time series study examining firearm homicide rates in large urban
counties found that permit-to-purchase laws were associated with significant reductions in
firearm homicides after controlling for the effects of Stand Your Ground lawsCrifasi et al.
(2018). Further evidence that the contemporaneous Stand Your Ground law does not change
the qualitative conclusion of our study can be found in the placebo study. There were 16
additional states that adopted Stand Your Ground laws within a few years of Missouri’s
permit-to-purchase repealCrifasi et al. (2018). Only one state (Oklahoma) of the 16 had
a difference-in-difference placebo effect estimate using lower controls that was larger than
Missouri and none of the states had placebo effect estimates using upper controls that were
larger than Missouri.
Although only one of many potential patterns of bias, the history-by-group interaction bias
addressed in this paper has been mentioned in the literature since at least the middle of the
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20th century. A version of it is referred to selection-maturation interaction in a taxonomy
of possible threats to the validity of experimental and quasi-experimental designs presented
in Campbell and Stanley (Campbell and Stanley, 1963). Fundamentally, bracketing relies
on constructing control groups across which this potential source of confounding is sys-
tematically varied (Hasegawa and Small, 2017). Other methods for constructing adequate
control groups in the presence of history-by-group interactions, such as the synthetic control
method (Abadie et al., 2010), have also found success in comparative case studies of the
effect of permit-to-purchase laws on firearm homicide rates (Rudolph et al., 2015). While
we do not argue that bracketing is uniformly superior to the synthetic control method, the
practitioner may find that each has strengths that lend themselves to different settings.
When the researcher believes that unmeasured history-by-group confounding, h(U, p), can
be expressed as a linear factor model with time-varying slopes and group-specific loadings,
the synthetic control method provides an asymptotically unbiased point estimate of the
causal effect of treatment while bracketing can only provide bounds on the treatment effect.
However, when the practitioner suspects that only the weaker assumptions of the model
outlined in §4.2.1 hold, the bracketing bounds will remain unbiased, in that they contain
the true effect in expectation, while the point estimate using synthetic controls need not be
unbiased; see Appendix 4.5.7 for further discussion. A detailed example of such a case can
be found in the Appendix 4.5.8.
4.5. Appendix
4.5.1. Inferences Under Different Sampling Assumptions
The standard difference-in-difference estimator using a control group c, βˆdd.c, is
βˆdd.c = {Eˆ[Y1|G = t, S1 = 1]− Eˆ[Y0|G = t, S0 = 1]}
−{Eˆ[Y1|G = c, S1 = 1]− Eˆ[Y0|G = c, S0 = 1]}.
90
When the samples of (i) Y1|G = t, S1 = 1, (ii) Y0|G = t, S0 = 1, (iii) Y1|G = c, S1 = 1 and
(iv) Y0|G = c, S0 = 1 are independent, then the standard error of βˆdd.c is
SE(βˆdd.c) =
{SE(Eˆ[Y1|G = t, S1 = 1])2 + SE(Eˆ[Y0|G = t, S0 = 1])2
+SE(Eˆ[Y1|G = c, S1 = 1])2 + SE(Eˆ[Y0|G = c, S0 = 1])2}1/2. (4.13)
We use (4.13) to make inferences for our study of the effect of the repeal of Missouri’s
permit-to-purchase law, where the Eˆ and corresponding SEs are obtained from the CDC’s
WONDER system.
Let κtt be the % change in the treated group’s mean outcome in the after period compared
to its mean counterfactual outcomes in the after period in the absence of treatment,
κtt = 100× E[Y
(1)
1 |G = t, S1 = 1]− E[Y (0)1 |G = t, S1 = 1]
E[Y
(0)
1 |G = t, S1 = 1]
.
An estimate of κtt using control group c and assuming the parallel trends of standard-in-
differences is
κˆtt.c = 100× βˆdd.c
Eˆ(Y0|G = t, S0 = 1) + {Eˆ(Y1|G = c, S1 = 1)− Eˆ(Y0|G = c, S0 = 1)}
.
We approximate the standard error of κˆtt.c using the Delta method.
The model (4.1) can be extended to allow for observed covariates, clustering and multiple
time points using a regression framework (Imbens and Wooldridge, 2009). The difference-
in-difference estimator may be computed by regressing the observed outcome Y on a time
period dummy, a group dummy and a treatment variable. Observed covariates Xip that
could vary by time can be incorporated into the model and then the difference-in-difference
regression estimator can be computed by regressing Y on the observed covariates, a time
period dummy, a group dummy and a treatment variable. The model assumptions then
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need to hold only conditionally on the observed covariates. The comparative interrupted
time series can be applied to settings with more than two time periods. A full set of time
period dummies can be added to model (4.1). The effect of the treatment over time can be
allowed to vary by interacting the treatment dummy with time.
Within each group, there may be clusters of units, e.g., different countries that had the
same policy reform. For such settings, we can extend model (4.1) to the following (Donald
and Lang, 2007) where the index cip denotes the ith unit in cluster c at time period p:
Y
(d)
cip = h(Ucip, p) + βd+ ηcp + cip, (4.14)
where ηcp represents an effect shared by members of cluster c in period p, e.g., an economic
shock that is specific to a country c in period p. Under an assumption that the ηcp are
independent and identically distributed (i.i.d.) normal random variables, Donald and Lang
(2007) showed that if we compute the mean in each cluster at each time period, and regress
these cluster/period means on fixed effects for each cluster, a time period dummy and a
treatment variable, then the t statistic for the treatment variable ( βˆ−β
SE(βˆ)
) has a t distribution
with the number of clusters minus two degrees of freedom. Using this approach, we do not
need to have individual data but only summary data for each cluster. Other approaches to
inference that allow for the ηcp to be non-i.i.d. such as autocorrelated within group, have
been developed. (Bertrand et al., 2004; Hansen, 2007).
Note that the presence of at least two clusters in at least one group enables us to make
inferences that allow for shared effects ηcp. When there is only one cluster in each group,
e.g., we are comparing just two countries, one in which a policy reform was implemented
and one in which it was not, then there are zero degrees of freedom to estimate the variance
of the ηcp so inferences cannot be drawn that allow for ηcp to be nonzero using data from
entirely within the sample. For such settings, it may be possible to get information from
outside the sample to get a plausible estimate of the variance of the ηcp (Blitstein et al.,
2005; Donald and Lang, 2007).
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4.5.2. Proof of (4.9) in §4.2.2
Suppose h(U, 1) − h(U, 0) is a bounded increasing function of U. Then from (4.5) and
the property that bounded increasing functions of stochastically ordered random variables
preserve order, it follows that
E[βˆdd.uc] ≤ β ≤ E[βˆdd.lc]. (4.15)
Similarly, if h(U, 1)− h(U, 0) is a bounded decreasing function of U,
E[βˆdd.lc] ≤ β ≤ E[βˆdd.uc]. (4.16)
(4.9) follows from (4.15) and (4.16).
4.5.3. Proof for Result in §4.2.3
Here we prove that (4.10) has probability ≥ 1 − α of containing both min(θlc.t, θuc.t) and
max(θlc.t, θuc.t) under the assumption that the two sided CIs are constructed in the usual
way by taking the union of two one-sided 1 − (α/2) confidence intervals. The result is
basically derived by inverting multiparameter hypothesis tests about the minimum or max-
imum of two parameters (Lehmann, 1952; Berger, 1982). Let q = min(θlc.t, θuc.t) and
r = max(θlc.t, θuc.t). The probability that (4.10) does not contain both min(θlc.t, θuc.t) and
max(θlc.t, θuc.t) is bounded by the probability that q is less than the lower endpoint of the
interval plus the probability that r is greater than the upper endpoint of the interval. The
probability that q is less than the lower endpoint of the interval is the probability that both
one-sided tests H l0 : θlc.t ≤ q vs. H l1 : θlc.t > q and Hu0 : θuc.t ≤ q vs. H l1 : θuc.t > q give
p-values ≤ α/2, which has probability at most α/2 since each individual event has proba-
bility at most α/2. Similarly, the probability that r is greater than the upper endpoint of
the interval is the probability that both one-sided tests H l
′
0 : θlc.t ≥ r vs. H l
′
1 : θlc.t < r and
Hu
′
0 : θuc.t ≥ r vs. H l
′
1 : θuc.t < r give p-values ≤ α/2, which has probability at most α/2
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since each individual event has probability at most α/2. Thus, the probability that (4.10)
does not contain both min(θlc.t, θuc.t) and max(θlc.t, θuc.t) is bounded by α.
4.5.4. Modeling Time-varying Confounders
We model a setting with time-varying confounders as follows. We maintain the assumptions
in §4.2.1 except for (4.4). We let U contain all variables that affect the outcome that differ
in distribution between the groups (treated, upper control, lower control) in the before
period and let 0 summarize the effect of factors in the before period that do not differ in
distribution between the groups. We can model the average effect of the factors in 0 as
an intercept in the h(U, 0) function so that E(0|S0 = 1, G = g) = 0 holds for all groups
g = lc, uc, tc. The effect of factors that do not differ in distribution between the groups
in the after period as well as the effect of time-varying confounders in the after period are
summarized in 1. Some of these time-varying confounders may be variables in U that have
changed their level over time. Let U0 ≡ U be the value of the variables in U in the before
period and U1 be their value in the after period, where U0 = U1 for a unit only in the
population in the after period (with U defined this way, the validity of (4.3) needs to be
considered carefully). Then, assuming that the average effect of the factors in 1 that do
not differ between the groups in the after period is modeled as an intercept in h(U, 1), we
have
E(1|G = g, S1 = 1) = E[h(U1, 1)− h(U0, 1)|G = g, S1 = 1].
Then for (4.11) to hold, we need to have
E[h(U1, 1)− h(U0, 1)|G = uc, S1 = 1] ≥ E[h(U1, 1)− h(U0, 1)|G = t, S1 = 1]
≥ E[h(U1, 1)− h(U0, 1)|G = lc, S1 = 1] (4.17)
A set of sufficient conditions for (4.17) to hold when U is univariate and the assumptions
in §4.2.1 hold is the following: (a) S0 = S1 = 1 for all units so that all units are in the
study population in both periods; (b) U1−U0 is independent of U0 given G; (c) the function
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h(U, 1) is convex in U so that h has increasing differences in the sense that for u, u
′
, u
′′
, u
′′′
such that u− u′ = u′′ − u′′′ and u > u′′ , the following inequality holds: h(u, 1)− h(u′ , 1) ≥
h(u
′′
, 1)− h(u′′′ , 1), and (d) U1 − U0|G = lc  U1 − U0|G = t  U1 − U0|G = uc. The proof
that this set of sufficient conditions implies that (4.17) holds is as follows. Let Dlc be a
random variable with the distribution of U1 − U0|G = lc where Dlc is independent of U0
given G. Then from (c) and (4.5), it follows that
E[h(U0 +Dlc, 1)− h(U0, 1)|G = t] ≥ E[h(U0 +Dlc, 1)− h(U0, 1)|G = lc]. (4.18)
Now let Dt be a random variable with the conditional distribution of U1 − U0|G = t and
Duc be a random variable with the conditional distribution of U1 − U0|G = uc where Dt
and Duc are independent of U0 given G. Then from (d) and h being an increasing function,
it follows that E[h(U0 + Dt)|G = t] ≥ E[h(U0 + Dlc)|G = t]. Combining this with (4.18),
we have
E[h(U0 +Dt, 1)− h(U0, 1)|G = t] ≥ E[h(U0 +Dlc, 1)− h(U0, 1)|G = lc]
which is equivalent to
E[h(U1, 1)− h(U0, 1)|G = t] ≥ E[h(U1, 1)− h(U0, 1)|G = lc]. (4.19)
Similarly from (d) and h being an increasing function, it follows that E[h(U0 + Duc)|G =
uc] ≥ E[h(U0 +Dt)|G = uc], and from (c) and (4.5), it follows that
E[h(U0 +Dt, 1)− h(U0, 1)|G = uc] ≥ E[h(U0 +Dt, 1)− h(U0, 1)|G = t],
and combining these, we have that
E[h(U0 +Duc, 1)− h(U0, 1)|G = uc] ≥ E[h(U0 +Dt, 1)− h(U0, 1)|G = t]
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which is equivalent to
E[h(U1, 1)− h(U0, 1)|G = uc] ≥ E[h(U1, 1)− h(U0, 1)|G = t]. (4.20)
Combining (4.19) and (4.20) gives us the desired conclusion.
Proof that (4.9) still holds as long as when (i) in (4.6) holds, (4.11) holds or when (ii) in
(4.6) holds, (4.12) holds. When there are time varying confounders, we have that E[βˆdd.lc] is
the expression on the right hand side of (4.7) plus E(1|G = t, S1 = 1)−E(1|G = lc, S0 = 1)
and E[βˆdd.lc] is the expression on the right hand side of (4.8) plus E(1|G = t, S1 = 1) −
E(1|G = uc, S0 = 1). When (i) in (4.6) holds, the expression on the right hand side of (4.7)
is ≥ β and the expression on the right hand side of (4.8) is ≤ β. Combining the facts in the
last two sentences, we have that if (i) in (4.6) and (4.11) holds, E[βˆdd.uc] ≤ β ≤ E[βˆdd.lc]
and if (ii) in (4.6) and (4.12) holds, E[βˆdd.lc] ≤ β ≤ E[βˆdd.uc].
4.5.5. Test of Model/Assumptions by Examining the Groups’ Relative Trends in the Before
Period
We can test whether the violating pattern (iii) is present in the before period using an
intersection-union test (Lehmann, 1952; Berger, 1982), which find evidence (say p-value
< 0.05) for (iii) if there is evidence (p-value < .05) for both (a) the difference between
the upper control group and the counterfactual treated group is larger in the second part
of the before period than the first part and (b) the difference between the counterfactual
treated group and the lower control group is smaller in the second part than the first part;
for the firearm homicide data, splitting the before period into the two parts, 1999-2002
and 2003-2007, (a) gives a p-value of 0.96 and (b) gives a p-value of 0.5, so there is not
evidence for (iii) being violated. Pattern (iv) can be tested in a similar way and for the
firearm homicide data, there is not evidence for pattern (iv) holding (p-values of 0.04 and
0.5). Ideally, this testing procedure should have sufficient power to reduce the chance of
proceeding with the analysis when the assumptions of the model don’t, in fact, hold to
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an acceptable level. When sample sizes are beyond the control of the investigator or, for
example, when dealing with complete counts of firearm homicides where variability depends
on the rate itself rather than sampling error, increasing the level of the test can achieve
some improvement in power. The p-value is ≥ 0.5 for the test of each alternative, that (iii)
holds and that (iv) holds. Hence, α would have to be increased beyond 0.5 to affect the
conclusions about the plausibility of our model assumptions.
Alternatively, the presence of violating patterns (iii) and (iv) can be assessed visually with-
out requiring a formal testing procedure. In the left panel of 9 we plot the relative trends
of the population-weighted firearm homicide rates for the upper (dashed blue) and lower
(dashed red) groups and the counterfactual treated group (dashed black) over the before
period. The vertical bars indicate 95% CIs. Visually, there is no strong evidence that
pattern (iii) or (iv) is present. The difference between upper controls and counterfactual
Missouri and between counterfactual Missouri and the lower controls both get smaller in
the latter part of the before period. We can also partially assess whether this pattern might
hold over the entire study period, our primary concern, by addressing how the upper and
lower control trends compare between the before period and the entire study period. In the
right panel of 9 we plot the relative trends of the two control groups and treated group over
the entire study period. The dashed black lines are not comparable between panels because
the left panel is a counterfactual trend whereas the trend in the right panel is subject to
treatment (i.e. permit-to-purchase repeal). However, we can assess the comparability of the
pattern of the control group trends between the two panels. They appear similar, with a
slight narrowing of the difference in population-weighted firearm homicide rates over time.
When paired with the test described above, visual inspection can answer questions about
our model assumptions that our intersection-union tests do not address directly: If we
find evidence that pattern (iii) or (iv) is present, are the violations substantial enough to
arrest the planned analysis or should we still proceed but with increased caution? If the
test doesn’t find evidence of a violation is that because our assumptions hold, at least
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Figure 9: (Left Panel): Relative trends of the population-weighted firearm homicide rates
for the upper (dashed blue) and lower (dashed red) groups and the counterfactual treated
group (dashed black) over the before period. The vertical bars indicate 95% CIs. (Right
Panel): Relative trends of the population-weighted firearm homicide rates for the upper
(dashed blue) and lower (dashed red) groups and the treated group (dashed black) over the
entire period. The vertical bars indicate 95% CIs.
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approximately, or is it due to large standard errors and/or low power? We recommend that
testing and visual inspection should be used in conjunction when assessing the plausibility
of the model assumptions.
If one does find evidence for pattern (iii) or (iv) holding in the before period, and if one
thinks there has been a structural shift such that the model (4.1)-(4.4) and assumptions
(4.5)-(4.6) only start to hold in the latter part of the before period but continue to hold
in the after period, one could just use the latter part of the before period. This is similar
to the scenario in a difference-in-difference model when there is evidence of a diverging
trend during an earlier portion of the pre-intervention period, researchers can restrict the
analysis to include only the latter part of the before period with the hope that parallel trend
assumption is more likely to be valid (Volpp et al., 2007). However, the finding of pattern
(iii) or (iv) in the before period suggests caution.
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4.5.6. Analysis Using After Period of 2008-2013
For the period of 2008-2013, Missouri’s age-adjusted firearm homicide rate was 5.5, the
upper control group’s age-adjusted firearm homicide rate was 5.0 and the lower control’s
age adjusted firearm homicide rate was 2.9. Using an after period of 2008-2013, difference-
in-difference estimates for the upper and lower control groups are shown in Table 13. Using
an after period of 2008-2013, the interval (4.10) that has a ≥ 95% chance of containing
the effect of the repeal on the firearm homicide rate is [0.2, 1.4], corresponding to a 5%
to 31% increase in firearm homicides, providing evidence that the repeal increased firearm
homicides.
Table 13: Difference-in-difference estimates of effect of repeal of Missouri’s permit-to-
purchase handgun licensing requirement on firearm homicide rates per 100,000 persons
using after period of 2008-2013
Control Group Estimate 95% CI % Change Estimate 95% CI
Upper Controls 1.0 [0.6, 1.4] 22% [14% ,31%]
Lower Controls 0.6 [0.2, 1.0] 17% [5% ,19%]
4.5.7. Comparison with the Synthetic Control Method
Abadie et al. (2010) proposed constructing a synthetic control group which is a linear combi-
nation of multiple control groups that matches the before period outcomes of the treatment
group. The synthetic control method provides asymptotically unbiased estimates of the
causal effect of treatment assuming that the unmeasured confounders can be represented
by a factor model with the factors’ effects in each time period being linear with a time-
specific slope, whereas our bracketing method only provides bounds under this assumption.
However, this assumption is strong and is not generally satisfied in our model (4.1)-(4.4).
In the following section we provide a simple example that satisfies the assumptions of our
model but for which the estimate returned by the synthetic control method will be biased.
If the types of interaction between history and group in the after period that are of concern
have occurred in the before period (e.g., a similar recession occurred in the after period as the
before period), then the synthetic control method’s matching of the before period outcomes
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might enable it to match the treated group’s counterfactual trajectory in the after period
in the absence of treatment. However, if the types of interaction are different (e.g., there
is a more severe recession in the after period or the interactions between poor health and
the macroeconomy have been altered by other policy changes), then the synthetic control’s
matching in the before period does not provide much reassurance unless one has a basis
for strong functional form assumptions such as the factors representing the unmeasured
confounders’ having a linear effect in each time period. In contrast, the bracketing method
relies on assumptions such as (4.6) that the unmeasured confounders’ effect is increasing (or
decreasing) in importance over time over the whole range of the unmeasured confounders
that can be assessed using subject matter knowledge without making strong functional form
assumptions.
4.5.8. Example of How Synthetic Control Model Assumptions Are Violated in Our Model
For example, suppose U has an exponential distribution in each group with scale 0.2, 0.5
and τ in the lower control, upper control and treated groups respectively where 0.2 < τ <
0.5 and h(U, 0) = U , h(U, 1) = exp(U). Then the synthetic control linear combination
is τ−0.20.3 × lower control group + 0.5−τ0.3 × upper control group. For the after period, the
linear combination of the mean outcomes for the synthetic control linear combination is
τ−0.2
0.3 ×1.25+ 0.5−τ0.3 ×2 while the treated group’s counterfactual mean outcome in the absence
of treatment is −1/τ−1/τ+1 , and
τ−0.2
0.3 × 1.25 + 0.5−τ0.3 × 2 < −1/τ−1/τ+1 for all 0.2 < τ < 0.5. Thus
the synthetic control group’s after period mean is always less than than the counterfactual
after period mean for the treatment group in the absence of treatment.
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CHAPTER 5
Estimating Malaria Vaccine Efficacy in the Absence of a Gold Standard Case
Definition: Mendelian Factorial Design
Abstract
In this paper we develop methods to identify and estimate malaria vaccine efficacy
that do not require a gold-standard case definition of clinical malaria. Instead, we lever-
age genetic traits that are protective against malaria but not against other childhood
illnesses to identify vaccine efficacy in a randomized control trial. The sickle cell trait
is one such genetic variant that confers protection specifically against clinical malaria.
The method, which we call Mendelian factorial design, is inspired by Mendelian ran-
domization studies that use genetic variants as instrumental variables to estimate causal
effects of non-randomized exposures. Mendelian factorial design augments a random-
ized trial with genetic variation to produce a natural factorial experiment, which under
realistic assumptions allows for identification of vaccine efficacy. We motivate our meth-
ods with a hypothetical study of the pre-erythrocytic vaccine RTS,S where subject-level
information on sickle cell status is collected. A robust, covariance adjusted estimation
procedure is developed for estimating vaccine efficacy on the risk ratio and incidence ra-
tio scales. Simulations across a number of settings suggest that our estimator has good
performance whereas naive methods are systematically biased. We demonstrate that
a combined estimator using both our proposed estimator and the standard approach
yields significant improvements when the Mendelian factor is only weakly protective.
Finally, we extend the Mendelian factorial design framework to time-to-event studies.
5.1. Introduction
In 2017, there were an estimated 219 million cases of malaria of which 92% occurred in
Africa and an estimated 435,000 malaria related deaths of which 93% occurred in Africa;
nearly every case of malaria in Africa was cause by the parasite Plasmodium falciparum
(World Health Organization, 2018). Pregnant women and children under the age of 5 are
the most vulnerable groups affected by malaria. To date, of more than 30 vaccines under
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development, the only vaccine to undergo a pivotal phase III trial is the pre-erythrocytic
vaccine RTS,S which has shown to have limited efficacy (30 − 50% reduction in incidence
rates; Mahmoudi and Keshavarz (2017)). Consequently, the continued development of
an efficacious P. falciparum malaria vaccine has the potential for substantial public health
impacts. With so many potential vaccines in the development pipeline, a critically important
statistical challenge is to develop methods for estimating vaccine efficacy. To date, accurate
estimation of vaccine efficacy against clinical outcomes attributable to P. falciparum malaria
requires defining reliable case definitions, a task that is made difficult by the unspecific
presentation of malaria in endemic areas.
In the absence of a gold standard case definition, efficacy is usually assessed by choosing an
inexact case definition which may falsely exclude cases attributable malaria and falsely in-
clude non-malaria cases. The established definition of clinical malaria in malaria prevention
trials is the presence of a fever with a temperature ≥ 37.5oC and a P. falciparum parasite
density above a certain threshold, e.g., 2500 or 5000 parasites per µl of blood (Ter Kuile
et al., 2003; The RTS,S Clinical Trials Partnership, 2011; Olotu et al., 2013; Bejon et al.,
2013). Case definitions of this form inevitably exclude some true cases and include some
false cases due to heterogeneity in immunity and endemicity, fever killing effects, and par-
asite density measurement error. With specificity < 1, estimates of vaccine efficacy will
be biased downward. It has been shown in simulations that such case classification errors
have the potential to introduce substantial bias in many settings (Small et al., 2010). Real
trial data suggests that these challenges with the standard case definition often go unad-
dressed. In a multi-site pooled analysis of phase II RTS,S trial data using a fixed 2500
parasite per µl cutoff across all study sites, Bejon et al. (2013) reports estimates of vaccine
efficacy against malaria that were as high as 60% in sites with low parasite prevalence and
as low as 4% in high parasite prevalence sites. The authors suggest a biological reason for
this pattern: RTS,S prevents fevers in only a portion of mosquito bites and in areas where
parasite prevalence is high, children are likely bitten more often by infected mosquitos. How-
ever this pattern is also consistent with bias due to the fixed case definition having lower
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specificity in higher prevalence areas where, due to improved immunity, children can carry
higher parasite loads without fever. The standard case definition leaves much unanswered:
is the heterogeneity in vaccine efficacy epidemiologically important or just an artifact of
bias arising from an inexact case definition?
To overcome the challenges that accompany inexact case definitions, this paper introduces
a new method for identifying malaria vaccine efficacy using natural genetic variation, which
we call Mendelian factorial design. Importantly, the method does not depend on an inexact
case definition based on the parasite density, instead using all fevers (or deaths) with any
level of parasitemia to estimate efficacy. To identify vaccine efficacy, the new method re-
quires finding and recording genetic variants that provide specific protection against clinical
malaria and operate through a different biological pathway than the vaccine being evalu-
ated. A running example in this paper is the sickle cell trait, a hemoglobinopathy that has
been shown to protect against malaria at the blood-stage (erythrocytic) of the infection
and the RTS,S vaccine, which confers protection against malaria at the pre-erythrocytic,
liver-stage of the infection. There are many other vaccine types, e.g., transmission blocking
and erythrocytic vaccines, and genetic variants that might satisfy these identifying condi-
tions (Ndila et al., 2018). We will discuss these occasionally throughout the paper and more
thoroughly in the discussion.
In the following section, we introduce Mendelian factorial design informally in the context of
the more familiar use of genetic variants as instrumental variables in Mendelian randomiza-
tion studies, to which it has many parallels. In §5.3, we present a precise definition of vaccine
efficacy and malaria-attributable fevers in a potential outcome framework and propose an
identification strategy that holds under a few realistic assumptions. We then provide a sim-
ple
√
n-consistent and asymptotically normal covariate-adjusted estimator that is robust
to model misspecification and assess its performance in a simulation study over a range of
settings. We develop an improved “bounded” estimator that combines the strengths of our
estimator with that of the (biased) standard estimator. We demonstrate that it provides
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nearly uniform improvement over both estimators. Finally, in §5.4 we extend the Mendelian
factorial design to identify and estimate vaccine efficacy in time-to-first event studies.
5.2. Mendelian Factorial Design: Parallels with Mendelian Randomization
When an observed association between a non-randomized exposure and an outcome may
be confounded by an unobserved common cause, attributing the association to a causal
effect may be misleading (Rosenbaum, 2002c). An instrumental variable (IV) is a covariate
that is associated with the exposure but whose only association to the outcome is through a
direct pathway to the exposure (Martens et al., 2006). The IV takes the place of the physical
randomization in a randomized trial, influencing only the assignment of subjects to exposure
or control, setting up a natural experiment and providing an avenue for estimating the causal
effect of the non-randomized exposure on the outcome (Rassen et al., 2009). When genetic
variants are used as instrumental variables, the corresponding collections of methods are
often labeled as the Mendelian randomization (MR) approach (Smith and Ebrahim, 2008).
For example, Kang et al. (2013) proposed using the hemoglobin S variant (HbS) as an
instrument to identify the causal effect of malaria on stunted growth. It is known that
heterozygote carriers (HbAS, sickle cell trait) receive protection against clinical malaria
whilst those without the variant (HbAA) do not. The first column of Table 14 summarizes
the assumptions required of HbAS status such that it can be used in a MR study to identify
the causal effect of malaria on stunting. Assumption (1) requires that HbAS status in fact
influences exposure; assumption (2) ensures that HbAS status can be treated “as-if” it were
randomized; and assumption (3) says that HbAS only effects stunted growth through its
influence on exposure. Assumption (4) is required for point identification of the causal
effect, although there are other alternative assumptions that can be used to point identify
a causal effect such as monotonicity of the effect (Burgess et al., 2017).
Like MR, Mendelian factorial design (MFD) leverages genetic variation to identify a causal
effect of interest – in this instance, the efficacy of a vaccine, or roughly, the proportion
reduction of disease-attributable outcomes in a population when the vaccine is applied
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Table 14: Parallel assumptions for Mendelian randomization and Mendelian factorial design.
Assumption Mendelian Randomization Mendelian Factorial Design
(1) •HbAS associated with
malaria
• HbAS has protective efficacy
against malaria-attributable fever
(2) • No unmeasured con-
founders associated with
HbAS and stunted growth
• HbAS “as-if” randomized
(3) • Only direct pathway from
HbAS to stunted growth is
through malaria
• Protection provided by HbAS
is specific to malaria-attributable
fever
(4) • HbAS does not modify the
effect of malaria on stunting
• No interaction effect between
HbAS and vaccine (i.e., independent
protective pathways)
(Lachenbruch, 1998). However, instead of addressing the bias that often accompanies a
non-randomized exposure, MFD attends to the bias in estimating treatment efficacy arising
from an inexact case definition. The natural experiment arising from MR is used for causal
inference in the absence of an actual randomized experiment, enabling the investigator
to distinguish causal effects from unobserved confounding. The same natural experiment
is employed in MFD to augment a two-arm randomized trial and create a simple 2 × 2
factorial experiment. The factorial design allows the investigator to distinguish efficacy
against disease-attributable outcomes even when the case definition incorrectly classifies a
material number of non-disease outcomes as cases.
Although MR and MFD address different sources of bias in different settings, their designs
share many parallel features. This is illustrated in Table 14, where each assumption of MR
in the malaria stunting study corresponds to a closely related assumption that underlies a
MFD study of vaccine efficacy against malaria-attributable fever. In more general terms,
Assumption (1) says that the Mendelian gene or Mendelian factor, e.g., HbAS, is relevant.
In the MR study this means that it is associated with the non-randomized exposure and
in the MFD study this implies that the Mendelian gene is protective against the disease-
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Figure 10: Causal diagrams for MR (left) and MFD (right). Blue arrows indicate the causal
quantities of interest and red arrows indicate confounding addressed by each design. Gray
variables Y m and Y nm are unobservable but Y , which doesn’t distinguish between them is.
Assumptions (1), (2) and (3) correspond to the similarly numbered assumptions in Table
14.
.
attributable outcome. Assumption (2) requires that the Mendelian gene be unconfounded
with the outcome of interest or be “as-if” randomized, which implies the former. For the MR
study, assumption (3) says that the Mendelian gene has no pleiotropic effects (Smith and
Ebrahim, 2008), that is, HbAS only effects stunted growth through its influence on malaria
and not through its influence on another modifiable exposure or stunting itself. The parallel
assumption for a MFD study is that the Mendelian factor protects against outcomes of any-
cause only through reducing disease-attributable outcomes. Finally, assumption (4) says
that the causal effect in the MR study does not vary over different levels of the Mendelian
gene, or in other words, they do not interact. Similarly, the corresponding assumption in a
MFD study is that the vaccine and Mendelian factor do not interact. In other words, the
vaccine prevents the same proportion of disease-attributable outcomes at different levels of
the Mendelian gene. For example, this assumption is plausible when a malaria vaccine and
HbAS provide protection against malaria-attributable fevers through independent biological
pathways.
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Assumptions (1)-(3) in Table 14 may be better understood encoded in a causal diagram. The
causal diagram for MR and MFD are in the left and right panels of Figure 10, respectively.
G is a Mendelian gene (or factor), U are unobserved confounders, Z is a randomized vaccine,
and E is a non-randomized exposure. Y is the outcome of interest – in the MR study it
is stunted growth and in the MFD study it is clinical malaria. Y m and Y nm are malaria-
attributable and non-malaria fevers, respectively. We define these more precisely in §5.3.
Finally, the blue arrows indicate the causal quantities of interest and the red arrows indicate
the confounding addressed by each design. The causal diagram for MFD is a little bit
unusual. Y m and Y nm are grayed out, emphasizing that we don’t observed them, but
instead only observe the outcome that is not distinguished by cause, Y . This is represented
by the black bounding box. The MFD diagram hints at how the factorial structure and the
absence of an arrow between G and Y nm may be used to identify the arrow between Z and
Y m, the vaccine efficacy.
5.3. A Robust Framework for Estimating Vaccine Efficacy: Risk Ratios and Incidence
Rate Ratios
5.3.1. Notation: Observed Data
Let j = 1, . . . , J indicate sites in a multi-site randomized control trial (RCT) and i =
1, . . . , Ij indicate subjects at each center; then, ij uniquely identifies each subject in the
study. We let the total number of subjects in the trial be n =
∑
j Ij . For subject ij, let
Yij ∈ {0, 1} be an observed fever or death with any parasitemia; let Zij ∈ {0, 1} indicate
treatment/vaccine status and Gij ∈ {0, 1} indicate sickle cell variant status (Gij = 1 if
HbAS, Gij = 0 if HbAA); and let Xij ∈ Rd be a d-dimensional vector of baseline char-
acteristics. Because G is assigned at conception, careful consideration of what variables
constitute “baseline” variables should be made. Let Dij and Uij indicate the malaria para-
site density in the blood and the level of non-malaria infectious agents, respectively. Define
the observed data vector Oij = (Xij , Zij , Gij , Yij). While Uij is generally not observed
in malaria trials, Dij is. However, because the methods developed in this paper do not
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require or explicitly model parasite density we omit it from Oij . We drop the subscripts
and write O = (X,Z,G, Y ) to denote a random draw from a specified population. We will
use boldface to indicate corresponding vector and matrix quantities that collect the data of
subjects over each site or the entire trial. For example, Yj is the Ij × 1 vector that collects
all the outcome data for subjects at site j and Y = (YT1 , . . . ,Y
T
J )
T is the n× 1 vector that
collects the outcome data for all subjects in the multi-site trial. For an example of a matrix
quantity, Xj is an Ij × d matrix and X is a n× d matrix.
Multi-site RCTs, i.e., block randomized, are a common design for vaccine efficacy trials, such
as the Phase III RTS,S trial (The RTS,S Clinical Trials Partnership, 2011). Another design
that has commonly been employed in studying the protective efficacy of interventions such
as insecticide treated bed nets is the clustered RCT (Ter Kuile et al., 2003). The notation
is easily adapted for this design, letting j indicate a cluster and Zij = Zj for all i, j.
5.3.2. Potential Outcomes and Malaria-Attributable Fever (or Death)
Pitfalls of Standard Case Definitions
The standard case definition of clinical malaria is the presence of a fever (Y = 1) and a
parasite density above some threshold d (D > d). The WHO recommends setting d high
enough to achieve specificity > 80% at all sites to avoid severe underestimation of vaccine
efficacy (Moorthy et al., 2007). Sensitivity is also considered when determining d to avoid
under-powered studies. The prevailing method used to determine these thresholds is to
model risk of fever as a continuous function of observed parasite density among community
controls and clinically suspected cases (Smith et al., 1994). However, computing sensitivity
and specificity of a case definition requires an estimate of the malaria attributable fraction
of fevers (MAFF). Lee and Small (2018) show that obtaining unbiased estimates of MAFF
in the presence of measurement error of D and fever killing effects on parasite density is
a difficult task, especially when malaria and non-malaria infections can work in conjunc-
tion to trigger a fever. Still, when unbiased estimates of MAFF can be obtained, this case
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definition will, by design, result in false positive and false negative cases, which may bias
corresponding estimates of vaccine efficacy. Heterogeneous immunity and pyrogenic thresh-
olds further complicate estimating treatment efficacy using case definitions that depend on
a fixed threshold for D. In practice, standard thresholds without, it seems, careful estima-
tion of specificity and sensitivity such as 2500 parasites per µl (Olotu et al., 2013) and 5000
parasites per µl are commonly used (The RTS,S Clinical Trials Partnership, 2011). As far
as we are aware, there are no sufficiently specific case-definitions for death attributable to
malaria, the most severe effect of a malaria infection (Moorthy et al., 2007).
Defining Cases Using Potential Outcomes
Potential outcomes are a useful framework to precisely define causal effects of interest
(Rubin, 2005). The potential outcomes that we define now are closely related to those
defined in Lee and Small (2018). In what follows, we consider Y to indicate the presence of
fever but note that the framework we describe is also suitable when Y indicates death. The
aforementioned authors motivate their framework with a biological model of malaria and the
notion of a pyrogenic threshold (Gravenor and Kwiatkowski, 1998). A pyrogenic threshold
can roughly be defined as a level of malaria parasite density above which a fever will be
produced. Below the threshold, the infection will not be strong enough to trigger a fever.
This threshold may vary from individual to individual based on heterogeneous immunity
to symptomatic malaria. In general, we can think of D and U as having thresholds above
which a malaria or non-malaria infection, respectively, is strong enough to trigger a fever
in the absence of any other infection. We can also consider a curve of threshold pairs for D
and U above which a combined infection can trigger a fever.
Because Y indicates the presence of a fever resulting from any infection, we can treat Y as a
function of both D and U . Y can be thought of also as a function of Z and G through their
effect on D and U . Thus, we can write the potential outcome of Y for treatment z and sickle
cell status g as Y (D(z, g), U(z, g)) and the observed outcome as Y = Y (D(Z,G), U(Z,G)).
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Y (D(z, g), U(z, g)) factors additively into two natural terms,
Y (D(z, g), U(z, g))︸ ︷︷ ︸
Y (z,g)
= {Y (D(z, g), U(z, g))− Y (0, U(z, g))}︸ ︷︷ ︸
Ym(z,g)
+Y (0, U(z, g))︸ ︷︷ ︸
Y nm(z,g)
. (5.1)
Y can be expressed as a potential outcome in terms of d and u or z and g. When it is
unambiguous, we may use the abbreviated notation below the “curly” braces in (5.1) to
emphasize its dependence on z and g.
The statistical implication of a pyrogenic threshold is that Y (d, u) is monotonic in d for all u.
That is, Y (d, u) ≤ Y (d′, u) for 0 ≤ d ≤ d′. This ensures that the first term on the right hand
side of (5.1) is non-negative. This term, Y m(z, g), can be interpreted as malaria-attributable
fever, or a fever that would not have occurred had a malaria infection been absent. These
include cases where D was high enough to trigger a fever in the absence of any other
infection and also cases where D was high enough to trigger a fever in conjunction with a
non-malaria infection. The second term on the right hand side, Y nm(z, g), is a fever that
cannot be attributed to malaria. These are fevers that would have still occurred if malaria
parasites were not present. However, when D > 0, Y m(Z,G) is generally not observable
because it involves the counterfactual term Y (0, U(Z,G)). In the following section we will
demonstrate that under a few realistic assumptions we can identify vaccine efficacy without
directly observing the fevers (or deaths) attributable to malaria.
A Final Couple Pieces of Notation
With our potential outcome framework in place, we denote the complete data vector by
C = (X,Z,G,D,U, {Y k(z, g) : k = m,nm; z = 0, 1; g = 0, 1}) .
In reality, we only get to observe one potential outcome Y (Z,G) even though all four exist
and, as we have argued, Y nm and Y m cannot be distinguished with certainty so we only
observe O ⊂ C. Finally, we may sometimes treat Y , D and U as p × 1 vectors that
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correspond to fever status, parasite density, and non-malaria infectious load at p follow-up
visits during a RCT.
5.3.3. Vaccine Efficacy: Definitions, Assumptions and Identification
Defining Vaccine Efficacy
We begin this section by defining a general population-level estimand for vaccine efficacy
and then outline the assumptions required for identification when we cannot distinguish
Y m from Y nm. We suppose that for each j, Cij (and Oij) are i.i.d. draws from an from
an unknown, site-specific target population distribution Pj ∈ Pj for all i. We suppose
that the overall target population is an equally weighted mixture of the Pj and denote it
P ∈ P. We let µzg(P ), P → R be a functional of P that depends on treatment and sickle
cell status and takes the form µzg(P ) = EP [f{Y (z, g)}] for P -measurable functions f that
are (1) increasing and (2) linear. We use a superscript m to indicate that the functional
is specific to malaria-attributable outcomes and nm to indicate that it is specific to non-
malaria outcomes, for instance, µmzg(P ) = EP [Y m(z, g)] when f(y) = y. Below we give a
general definition of efficacy.
Definition 4 (Vaccine/Protective Efficacy). For a specified function f ,
(i) Vaccine Efficacy is defined as τ(g) = 1− µm1g(P )/µm0g(P ) for g = 0, 1 and
(ii) Protective Efficacy of G is defined as ν(z) = 1− µmz1(P )/µmz0(P ) for z = 0, 1.
We are primarily interested in two simple functions f : f(y) = y and when Y is a p × 1
vector of fevers, f(y) = 1T y. For f(y) = y , efficacy as defined in Definition 4 is the
proportion reduction in risk of malaria-attributable fever or death were an individual to
receive vaccination versus placebo. For f(y) = 1T y, efficacy is defined as the proportion
reduction in incidence of malaria-attributable fever were an individual to receive vaccination
versus placebo. Since you can only die once, f(y) = 1T y is not applicable when Y indicates
malaria-attributable death. By this same logic, f(y) = y can be used for assessing the risk
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of malaria-attributable deaths over arbitrarily long follow-up. However, if we are interested
in the risk of developing a malaria-attributable fever over a longer follow-up, during which
a subject can have multiple fevers, the function we’d be interested in is f(y) = max y
where max y is the maximum over the elements of a p × 1 vector y. This function is not
a linear function and thus vaccine efficacy against the risk of having at least one malaria-
attributable fever over a long follow cannot be handled in this framework. The importance
of the linearity of f will become evident shortly.
Identifying Vaccine Efficacy
In §5.2 we informally discussed the assumptions required to identify vaccine efficacy using
MFD. Assumptions 1 - 5 formalize the assumptions that are summarized in the second
column of Table 14 and provide the basis for the identification of τ proved in Proposition
4.
Assumption 1 (Additivity of µ). For all z = 0, 1 and g = 0, 1, µzg(P ) can be decomposed
linearly as
µzg(P ) = µ
m
zg(P ) + µ
nm
gz (P ) .
Assumption 1 is guaranteed by (5.1) and the linearity of f . We mentioned above that
evaluating the vaccine efficacy on the risk scale for malaria-attributable fevers over a long
follow-up is problematic when using MFD to estimate τ . The risks of developing a malaria-
attributable fever and a non-malaria fever do not satisfy Assumption 1 over long follow-ups
because of the non-linearity of f(y) = max y.
Assumption 2 (No Interaction / Independent Protective Pathways). τ(g) is constant over
g = 0, 1 and ν(z) is constant over z = 0, 1. That is, τ := τ(0) = τ(1) and ν := ν(0) = ν(1).
The biological reasoning behind Assumption 2 is as follows. If a vaccine and genetic trait
protect against malaria through independent pathways at different times in the parasite’s
life cycle, it is plausible that the vaccine will prevent the same fraction of fevers among
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those who have the genetic trait (G = 1) and those who do not (G = 0). Similarly
plausible is that possession of the genetic trait will prevent the same fraction of fevers among
those to whom the vaccine was administered (Z = 1) and to those it was not (Z = 0).
The goal of pre-erythrocytic vaccines like RTS,S is to provoke an immune response that
prevents the parasites from entering the liver, stopping the parasites from ever re-entering
the bloodstream and causing clinical symptoms (Regules et al., 2011). In contrast, the
sickle cell trait appears to protect against clinical symptoms by inhibiting the growth of
parasites once they have re-entered the bloodstream from the liver and by making the host
more tolerant to parasite infection (Ferreira et al., 2011; Taylor et al., 2012; Williams, 2011).
This suggests that Assumption 2 is satisfied for pre-erythrocytic vaccines and the sickle cell
trait.
Assumption 3 (No Interference). A subject’s potential outcomes are functions of its vac-
cine and sickle cell status alone. That is Yij(z,g) = Yij(zij , gij).
Assumption 3 implies that the treatment and sickle cell status of an individual in the
trial effects only their own outcome. This assumption can be rephrased in the context
of infectious disease as stating that protection conferred by genetics or vaccine do not
materially disrupt disease transmission. This assumption is plausible when considering
individuals at two different sites j 6= j′ in a multi-site trial but is more complicated for
individuals at the same site who may live in close proximity. Stochastic simulation models
of malaria vaccination using pre-erythrocytic and blood stage-vaccines have, however, found
that transmission effects of such vaccines delivered as they would be in pediatric malaria
vaccination programs were minimal (Penny et al., 2008, 2015). Less is known about the
suitability of Assumption 3 with respect to the sickle cell variant.
Assumption 4 (Randomization / “as-if” Randomized). At each site j = 1, . . . , J , vaccines
are administered randomly and sickle cell status is distributed “as-if” random; that is,
(Z,G) ⊥⊥ (Y (z, g), Y m(z, g), Y nm(z, g), X)
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for all z, g ∈ {0, 1}2. Additionally, we assume that Z ⊥⊥ G.
The randomization of Z is ensured by the RCT. We assume that within each center, the
sickle cell trait is distributed “as-if” random. Population stratification and linkage disequi-
librium are common biological violations of the “as-if” random assumption of Mendelian
genes (Kang et al., 2013). Briefly, population stratification is when a subgroups that differ
on prognostic factors for developing malaria and other childhood illnesses also systemati-
cally differ in the prevalence of HbAS. If either the probability of inheriting HbAS or the
distribution of prognostic factors is relatively homogenous within a study site, then popu-
lation stratification would likely not be a material threat to the “as-if” random assumption
about G. Linkage disequilibrium is the dependence of gene frequencies at two or more loci
(Morton, 2001). If HbAS is in linkage disequilibrium with a gene that affects the risk of
childhood illness this may threaten the validity of Assumption 4. Linkage disequilibrium
with a gene that affects the risk of malaria is less problematic as this would not violate
the exclusion restriction formalized in the next assumption. However, this would require a
more delicate treatment of potential outcomes, e.g., we would need to consider the genes in
linkage disequilibrium as having potential outcomes depending on G (see VanderWeele and
Hernan (2013) for a discussion a related topic of “versions” of treatment).
Assumption 5 (Valid Mendelian Factor). G is a “valid Mendelian factor” in that it sat-
isfies the following conditions:
(i) ν 6= 0; and
(ii) 1− µnmz1 (P )/µnmz0 (P ) = 0 for z = 0, 1.
Part (i) of Assumption 5 says that the Mendelian factor is relevant to malaria-attributable
outcomes. A large body of literature on the protective properties of the sickle cell trait
against malaria supports this assumption for HbAS.. Several cohort studies have found
evidence that HbAS has 30-50% efficacy against uncomplicated clinical malaria and multiple
other case-control and cohort studies of Africa have estimated even greater efficacies against
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sever malaria cases of 70-90% (see Gong et al. (2013) for a list of several studies reporting
the protective efficacy of HbAS). Assumption 5(ii) can be expressed in terms of potential
outcomes by the restriction that U depends only on treatment status, U(z, g) = U(z). The
plausibility of Assumption 5(ii) is supported by evidence that the protection conferred by
HbAS is “remarkably specific” to malaria, providing little protection to other childhood
diseases (Williams et al., 2005).
The following proposition provides a simple, non-parametric identification strategy for treat-
ment efficacy as defined in Definition 4 under Assumptions 1 - 5. We also make the standard
assumptions of consistency, that Y = Y (z, g) when Z = z and G = g, and positivity, that
the probability of treatment Z and the prevalence of G in each site are both bounded away
from 0 and 1.
Proposition 4 (Nonparametric Identification). Suppose that Assumptions 1 - 5 are satis-
fied. Then the vaccine efficacy τ is identified from the observed data O as
τ = 1− EX [EP [f(Y )|X,Z = 1, G = 1]]− EX [EP [f(Y )|X,Z = 1, G = 0]]
EX [EP [f(Y )|X,Z = 0, G = 1]]− EX [EP [f(Y )|X,Z = 0, G = 0]] , (5.2)
where EX is the expectation over the marginal distribution of X implied by P .
Proof. The proof of Proposition 4 can be found in Appendix 5.6.1.
Remarks
Proposition 4 still holds under a weaker version of Assumption 4 requiring only that Z and G
are independent of potential outcomes (and of each other) conditional on baseline covariates
X. Depending on how rich the set of baseline covariates X is, this weaker assumption may
be more tenable in the presence of population stratification and linkage disequilibrium.
Equation (5.2) suggests a ratio estimator for τ that is remarkably similar to the Wald
estimator used in Mendelian randomization studies (Wald, 1940; Burgess et al., 2017).
Without covariates, the Wald estimator of the effect of a non-randomized exposure E on
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g = 1 g = 0
z = 1 µnm(1− η) + µm(1− τ)(1− ν) µnm(1− η) + µm(1− τ)
z = 0 µnm + µm(1− ν) µnm + µm
Figure 11: 2 × 2 table for Mendelian factorial design. Each cell represents µzg(P ) for all
combinations of (z, g) ∈ {0, 1}2, which is identified by the observed data O (Proposition
4). Differencing over the columns then taking the ratio over the rows yields 1 − τ . For
notational clarity, we drop the subscript from µ00. η is the “spillover efficacy” the vaccine
may provide against non-malaria outcomes.
outcome Y using Mendelian gene G can be written as
Y¯G=1 − Y¯G=0
E¯G=1 − E¯G=0 , (5.3)
where V¯G=g is the sample average of V for individuals with G = g. Both (5.2) and (5.3)
involve ratios of averages differenced over G. The analogy between (5.2) and the Wald
estimator in (5.3) is not by coincidence, but instead arises from a symmetry between the
structures of Mendelian randomization with additive effects and Mendelian factorial design
with multiplicative effects. More precisely, in Mendelian randomization, the potentially
confounded association between the Mendelian gene and the outcome can be decomposed
multiplicatively into the additive effect of the instrument on the exposure and the additive
effect of the exposure on the outcome. In a Mendelian factorial design, the outcomes can be
additively decomposed into disease-attributable outcomes and non-disease outcomes upon
which the treatment and Mendelian factor have multiplicative effects. This simple structure
of Mendelian factorial design can be seen clearly in the 2× 2 table in Figure 11 of expected
outcomes µzg for different combinations of z and g. Differencing over the columns and
taking the ratio over the rows immediately yields 1− τ . The η term in the top row can be
thought of as the spillover efficacy of the vaccine against non-malaria outcomes. The term
drops out when differencing over the columns.
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5.3.4. Robust Covariance Adjusted Estimation and Inference
We now propose a simple substitution estimator that allows for covariance adjustment and
is robust to arbitrary misspecification of a model for EP [f(Y ) |X,Z,G]. The estimation
procedure closely resembles that which is developed in Rosenblum and van der Laan (2010)
with a couple minor modifications to deal with the factorial structure of our identification
procedure and the possibility that HbAS prevalence varies across sites in a multi-site RCT.
The simple procedure is detailed below in Algorithm 1 and requires estimating a simple
generalized linear model (GLM) with the R function glm in the stats package at most two
times. In what follows, we suppose f(y) = 1T y for expository purposes. That is, we will
focus on vaccine efficacy defined as the proportion reduction in the expected number of
malaria-attributable fevers.
Algorithm 1 (Estimation of τ). The following substitution estimator is based on Rosenblum
and van der Laan (2010). For clarity, we let f(y) = 1T y.
1. Estimate EP [f(Y ) |X, Z, G] with glm using a canonical link function (depends on f).
• Let the linear part include an intercept, main terms for Z and G, and interaction
Z ×G, for example,
mu hat 0 <- glm(f(Y) ∼ X*G*Z, family = poisson())
• denote the resulting estimator as µˆ0(Z,G,X).
2. If there is more than one site and the prevalence of G and sample sizes variy across
sites, let log mu hat = log µˆ0(Zij , Gij , Xij), p g = (1/Ij)
∑Ij
i=1Gij, w = n/Ij, and S
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be a categorical variable for site; update µˆ0 as follows
mu hat 1 <- glm(f(Y) ∼ offset(log mu hat) + S +
I(w*Z*G/p g) + I(w*Z*(1-G)/(1-p g)) + I(w*(1-Z)G/p g) +
I(w*(1-Z)*(1-G)/(1-p g)), family = poisson())
and denote the resulting estimator as µˆ1(Z,G,X).
3. Let µzg(Pn) =
1
J
∑J
j=1
1
Ij
∑Ij
i=1 µˆ1(z, g,Xij).
4. Construct the plug-in MFD estimator
τˆ = 1− µ11(Pn)− µ10(Pn)
µ01(Pn)− µ00(Pn) .
The estimator τˆ returned by Algorithm 1 is a special case of a target maximum likelihood
estimator (TMLE) (Van der Laan and Rose, 2011). A straightforward modification of The-
orem 1 in Rosenblum and van der Laan (2010) yields that τˆ is consistent and asymptotically
normal under mild regularity conditions even when the working model for the conditional
expectation is misspecified. Other initial working models µˆ0 may be used as long as they
satisfy certain restrictions on how data-adaptive they are (Van der Laan and Rose, 2011).
The weight terms w are important because we assume that the target population P is an
equally weighted mixture of the site-specific populations Pj but allow for study designs with
different different sample sizes across sites. The weights ensure that µˆ1 solves the efficient
influence function estimating equation (see Appendix 5.6.4). Before we state the result, we
introduce some some important notation and definitions.
Working Models and their Limits:
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Let the maximum likelihood parameter estimates from steps 1 and 2 of Algorithm 1 be β
(0)
n
and β
(1)
n , respectively, and define βn = [β
(0)
n ,β
(1)
n ]. Now, recall that P is the true, unknown
data generating distribution. We can decompose its corresponding density p as follows as
follows
p = p(X)p(Z)pj(G)p(Y |X, Z, G) (5.4)
where pj(G) is the probability a child has the sickle cell trait in site j. p(Z) is assumed
to be known, e.g., p(Z) = 1/2 in a balanced trial. Pn is our estimate of P where pn, the
density of Pn, can be decomposed similarly as
pn = pn(X)p(Z)pj,n(G)pβn(Y |X, Z, G) (5.5)
where pn(X) is the empirical distribution of X, pj,n(G) is the observed prevalence of the
sickle cell trait among children in enrolled in the study at site j, and pβn(Y |X, Z, G) is the
estimated parametric working model for the conditional distribution of Y from steps 1 and 2
in Algorithm 1. We assume that the number of centers are fixed, that they are representative
of the population of interest, and that the sites carry equal weight in the population they
represent but that the sample sizes Ij might be different. Hence, the observations that make
up the empirical distribution are weighted by n/Ij . We assume that the site-level sample
sizes Ij grow at the same rate as n → ∞ and so it follows that pn(X) a.s.→ p(X) as n → ∞
by the Gilvenko-Cantelli Theorem and an application of the strong law of large numbers
gives us that pj,n(G)
a.s.→ pj(G) for all j = 1, . . . , J as n→∞. Let P∞ = limn Pn and write
its density p∞ as
p∞ = p(X)p(Z)pj(G)pβ(Y |X, Z, G) (5.6)
where β = [β(0),β(1)] are the maximizers of the expected log-likelihoods of the GLMs in
steps 1 and 2 where the expectation is taken over P , if such maximizers exist (see Rosenblum
and van der Laan (2010) for further discussion of the existence of β). When β exists, the
conditions given in Proposition 5, are sufficient for βn to converge to β in probability
(Rosenblum and van der Laan, 2009). Note that unless the working parametric model for
119
the conditional mean is correctly specified, P∞ will not equal P in general.
For notational convenience, we let P and Pn be the expectation operators over P and Pn,
respectively. For example, we can write µzg(Pn) from step 3 of Algorithm 1 as Pnµˆ1(z, g,X).
Efficient Influence Functions:
For an arbitrary distribution Q ∈ P, the efficient influence function (EIF) for µzg(Q) can
be written as
ϕzg(Q)(O) =
1(Z = z)1(G = g)(f(Y )− EQ[f(Y )|X, Z = z, G = g])
qj(G = g)q(Z = z)
+ EQ[f(Y )|X, Z = z, G = g]− µzg(Q) , (5.7)
for z, g ∈ {0, 1}2. We will define µz(Q) := µz1(Q)− µz0(Q) and ϕz(Q) := ϕz1(Q)− ϕz0(Q)
for z = 0, 1. Standard calculations verify that ϕz(Q) is the efficient influence function for
µz(Q) by demonstrating that ϕz(Q) can be expressed as a pathwise derivative of µz(Q)
where Q is a parametric submodel of Q such that Q = Q=0 (Kennedy, 2016). ϕz(Q) is
said to be a pathwise derivative of µz(Q) if EQ[ϕz(Q)S] = ∂µz(Q)/∂|=0 where S is the
score function of the parametric submodel. Finally, let ϕ∗zg(Q) = ϕzg(Q) − EP [ϕzg(Q) |G]
and define ϕ∗z(Q) := ϕ∗z1(Q) − ϕ∗z0(Q). We can now state the consistency and asymptotic
normality result for τˆ .
Proposition 5 (Consistency and Asymptotic Normality). In addition to Assumptions 1 -
5, suppose that the number of sites J is fixed, the Ij grow at the same rate as n, and the
maximizers β = [β(0),β(1)] exist. Also, suppose that ||β||∞ < M for pre-specified M < ∞.
Finally, let (X,Y ) be bounded and the terms in the linear parts of the GLMs in steps 1 and 2
of Algoritm 1 be bounded functions on compact subsets of {0, 1}2×Rd. Then, τˆ is consistent
and
√
n(τˆ − τ) convergence in distribution to a Gaussian with mean 0 and variance
σ2 = EP
[
µ1(P )
µ0(P )2
(ϕ∗0(P∞)(O)− Pϕ∗0(P∞)(O)} −
1
µ0(P )
{ϕ∗1(P∞)(O)− Pϕ∗1(P∞)(O)}
]2
.
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When the prevalence of G does not vary between sites and the study is balanced, i.e., Ij =
n/J for all j, then step 2 of Algorithm 1 can be skipped. Step 2 may also be skipped if it
is a single-site trial. Furthermore, if the working model for EP [f(Y ) |X,Z,G] is correctly
specified then σ2 achieves the semiparametric efficiency bound.
Proof. A sketch of the proof of Proposition 5 can be found in Appendix 5.6.4.
Remark 3. We remarked in §5.3.3 that Proposition 4 still holds under a weaker version of
Assumption 4 where the independence is conditional on baseline covariates X. Proposition
5 also holds under these weaker assumptions as long as either the working model for the
conditional expectation or the conditional assignment models for G and Z are correctly
specified.
Variance Estimator:
Notice that ϕ∗z is defined as a projection of ϕz into a lower dimensional subspace and
will thus have smaller variance. With that in mind, we can use ϕz(Pn) to construct a
conservative plug-in estimator of σ2. In Appendix 5.6.4 we show that Pn solves the EIF
estimating equations, that is, Pnϕz(Pn)(O) = 0 for z = 0, 1. It follows then that the plug-in
estimator of the scale variance σ2 can be written simply as
n · v̂ar(τˆ) = 1
n
J∑
j=1
Ij∑
i=1
{
ϕ0(Pn)(Oij)
µ1(Pn)
µ1(Pn)2
− ϕ1(Pn)(Oij) 1
µ0(Pn)
}2
(5.8)
With this variance estimator we can now use Proposition 5 to conduct inference on and
construct confidence intervals for τˆ .
Naive Estimator:
For simplicity, let’s assume that we have balanced sites, i.e., Ij = n/J for all j. Then, had
we assumed that all fevers with any parasitemia were malaria-attributable fevers, we might
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considered the following naive estimator
τˆ0 = 1− Pnµˆ0(1, G,X)Pnµˆ0(0, G,X) . (5.9)
The naive estimator corresponds with standard estimates of VE with respect to a commonly
used secondary case definition of the presence of a fever (Y = 1) and any positive parasite
density (D > 0) (Olotu et al., 2013). We will see in the following section that the estimator
is systematically biased but can be combined with our MFD estimator τˆ to construct an
estimator that outperforms both estimators on their own.
5.3.5. Simulation Study: Comparison to Naive Identification Strategy
In this section we investigate the performance of our proposed MFD estimator τˆ and com-
pare it to that of the naive estimator τˆ0 that assume all fevers with any parasitemia are
malaria fevers. As in the previous section, we consider f(y) = 1T y and thus τ is the propor-
tion reduction in expected number of malaria-attributable fevers. We consider a single-site
RCT J = 1 with equal sized vaccine and placebo arms and the prevalence of HbAS set to
20% based on existing estimates of the prevalence in sub-Saharan Africa (Ter Kuile et al.,
2003; Elguero et al., 2015).
We simulate the number of malaria-attributable fevers and non-malaria fevers from negative
binomial distributions in a single year of follow up for each individual. Evidence suggests
that the negative binomial distribution fits the empirical distribution of the number of clin-
ical malaria events an individual experiences well (Olotu et al., 2013). We can also see from
(5.1) that Y m and Y nm are negatively dependent – a fever cannot be both attributable
to malaria and have been present in the absence of malaria. To model this dependence
structure, we use a Gaussian copula with negative dependence parameter ρ = −0.1 (Genest
and Neslehova´, 2007). The negative dependence is modest when fevers are rare but will be
more pronounced in areas where fever risk is higher, e.g., villages with poor sanitation. We
suppose there is a single observed covariate X that enters the conditional mean function
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for both 1TY m and 1TY nm and that there is unobserved heterogeneity in the conditional
means between individuals. The generating distributions were calibrated so that the av-
erage number of any-cause fevers is 1.5 per child-year. We also calibrated the generating
distributions to achieve different levels of case specificity, which we define formally below.
Two different sample sizes were chosen to assess how performance improved asymptotically:
1000 subjects per trial arm, i.e., n = 2000, and 2500 subjects per trial arm, i.e., n =
5000. For n = 2000, we consider 5 × 2 × 2 different combinations of vaccine efficacy
τ ∈ {0.3, 0.4, 0.5, 0.6, 0.7}, protective efficacy of the Mendelian factor ν ∈ {0.3, 0.5}, and
specificities s ∈ {0.5, 0.8}. Formally, we define specificity s here as the expected number of
malaria-attributable fevers divided by the expected number of fevers with any parasitemia
and of any cause under placebo,
s =
EP
[
1TY m(0, G)
]
EP [1TY (0, G)]
=
p(G = 1)µm01 + p(G = 0)µ
m
00
p(G = 1)µ01 + p(G = 0)µ00
. (5.10)
The specificity choices are motivated by Mabunda et al. (2009), which estimated the speci-
ficity of standard case definitions using > 0 and > 2500 parasites per µl cutoffs for children
under five years of age to be roughly 50% and 80%, respectively. The strength of the
Mendelian factor was calibrated to the aforementioned estimates of the protective efficacy
of HbAS. We consider the same combinations for n = 5000 except only for the weaker pro-
tective efficacy setting. The spillover efficacy η was assumed to be zero. Finally, we allow for
non-constant vaccine and Mendelian protective efficacy – both τi and νi are log-normally
distributed with mean τ and ν, respectively, and standard deviation approximately 0.05
giving coefficients of variation of about 8-17%. Rather than conferring complete protection
to a fraction of the vaccinated subjects, all vaccinated subjects receive partial protection.
This is consistent with evidence that RTS,S is a “leaky” vaccine, providing at least partial
protection to all recipients of the vaccine (Moorthy and Ballou, 2009). Each setting was
simulated Nsim = 5000 times. More details of the simulation settings can be found in
123
Appendix 5.6.5.
We use Poisson regression for the initial working model estimate in Algorithm 1 and be-
cause J = 1, we skip step 2. The results of the simulation study are summarized in the
following two tables. In Table 15 we compare the absolute proportional bias and root mean
squared error (RMSE) of the τˆ (MFD) and τˆ0 (Naive). For n = 2000, the MFD estimator
has very good bias properties, with proportional bias less than 5% for most settings. The
RMSE increases for Mendelian genes that are less protective and as the specificity decreases.
The only area of poor bias performance is when the Mendelian gene is weakly protective
(ν = 0.3) and the specificity is low (0.5). However, although the estimator in this setting
has high variance the bias and power at τ = 0.7 are reasonably adequate. Like the presence
of small sample bias and high variance for weak instruments in instrumental variable anal-
ysis (Imbens and Rosenbaum, 2005), the poor performance appears to be a small sample
property as the performance for the weak Mendelian gene, low specificity setting improves
notably for n = 5000.
The bias in the naive estimator only varies over the different specificity settings and does
not improve as the sample size grows. In fact, because there is no spillover efficacy, the
proportional absolute bias is equal to 1 − s. You can see from the table that the RMSE
is driven almost entirely by the bias component for the naive estimator and it actually
increases in absolute terms as the vaccine efficacy increases. These properties lead to very
poor coverage of confidence intervals derived from the naive estimator. That one should
expect efficacy estimates to be biased by as much as 20% when specificity is at the level
recommended by the WHO should be cause for concern.
Table 16 compares the coverage of two-sided 95% confidence intervals and the power against
the two-sided alternative at 5% significance for the MFD and naive procedures. The MFD
confidence interval has correct or conservative coverage and decent power in even some of
the more unfavorable settings. Even in the small sample, weakly protective Mendelian gene,
and low specificity setting the power is not negligible at higher vaccine efficacies. Because
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Table 15: Proportional absolute bias and root mean squared error (RMSE) of MFD and
naive estimators using Nsim = 5000 simulations.
Specificity = 0.8 Specificity = 0.5
Prop. |Bias| RMSE Prop. |Bias| RMSE
ν τ MFD Naive MFD Naive MFD Naive MFD Naive
n = 2000
0.50 0.30 0.03 0.20 0.15 0.07 0.12 0.50 0.29 0.15
0.40 0.02 0.20 0.14 0.08 0.07 0.50 0.27 0.20
0.50 0.02 0.20 0.12 0.10 0.05 0.50 0.25 0.25
0.60 0.02 0.20 0.11 0.12 0.04 0.50 0.24 0.30
0.70 0.01 0.20 0.10 0.14 0.02 0.50 0.22 0.35
0.30 0.30 0.12 0.20 0.36 0.07 0.59 0.50 5.47 0.15
0.40 0.11 0.20 0.30 0.09 0.32 0.50 4.54 0.20
0.50 0.08 0.20 0.29 0.10 0.21 0.50 5.80 0.25
0.60 0.06 0.20 0.24 0.12 0.18 0.50 4.61 0.30
0.70 0.03 0.20 0.21 0.14 0.11 0.50 1.69 0.35
n = 5000
0.30 0.30 0.06 0.20 0.18 0.06 0.18 0.50 0.37 0.15
0.40 0.04 0.20 0.17 0.08 0.13 0.50 0.34 0.20
0.50 0.02 0.20 0.14 0.10 0.08 0.50 0.30 0.25
0.60 0.02 0.20 0.13 0.12 0.06 0.50 0.29 0.30
0.70 0.01 0.20 0.12 0.14 0.04 0.50 0.27 0.35
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Table 16: Coverage of two-sided 95% confidence interval and power against two-sided alter-
native at 5% significance level of MFD and naive estimators using Nsim = 5000 simulations.
Specificity = 0.8 Specificity = 0.5
Coverage Power Coverage Power
ν τ MFD Naive MFD Naive MFD Naive MFD Naive
n = 2000
0.50 0.30 0.95 0.50 0.56 1.00 0.96 0.00 0.29 0.99
0.40 0.95 0.17 0.79 1.00 0.96 0.00 0.44 1.00
0.50 0.96 0.01 0.94 1.00 0.96 0.00 0.59 1.00
0.60 0.96 0.00 0.99 1.00 0.96 0.00 0.73 1.00
0.70 0.96 0.00 1.00 1.00 0.97 0.00 0.84 1.00
0.30 0.30 0.95 0.50 0.30 1.00 0.95 0.00 0.19 0.99
0.40 0.95 0.16 0.44 1.00 0.96 0.00 0.25 1.00
0.50 0.96 0.01 0.57 1.00 0.96 0.00 0.33 1.00
0.60 0.96 0.00 0.74 1.00 0.97 0.00 0.42 1.00
0.70 0.96 0.00 0.86 1.00 0.98 0.00 0.51 1.00
n = 5000
0.30 0.30 0.95 0.11 0.45 1.00 0.95 0.00 0.26 1.00
0.40 0.96 0.00 0.68 1.00 0.96 0.00 0.38 1.00
0.50 0.95 0.00 0.87 1.00 0.96 0.00 0.52 1.00
0.60 0.96 0.00 0.96 1.00 0.97 0.00 0.66 1.00
0.70 0.96 0.00 0.99 1.00 0.97 0.00 0.77 1.00
the naive estimator is systematically biased, the coverage properties are extremely poor in
all settings. The variance of the naive estimator tends to be far smaller than the MFD
estimator. This fact coupled with the systematic bias leads to high power and low coverage
across all settings.
Even in settings where the mean proportional bias is high, the MFD estimator appears
to have the desirable property of being median unbiased. Figure 12 demonstrates this for
τ = 0.3, 0.5, and 0.7 in all six settings detailed in Tables 15 and 16. The dashed lines
indicates the true value of τ , the boxes represents the IQRs, and the whiskers indicate the
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Figure 12: Distributions of simulated MFD estimator τˆ and naive estimator τˆ0 over several
settings and τ = 0.3, 0.5, 0.7. Setting 1: strong factor (ν = 0.5), high specificity (s = 0.8);
setting 2: strong factor, low specificity (s = 0.5); settings 3 and 5: weak factor (ν = 0.3),
high specificity; settings 4 and 6: weak factor, low specificity. Dashed lines indicate true
efficacy, boxes indicate IQRs, whiskers are 5% and 95% quantiles, diamonds are mean
estimate, and vertical solid lines are median estimates.
5% and 95% quantiles of the simulated estimates. The diamonds indicate the means and the
vertical solid lines the medians. The worsening performance of the MFD as the Mendelian
gene weakens is clear (settings 2 vs. 1, 4 vs. 3, and 6 vs. 5) as is the improvement in the
weak Mendelian gene settings as the sample size grows (settings 5 vs. 3 and 6 vs. 4). The
naive estimates have much lower variance but are systematically mean and median biased
downward. The MFD estimates are also mean biased downward. Although the estimator is
asymptotically normal, the ratio of means that are jointly asymptotically normal may have
a peculiar non-normal form in finite samples which may explain this particular pattern of
bias (Marsaglia et al., 2006).
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5.3.6. Improved Estimators: Leveraging the Identifying Assumptions
A Simple Correction to the Naive Estimator
The observation that the proportional absolute bias of τˆ0 is equal to 1 − s in Table 15 for
all settings comes from the fact that, when the sample sizes are balanced across sites, an
immediate application of Theorem 1 of Rosenblum and van der Laan (2010) yields that τˆ0
is a consistent estimator of sτ + (1− s)η. When samples are small or the Mendelian gene is
only weakly protective, we observed that the MFD estimator will be less powerful and may
suffer from small sample bias. In such settings, the asymptotic limit of τˆ0 suggests a simple
correction to the naive estimator: dividing by s. Call this the s-corrected estimator, which
is consistent for τ when η = 0 and s is known or consistently estimated itself. If instead we
only have a 1−β confidence interval for s, Cβ, then we can still construct a valid confidence
interval for τ using the s-corrected estimator. Let CIs,α+β be a 1 − α − β confidence
interval for τ constructed using the s-corrected estimator and define the s-corrected 1− α
confidence interval CIcorr,α =
⋃
s∈Cβ CIs,α+β. Berger and Boos (1994) show that one can
construct valid p-values by maximizing a non-pivotal p-value over the confidence set of a
nuisance parameter. This result is easily inverted, providing a procedure to construct valid
confidence intervals from which it follows that CIcorr,α will have the correct (conservative)
coverage for τ . However, as we mentioned earlier in §5.3.2, estimating and conducting
inference about s is challenging. However, we can still make use of the naive estimator even
when we do not know s.
The Best of Both Worlds? Combining MFD and Naive Estimators
The naive estimator and the MFD estimator have complementary strengths and different
weaknesses – τˆ0 tends to be more efficient but is asymptotically biased and τˆ is consistent but
has higher variance and requires larger sample sizes. The naive estimator also has the nice
feature of being a consistent lower bound of τ as long as η ≤ τ – it is very plausible that a
well designed vaccine will have a higher vaccine efficacy than spillover efficacy. Additionally,
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we have the logical constraint that τ ≤ 1 since a treatment efficacy greater than one would
imply that it would be possible to have a negative number of malaria-attributable fevers,
a scenario eliminated by the assumption that Y (d, u) is monotonically increasing in d for
all levels u. The following proposition constructs an estimator that uses these upper and
lower bounds to improve the performance of τˆ in difficult settings, e.g., small samples, weak
Mendelian factor, and low specificity.
Proposition 6 (Bounded Estimator). Suppose that η ≤ τ . Let τˆ0 be the naive estimator
and let
Lα = τˆ − Φ(1− α)v̂ar(τˆ)1/2
L0,α = τˆ0 − Φ(1− α)v̂ar(τˆ0)1/2 .
Define the upper confidence bounds Uα and U0,α similarly. Then (i)
τˆbnd = min [1,max {τˆ , L0,α˜}] (5.11)
is consistent for τ when α˜ is bounded away from 1; and (ii), for 0 ≤ α0 ≤ α/2
CIbnd,α =
[
max{Lα/2−α0 , L0,α0},min
{
1, Uα/2
}]
(5.12)
is an asymptotically valid 1− α confidence interval for τ .
Proof. The proof of Proposition 6 can be found in Appendix 5.6.3.
Because the naive estimator has much smaller variance than the MFD estimator, one will
likely choose α0 and α˜ to be much smaller than α. In general, it makes sense to choose
α˜ = α0 to ensure that τˆbnd ∈ CIbnd,α.
The lower bound used to construct τˆbnd acts like a high probability, stochastic lower bound
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Figure 13: Densities and means of naive estimator (blue, dash) MFD estimator (gray, dot),
and bounded estimator (green, dot-dash); True vaccine efficacy (black, solid). For the
setting with n = 1000(×2), τ = 0.5, ν = 0.3, spec. = 0.5, and α˜ = 0.001
to τ while 1 is an exact upper bound. When the Mendelian gene is weak, the denominator
in τˆ can sometimes be very close to zero, leading to unreliable estimates of vaccine efficacy.
The bounded estimator is designed to mitigate the effect of these cases while keeping the
median unbiasedness of τˆ intact. Figure 13, illustrates how this plays out in a the setting
where the τˆ performs poorly with n = 2000, a weak Mendelian factor, low specificity, and
τ = 0.5. The figure shows the estimated densities and means of the naive estimator (blue,
dash), MFD estimator (gray, dot), and bounded estimator (green, dot-dash) over 5000
simulations. The true vaccine efficacy is indicated by the black solid line. As expected, τˆ
is much more variable and less biased than τˆ0, but still materially biased in this setting.
The bounded estimator τˆbnd is nearly mean unbiased. You can see how it achieves this by
“clumping” unreliable MFD estimates near the stochastic lower bound and the exact upper
bound.
We also assess how well τˆbnd performs in the same setting as in Figure 13 but with an
even smaller sample size (n = 1000). Using α = 0.05, α0 = 0.001, and α˜ = 0.001, we
find that τˆbnd has substantially improved bias and RMSE while CIbnd,α has very favorable
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Figure 14: Absolute proportional bias (left panel) and RMSE (right panel) for MFD,
naive, and bounded estimators with sample size n = 1000 and Nsim = 5000 simulations.
For bias and RMSE values above 1, only a maximum of 1 is shown. The actual abso-
lute proportional bias values for the MFD estimator are 2.21 and 1.56 for τ = 0.3 and
0.4, respectively. The actual RMSE values for the MFD estimator from left to right are
18.58, 67.90, 32.29, 8.42, and 6.75.
power while maintaining the correct (conservative) coverage. In Figure 14, we compare
the absolute proportional bias (left panel) and RMSE (right panel) of the three estimators.
Absolute proportional bias and RMSE values larger than 1 are not shown. The bounded
estimator uniformly outperforms both the MFD and naive estimators in terms of bias and
has performance comparable to that of the MFD estimator estimated on a sample five times
as large (n = 5000) for τ = 0.5, 0.6, and 0.7. The RMSE of τˆbnd shows large improvements
over the τˆ and is comparable to the RMSE of τˆ estimated in the same setting on a sample
size of n = 5000 for all values of τ considered.
The power and coverage properties of CIbnd,α give the clearest picture of how the comple-
mentary strengths of the MFD and naive procedures are retained by the bounded procedure.
In the left panel of Figure 15, we see that CIbnd,0.05 has only marginally more conservative
coverage than the MFD confidence interval [L0.025, U0.025] (right panel) while retaining the
favorable power properties of the naive confidence interval [L0,0.025, U0,0.025] (left panel).
The dashed line in the right panel indicates 95% coverage.
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Figure 15: Power against two-sided alternative at 5% significance (left panel) and coverage
of 95% confidence interval (right panel) for MFD, naive, and bounded estimators with
sample size n = 1000 and Nsim = 5000 simulations. The dashed black line in the right
panel indicates 95% coverage.
Importantly, the superior performance of the bounded estimator in this particular setting
does not appear to come at the expense of performance in the settings where τˆ generally
does well, improving on the τˆ in almost all settings investigated in the simulation study.
5.4. Time-to-First Malaria Fever: Mendelian Factorial Design Under The Propor-
tional Hazards Assumption
The World Health Organization (WHO) recommends that the primary endpoint in pivotal
Phase III trials assessing the efficacy of malaria vaccines be the time-to-first malaria fever
and that the efficacy be measured as one minus the hazard ratio returned by a Cox pro-
portional hazard regression (Moorthy et al., 2007). In this section we use our potential
outcome framework to precisely define vaccine efficacy in time-to-first malaria fever studies
and show how it can be identified using MFD and estimated using data on time-to-first
fever of any cause.
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5.4.1. Parameter Identification and Estimation under Modeling Assumptions
In this section we can think about our clinical outcomes as stochastic processes indexed
by t, Y := {Yt}t≥0. This allows us to consider quantities like the time to first fever,
T = min{t : Yt = 1}.
If we follow the WHO recommendation above in the context of the potential outcome frame-
work developed in §5.3.2, a natural quantity to study in a time-to-event analysis of vaccine
efficacy is the hazard rate of malaria-attributable fevers, i.e., the instantaneous risk of devel-
oping a malaria-attributable fever at time t conditional on being free of malaria-attributable
fevers up to time t. The risk set used in this hazard function includes individuals who have
experienced non-malaria fevers prior to time t. This is analogous to a subdistribution hazard
in the competing risks literature where non-malaria fevers can be viewed as a competing
risk (Fine and Gray, 1999). Unfortunately, when Y m is not observable, vaccine efficacy
based on a hazard ratio using the definition of malaria-attributable fever in (5.1) is not
identifiable using MFD. This is due to the fact that on the hazard ratio scale, Assumption 1
(additivity) does not hold when Y m and Y nm are dependent – recall, if Y nmt equals 1 then
Y mt must equal 0 but is otherwise free to take values in {0, 1}. Only under independence (or
independence conditional on X) can we additively decompose the hazard of developing a
fever of any cause into the hazard of developing a malaria-attributable fever and the hazard
of developing a non-malaria fever. That said, under a few additional assumptions we can
still identify vaccine efficacy in terms of the hazard rate for malaria-attributable fevers in
the absence of non-malaria infections. This hazard is analogous to a cause-specific haz-
ard in the competing risks literature when competing risks can be considered conditionally
independent (Hsu et al., 2017).
Malaria-attributable Fevers in the Absence of Competing Infections
If we assume that there is no combined effect of malaria and non-malaria infections on
fevers (Assumption 2(iii) of Lee and Small (2018)), then we can provide an alternative
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decomposition of Y to the decomposition presented in (5.1):
Y (D(z, g), U(z)) = Y (D(z, g), 0) ∨ Y (0, U(z)) , (5.13)
where Y (D(z, g), 0) are malaria-attributable fevers in the absence of non-malaria infec-
tions, Y (0, U(z)) are non-malaria fevers in the absence of malaria infections, and ∨ is a
pairwise maximum. For stochastic processes, A ∨ B = {max(At, Bt)}t≥0. We will refer to
Y (D(z, g), 0) and Y (0, U(z)) as isolated malaria fevers and isolated non-malaria fevers. If
X sufficiently captures shared risk factors for malaria and non-malaria infections, then it is
plausible that D(z, g) ⊥⊥ U(z) | X and thus Y (D(z, g), 0) ⊥⊥ Y (0, U(z)) | X for all z, g.
One might wonder if isolated malaria fevers are the endpoint of greatest interest. Perhaps
malaria-attributable fevers as defined in (5.1) are more representative of the real-world
burden of malaria infections. Regardless, one could argue that the standard case definition
of clinical malaria, e.g., Y = 1 and D > 2500 parasites per µl, is an approximation of
an isolated malaria fever. This argument has two parts: (1) the fixed threshold suggests
that the standard case definition does not consider the possibility of combined effects of
malaria and non-malaria fevers; and (2) the standard case definition does not consider
whether a non-malaria fever would have occurred had there been no malaria infection.
The approximation is rough, however, because while the definition of isolated malaria fever
allows for individual-specific pyrogenic thresholds, the standard case definition does not.
Identifying Vaccine Efficacy
We can now define the potential time to first isolated malaria fever as Tm(z, g) = min{t :
Yt(D(z, g), 0) = 1} and the potential time to first isolated non-malaria fever as Tnm(z, g) =
min{t : Yt(0, U(z)) = 1}. We can write the conditional hazard functions for Tm(z, g) and
Tnm(z, g) as
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λkzg(t |X) = lim
∆→0+
P
(
T k(z, g) ∈ [t, t+ ∆ )|T k(z, g) ≥ t, X
)
/∆ (5.14)
for k = m,nm and all z, g. We drop the superscript k to indicate the conditional hazard
function for the a fever of any cause and define
T (z, g) = min{t : Yt(z, g) = 1} = min{Tm, Tnm} .
Assumption 6 (Proportional Hazards). λkzg(t |X), k = m,nm follow a Cox proportional
hazard model with baseline hazard functions λk(t), k = m,nm. That is,
(i) λmzg(t |X) = λm(t) exp{log κ+ log(1− τ)z + log(1− ν)g + βTmX} , and
(ii) λnmzg (t |X) = λnm(t) exp{log φ+ log(1− η)z + βTnmX}
where ν > 0.
In equation (i) above, vaccine efficacy τ is equal to one minus the hazard ratio of isolated
malaria fever under vaccination versus placebo. In (ii), η can again be thought of as a
“spillover efficacy” term. Note that Assumptions 2 and 5 are satisfied under these modeling
assumptions.
Assumption 7 (Conditionally Independent First Fever Processes). The time to first iso-
lated malaria fever and time to first isolated non-malaria fever are conditionally indepen-
dent. That is,
Tm(z, g) ⊥⊥ Tnm(z) | X for (z, g) ∈ {0, 1}2
Because Tm(z, g) depends only on Y (D(z, g), 0) and Tnm(z, g) depends only on Y (0, U(z)),
Assumption 7 is satisfied when Y (D(z, g), 0) ⊥⊥ Y (0, U(z)) | X for all z, g. We previously
argued that this condition is plausible when X sufficiently describes shared risk factors for
malaria and non-malaria infections.
Assumption 8 (Shared Conditional Baseline Hazard Function). Time-to-first isolated
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malaria fever and time to first isolated non-malaria fever have a shared baseline hazard func-
tion conditional on X. That is, λ(t) := λm(t) = λnm(t) for all t ≥ 0 and β := βm = βnm.
Under these additional assumptions, we can use an MFD strategy to identify τ in time-to-
first fever studies.
Proposition 7 (Identification of τ). Suppose that Assumptions 6 - 8 hold. Then the hazard
function for T (z, g) can be written as
λzg(t |X) = λ(t) exp{α+ ωz + γg + λz × g + βTX} . (5.15)
Furthermore, under Assumptions 3 and 4, τ is identified from the observed data O as
τ = 1− exp{ω + γ + λ} − exp{ω}
exp{γ} − 1 . (5.16)
Proof. The proof of Proposition 7 can be found in Appendix 5.6.2
Remark 4. The conditions of Proposition 7 lead to an additivity property of the conditional
hazard functions that is analogous to Assumption 1. This additivity can be seen in the first
equality of (5.26).
Remark 5. A weaker version of the randomization / “as-if” randomized condition imposed
by Assumption 4 would suffice to identify τ . Namely, that Z,G are independent of all
potential outcomes conditional on X.
Estimation and Inference via the Delta Method
The parameters in (5.15) can be estimated consistently via maximum partial likelihood
estimation (Cox, 1975) with the R function coxph implemented in the survival package.
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These estimates (ωˆ, γˆ, λˆ) are asymptotically normal with the limiting distribution
√
n


ωˆ
γˆ
λˆ
−

ω
γ
λ

 D−→ N


0
0
0
 , I([ω, γ, λT ])−1
 , (5.17)
where I([ω, γ, λT ])−1 is the inverse of the partial likelihood-based information matrix. Ap-
plying the continuous mapping theorem to (5.16) yields the following consistent MFD esti-
mator of τ ,
τˆ = 1− exp{ωˆ + γˆ + λˆ} − exp{ωˆ}
exp{γˆ} − 1 . (5.18)
Applying the delta method to (5.17) and (5.18) and noting that Iˆ([ωˆ, γˆ, λˆT ])−1/n, the aver-
age sample information, is consistent for I([ω, γ, λT ])−1 gives us an approximate distribution
for τˆ for large enough samples,
τˆ ∼˙ N
(
τ,∂τˆT Iˆ([ωˆ, γˆ, λˆT ])−1 ∂τˆ
)
, (5.19)
where ∂τˆ = [∂τˆ/∂ωˆ, ∂τˆ/∂γˆ, ∂τˆ/∂λˆ]T . We can use this approximate distribution to conduct
inference on τ .
An analogous bounded estimator and confidence interval to those described in Proposition
6 can be constructed using the naive estimator 1 − exp{ωˆ}. It can easily be shown that
this estimator is consistent for a convex combination of τ and η and is thus is a consistent
estimator for a lower bound of τ as long as η ≤ τ .
5.4.2. Causal Identification: Selection Bias and Frailty
Even if these strong modeling assumption assumptions hold, τ defined in §5.4.1 does not
have a straightforward causal interpretation. Several authors have discussed in depth the
subtleties and common misconceptions of interpreting hazard ratios as a causal quantity
(Herna´n, 2010; Aalen et al., 2015; Martinussen et al., 2018). We observe one of these
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subtleties when examining the definition of τ given in Assumption 6(i),
τ = 1− lim∆→0+ P(T
m(1, g) ∈ [t, t+ ∆ )|Tm(1, g) ≥ t, X)
lim∆→0+ P(Tm(0, g) ∈ [t, t+ ∆ )|Tm(0, g) ≥ t, X)
. (5.20)
These authors point out that the hazard functions in the numerator and the denominator
of (5.20) condition on different sets of subjects for t > t(1) = minij,g,z T
m
ij (g, z). The causal
contrast is thus some combination of treatment efficacy and a selection effect. Initially,
randomized assignment of Z and “as-if” randomization of G ensure that the units in each
combination of trial arm and HbAS status are comparable on average. However, condition-
ing on the study subjects at risk of their first isolated malaria fever at time t > t(1), i.e.,
Tm(z, g) ≥ t, has the potential to introduce selection bias. For instance, suppose that base-
line susceptibility to malaria is heterogeneous even after conditioning on X. If Z provides
protection against developing an isolated malaria fever, we might find that the children
with high susceptibility to malaria in the control arm are more likely to develop fevers than
similar children in the treatment arm. Consequently, as time passes, the children at risk in
the control arm will be less susceptible on average to fever than those in the treatment arm,
absent treatment. The comparability of the subjects in each combination of z, g ∈ {0, 1}2
ensured by Assumption 4 at the beginning of the study is not guaranteed as the follow-up
progresses.
When malaria-attributable fever is rare or when the follow-up time is short, the selection
effect may be less consequential (Aalen et al., 2015). If X does not sufficiently capture het-
erogenous susceptibility to isolated malaria fever, modeling subject-level frailty can further
alleviate the selection bias of estimates of τ (Wienke, 2010). frailty can be introduced as a
multiplicative random effect,
λmzg(t |X) = λ(t)W exp{logα+ log(1− τ)z + log(1− ν)g + βTX} ,
λnmzg (t |X) = λ(t)W exp{log φ+ log(1− η)z + βTX} (5.21)
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where W is a random, subject-level frailty shared by both malaria and non-malaria fever
hazard functions. Proposition 7 extends immediately to the frailty model implied by (5.21)
where, in addition to X, the hazard ratio is conditional on W . Estimation can be carried out
via the Expectation-Maximization algorithm (Klein, 1992) or penalized partial maximum
likelihood methods (Therneau et al., 2003).
Alternatively, frailty models can be used to conduct a sensitivity analysis of Cox regression-
based estimates of τ to selection bias (Stensrud et al., 2017). In general, however, modeling
frailty usually requires parametric assumptions about W , for example, that it comes from
the family of power variance function distributions (Wienke, 2010).
Although τ itself has a subtle and potentially awkward causal interpretation, simple func-
tions of τ have been shown to have more natural causal interpretations. For example,
1/(2− τ) is the probabilistic index, which is defined as the probability that Tm(1, g) for one
individual is longer than Tm(0, g) for another individual with comparable baseline covariates
(and frailty) (De Neve and Gerds, 2019).
Importantly, all the causal interpretations discussed in this section require the correct iden-
tification of the parameter τ established in Proposition 7.
5.5. Discussion
The strategy that we’ve developed for identification and estimation of malaria vaccine effi-
cacy does not rely on the explicit definition of an inexact, but observable case definition. In
short, we propose separating the approach to identifying VE into two distinct steps: first,
define a gold-standard case that may be unobservable and then, identify VE using a strategy
that doesn’t require overt observation of these gold-standard cases. Our gold-standard case
definition is one that is 100% specific and sensitive. It is precisely defined using a potential
outcome framework. As we’ve noted, these cases are not distinguishable from observed
data alone. Regardless, we demonstrate that with Mendelian factorial design we are able
to leverage genetic variation in an analogous fashion to Mendelian randomization studies
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to identify VE with respect to this exact, but unobservable, case definition.
In observational studies, evidence factors are defined as several approximately independent
tests of the same hypothesis, each of which depend on different assumptions about bias from
non-random treatment assignment (Rosenbaum, 2011). In the presence of bias, these tests
can be thought of as independent pieces of evidence in that the violation of assumptions
underlying one test does not imply the other tests are similarly biased. Like an evidence
factor, the MFD estimate can provide an additional piece of evidence in vaccine efficacy
studies that relies on a different set of assumptions than the methods currently in use.
For instance, the naive estimator assumes all fevers with any parasitemia are malaria-
attributable, corresponding to a commonly used secondary case definition. Although not
independent like true evidence factors, we demonstrated that the naive estimator and the
MFD estimator can be combined to construct a bounded estimator that outperforms both
estimators when used on their own. In particular, the bounded estimator provides significant
improvements when the Mendelian gene is only weakly protective, a challenging setting
similar to the weak instrument setting in IV studies.
There is evidence that HbAS is moderately protective against uncomplicated malaria and
highly protective against severe malaria illness suggesting that MFD may be particularly
useful for estimating VE against severe malaria, whose symptoms are not specific and
overlap significantly with the symptoms of other severe childhood comorbidities (Bejon
et al., 2007).
The performance of the combined estimator across a range of simulation settings with
sample sizes that are similar to those found in phase II and III clinical trials is promising.
The results suggests that, if feasible, it would be prudent to begin collecting subject data
on inherited hemoglobinopathies and other genetic traits that provide protection against
clinical malaria, such as the sickle cell trait. Estimating the efficacy of prevention strategies
that target transmission directly, such as a malaria transmission-blocking vaccine (Wu et al.,
2015) and insecticide-treated bed nets (Ter Kuile et al., 2003), are feasible under the MFD
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framework developed in this paper. The assumption of no interference will likely fail but
weakening Assumption 3 to allow for partial interference (Hudgens and Halloran, 2008), e.g.,
interference within but not between villages or sites, is plausible. Cluster randomized trial
designs would allow for identification of natural definitions of treatment efficacy that are
functions of the fraction of subjects who receive treatment (Athey et al., 2018). The study
of erythrocytic vaccines in the MFD framework may be more challenging, as the assumption
that protective hemoglobinopathies and these blood-stage vaccines don’t interact is tenuous
at best. With more than thirty vaccines currently under development, both pre-erythrocytic
and those targeting different stages of the disease cycle, the methods described in this paper
have the potential to improve the reliability of vaccine efficacy estimates for a number of
forthcoming trials (Mahmoudi and Keshavarz, 2017).
Many interesting research directions related to Mendelian factorial design remain. We
mention a few in closing. Developing MFD methods using only aggregate site-level data
on HbAS prevalence is one such direction. This might allow for MFD-based meta-analyses
of past trial results in which hemoglobinopathy data were not collected if, (1) accurate
prevalence data could be collected ex post and (2) the prevalence varied sufficiently between
studies. There is evidence that there are a number of other genetic traits that confer
protection against malaria (Ndila et al., 2018). When there are several potential valid
Mendelian factors, we may again find inspiration from MR and other IV methods. It would
be beneficial to develop falsification tests of the validity of potential Mendelian factors
akin to tests for over-identifying restrictions like the Sargan-Hansen test in IV regression
(Hansen, 1982). As it has been demonstrated in MR, using many ostensible Mendelian
factors where some are invalid may have the potential to improve the robustness of MFD
analysis (Kang et al., 2016).
141
5.6. Appendix
5.6.1. Proof of Proposition 4
In this Appendix we give a proof of the general identification result in Proposition 4.
Proof of Proposition 4. By consistency and Assumption 3 we have that
EP [f(Y )|X,Z = z,G = g] = EP [f(Y (z, g))|X,Z = z,G = g] (5.22)
for all z, g. Assumption 4 ensures that PX|Z,G = PX and PY (z,g)|Z,G = PY (z,g). Hence,
EX [EP [f{Y (z, g)}|X,Z = z,G = g]] = EX|Z=z,G=g[EP [f{Y (z, g)}|X,Z = z,G = g]]
= EP [f{Y (z, g)}|Z = z,G = g]
= EP [f{Y (z, g)}]
= µzg(P ) . (5.23)
Applying Assumption 1, the right hand side of (5.2) becomes
1− (µ
m
11(P )− µm10(P )) + (µnm11 (P )− µnm10 (P ))
(µm01(P )− µm00(P )) + (µnm01 (P )− µnm00 (P ))
. (5.24)
Because G is a valid Mendelian factor (Assumption 5(ii)) we have that µnmz1 (P )−µnmz0 (P ) = 0
for z = 0, 1, further simplifying (5.24) to
1− (µ
m
11(P )− µm10(P ))
(µm01(P )− µm00(P ))
.
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Finally, we have that
1− (µ
m
11(P )− µm10(P ))
(µm01(P )− µm00(P ))
= 1− −νµ
m
10(P )
−νµm00(P )
by Assumption 2 and Definition 4(ii)
= 1− µ
m
10(P )
µm00(P )
= τ by Definition 4(i) .
Assumption 5(i) ensures that the right hand side of the first equality is well-defined.
5.6.2. Proof of Proposition 6
We give a short proof of the asymptotic unbiasedness of τˆbnd and the asymptotical validity
of CIbnd,α as a 1− α confidence interval for τ .
Proof of Proposition 6. We give a proof for when the sample sizes are balanced across sites.
When this is the case, we skip step 2 of Algorithm 1 and use µˆ0 to construct τˆ0. Treating G
as an element of X, the consistency of τˆ0 for sτ+(1−s)η and its asymptotic linearity follows
almost immediately from Theorem 1 of Rosenblum and van der Laan (2010). When η < τ ,
the theorem implies that τˆ0 is consistent for some τ
′ < τ . Because τ ≤ 1 by definition,
the continuous mapping theorem implies that τˆbnd is consistent for min[1,max{τ ′, τ}] = τ .
The lower bound of CIbnd,α is constructed by taking the intersection of a lower one-sided
confidence interval for τ with coverage 1 − α/2 + α0 and a lower one-sided confidence
interval for τ ′ with coverage 1− α0. Because τ ′ < τ , this second confidence interval is also
asymptotically valid for τ . If α0 is chosen a priori, then the intersection is an asymptotically
valid 1−α/2 lower one-sided interval for τ (Neuwald and Green, 1994). The upper confidence
bound is constructed by taking the intersection of a 1 − α/2 upper one-sided confidence
interval for τ and (−∞, 1]. Since τ ≤ 1 the resulting interval is an asymptotically valid
1− α/2 upper confidence-interval for τ . The intersection of the resultant upper and lower
1 − α/2 one-sided confidence intervals yields an asymptotically valid two-sided confidence
interval with coverage 1− α.
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5.6.3. Proof of Proposition 7
In this Appendix we provide a proof of the parameter identification result for the hazard
ratio under the proportional hazards assumption.
Proof of Proposition 7. Let Λzg(t |X) =
∫ t
−∞ λzg(t |X) dt be the cumulative hazard func-
tion for Y . Define Λkzg(t |X), k = m,nm similarly. The survival function Szg(t |X =
P(T (z, g) > t |X) can be expressed as Szg(t |X) = exp{−Λzg(t |X)} and the probability
density of Y as fzg(t |X) = λzg(t |X)Szg(t |X). We can express fzg(t |X) as
fzg(t |X) = ∂
∂ t
Fzg(t |X)
=
∂
∂ t
{
1− Snmzg (t |X)Smzg(t |X)
}
by Assumption 7
= fmzg(t |X)Snmzg (t |X) + fnmzg (t |X)Smzg(t |X)
= {λmzg(t |X) + λnmzg (t |X)}Snmzg (t |X)Smzg(t |X)
= {λmzg(t |X) + λnmzg (t |X)} × exp
{
−
∫ t
−∞
λmzg(t |X) + λnmzg (t |X) dt
}
. (5.25)
From (5.25) and Assumptions 6 and 8, we have that the hazard function for Y is
λzg(t |X) = λmzg(t |X) + λnmzg (t |X)
= λ(t) exp{βTX} (κ(1− τ)z(1− ν)g + (1− η)z)
= λ(t) exp{α+ ωz + γg + λz × g + βTX} , (5.26)
Proving the first part of the proposition. To prove the second part of the proposition we
first observe that the last equality above in (5.26) is simply a reparameterization – when z
and g are binary, κ(1 − τ)z(1 − ν)g + φ(1 − η)z and exp{α + ωz + γg + λz × g} can each
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take four distinct values. The reparameterization yields a system of four equations,
exp{α} = κ+ φ (5.27)
exp{α+ ω} = κ(1− τ) + φ(1− η) (5.28)
exp{α+ γ} = κ(1− ν) (5.29)
exp{α+ ω + γ + λ} = κ(1− τ)(1− ν) + φ(1− η) . (5.30)
Subtracting (5.28) from (5.30) and (5.27) from (5.29), then dividing the former by the latter
yields
1− τ = exp{ω + γ + λ} − exp{ω}
exp{γ} − 1 . (5.31)
Under Assumptions 3 and 4 we have that λzg(t |X) can be identified by the observed data
O:
λzg(t |X) = lim
∆→0+
P(T (z, g) ∈ [t, t+ ∆)|T (z, g) ≥ t, X) /∆
= lim
∆→0+
P(T ∈ [t, t+ ∆)|T ≥ t, X, Z = z, G = g) /∆ . (5.32)
Applying (5.26), we have that α, ω, γ, λ are identifiable and thus τ can be identified by the
observed data using (5.31).
5.6.4. Proof (Sketch) of Proposition 5
In this section we sketch a proof of Proposition 5 by showing that µzg(Pn) is consistent for
µzg(P ) and asymptotically linear, that is,
µzg(Pn)− µzg(P ) = (Pn − P)ϕ∗zg(P∞) + oP
(
1/
√
N
)
. (5.33)
for all z, g. Theorem 1 of Rosenblum and van der Laan (2010) checks a number of technical
conditions to verify that Theorem 1 of van der Laan and Rubin (2006) can be applied. A
particularly important condition is that the µzg(P ) are linear. This does not hold in the
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setting when the prevalence of G in each site is not known a priori. Hence, a straightforward
application of the theorem is not appropriate. However, if certain weaker conditions hold,
then the important parts of Theorem 1 of van der Laan and Rubin (2006) still apply. We
first show that we can write
µzg(Pn)− µzg(P ) = (Pn − P)ϕ∗zg(Pn) . (5.34)
If ϕ∗zg(Pn) is Donsker then by the second part of Theorem 1 of van der Laan and Rubin
(2006), we have that µzg(Pn) is
√
n-consistent for µzg(P ). Then, if P{ϕ∗zgPn−ϕ∗zg(P∞)}2 →
0 in probability as n→∞ the third part of Theorem 1 of van der Laan and Rubin (2006)
implies that µzg(Pn) is asymptotically linear with form (5.33). Consistency of µzg(Pn) and
Assumptions 1 - 5 imply that the plugin estimator τˆ is consistent for τ . Finally, we apply
the delta method to derive the asymptotic variance σ2 of
√
n(τˆ−τ). It follows from the last
part of Theorem 1 of van der Laan and Rubin (2006) that σ2 achieves the semiparametric
efficiency bound if the working model for the conditional expectation of f(Y ) is correctly
specified. In what follows, when taking expectations of functionals of Pn we treat these
functionals as fixed.
Verifying (5.34):
Given the choice of the terms included in the linear part of the GLM estimate µˆ1 in Algo-
rithm 1, the score equations that µˆ1 solve imply that
Pn
{
1(Z = z)1(G = g)
p(Z = z)pj,n(G = g)
(f(Y )− µˆ1(z, g,X))
}
= 0 for all z, g ∈ {0, 1}2 . (5.35)
The choice of the weighting w = n/Ij when estimating µˆ1 is required since Pn does not
equally weight observations unless the size of each site is the same. Also note, that by
definition, Pnµˆ1(z, g,X) = µzg(Pn). Taken together, we have that Pnϕzg(Pn) = 0 for all
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z, g ∈ {0, 1}2. By iterated expectations, we have that
Pϕ∗zg(Pn) = Pϕzg(Pn)− P {EP [ϕzg(Pn) |G]} = Pϕzg(Pn)− Pϕzg(Pn) = 0 . (5.36)
All that remains to be shown is that −Pn {EP [ϕzg(Pn) |G]} = µzg(Pn)− µzg(P ). We start
by evaluating EP [ϕzg(Pn) |G]:
EP [ϕzg(Pn) |G] = EP
[
1(Z = z)1(G = g) {f(Y )− µˆ1(z, g,X)}
pj,n(G = g)p(Z = z)
∣∣∣G]
+ EP [µˆ1(z, g,X)− µzg(Pn) |G]
=
1(G = g)
pj,n(G = g)
(µzg(P )− EP [µˆ1(z, g,X) |G])
+ EP [µˆ1(z, g,X) |G]− µzg(Pn) . (5.37)
The second equality follows from an application of iterated expectations, Assumption 4,
and the fact that µzg(Pn) and µˆ1 are treated as fixed when taking expectations. Taking the
empirical expectation Pn we get
Pn {EP [ϕzg(Pn) |G]} = Pn
{
1(G = g)
pj,n(G = g)
(µzg(P )− EP [µˆ1(z, g,X) |G])
}
+ Pn {EP [µˆ1(z, g,X) |G]− µzg(Pn)}
= µzg(P )− EP [µˆ1(z, g,X) |G = g]
+ Pn {EP [µˆ1(z, g,X) |G]} − µzg(Pn)
= µzg(P )− EP [µˆ1(z, g,X)] + EP [µˆ1(z, g,X)]− µzg(Pn)
= −(µzg(Pn)− µzg(P )) . (5.38)
The second to last equality comes from the fact that X ⊥⊥ G by Assumption 4. This is our
desired result and (5.34) now follows.
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Checking that ϕ∗zg(Pn) is Donsker:
This is analogous to condition (iv) in the proof of Theorem 1 in Rosenblum and van der
Laan (2010). We make the same assumptions of boundedness on β and on the terms in
the linear part of the generalized linear models in steps 1 and 2 of Algorithm 1. Under the
additional assumption that 0 < δ ≤ pj(G = g) for all g = 0, 1 and j = 1, . . . , J , a nearly
identical verification that ϕ∗zg(Pn) is Donsker follows. Hence, µzg(Pn) are
√
n-consistent for
all z, g ∈ {0, 1}12.
Verifying that P{ϕ∗zg(Pn)− ϕ∗zg(P∞)}2 P→ 0:
The steps to verify that P{ϕ∗zg(Pn)− ϕ∗zg(P∞)}2 → 0 in probability are very similar to the
verification of condition (v) in Rosenblum and van der Laan (2010). There are a few extra
steps required to deal with the fact that we are estimating pj(G = g) with pj,n(G = g). We
first note that we can write
P{ϕ∗zgPn − ϕ∗zg(P∞)}2 = P[{ϕzg(Pn)− ϕzg(P∞)} − EP [ϕzg(P∞)− ϕzg(Pn) |G]]2
≤ 2P{ϕzg(Pn)− ϕzg(P∞)}2 + 2P{EP [ϕzg(P∞)− ϕzg(Pn) |G]}2
≤ 4P{ϕzg(Pn)− ϕzg(P∞)}2 . (5.39)
The last line comes from applying Jenson’s inequality to the inner expectation of the second
term followed by an application of iterated expectations. We need to show that P{ϕzg(Pn)−
ϕzg(P∞)}2 converges to 0 in probability. In what follows we distinguish the working model
using the fitted parameters βn and the model using the unique maximizer of the expected
log-likelihood β as µˆ1,n and µˆ1,∞, respectively. For brevity, we also let 1zg = 1(Z =
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z)1(G = g), p(z) = p(Z = z), pj(g) = pj(G = g), and pj,n(g) = pj,n(G = g). We can write
P{ϕzg(Pn)− ϕzg(P∞)}2
= P
{
1zg
p(z)pj,n(g)
{f(Y )− µˆ1,n(z, g,X)}+ µˆ1,n(z, g,X)− µzg(Pn)
− 1zg
p(z)pj(g)
{f(Y )− µˆ1,∞(z, g,X)} − µˆ1,∞(z, g,X) + µzg(P )
}2
≤ 4
p(z)2
P
{
f(Y )2
}( 1
pj,n(g)
− 1
pj(g)
)2
+
4
p(z)2
P
{
µˆ1,∞(z, g,X)
pj(g)
− µˆ1,n(z, g,X)
pj,n(g)
}2
+ 4P {µˆ1,n(z, g,X)− µˆ1,∞(z, g,X)}2 + 4P {µzg(P )− µzg(Pn)}2
≤ C1
(
1
pj,n(g)
− 1
pj(g)
)2
+
4
p(z)2
P
{
µˆ1,∞(z, g,X)
pj(g)
− µˆ1,n(z, g,X)
pj,n(g)
}2
+ C2||β0 − β||2 + 4{µzg(P )− µzg(Pn)}2 . (5.40)
The first equality follows immediately from definitions. The first inequality follows from
rearranging terms and noting that (x1 + · · ·+xk)2 ≤ k(x21 + · · ·+x2k) by Jensen’s inequality.
The first term after the second inequality comes from the boundedness of Y . Since pj,n(g)
P→
pj(g) and we have assumed that pj(g) are bounded away from zero, the continuous mapping
theorem implies that this term converges to 0 in probability. The third term comes from
the fact that our working model has uniformly bounded first derivatives. This is due to
the boundedness assumptions on X and the terms of the linear part of our working model.
The conditions given in Proposition 5, are sufficient for βn to converge to β in probability
(Rosenblum and van der Laan (2009), Appendix D). Consequently, the third term also
converges to 0 in probability. The fourth term disappears in probability since we proved
earlier that µzg(Pn) is consistent for µzg(P ). All that is left to handle is the second term.
149
A little bit of rearranging gives us
4
p(z)2
P
{
µˆ1,∞(z, g,X)
pj(g)
− µˆ1,n(z, g,X)
pj,n(g)
}2
=
4
p(z)2
P
{
µˆ1,∞(z, g,X)− µˆ1,n(z, g,X)
pj(g)
+ µˆ1,n(z, g,X)
(
1
pj,n(g)
− 1
pj(g)
)}2
≤ 8{p(z)pj(g)}2P {µˆ1,∞(z, g,X)− µˆ1,n(z, g,X)}
2
+
8
p(z)2
P
{
µˆ1,n(z, g,X)
2
}( 1
pj,n(g)
− 1
pj(g)
)2
= C3||β0 − β||2 + C4
(
1
pj,n(g)
− 1
pj(g)
)2
. (5.41)
The first inequality follows again from Jenson’s inequality. The first term in the last line fol-
lows from the same arguments made earlier and the second term follows from the fact that
P
{
µˆ1,n(z, g,X)
2
}
is bounded. As we’ve already demonstrated, these two terms vanish in
probability. Combining (5.39), (5.40), and (5.41) gives us that P{ϕ∗zg(Pn)−ϕ∗zg(P∞)}2 P→ 0.
(5.35) follows immediately and an application of Proposition 4 implies that τˆ is also asymp-
totically linear. All that remains is to compute its asymptotic variance.
Asymptotic Variance:
To compute the asymptotic variance of τˆ we begin with a taylor expansion around τ :
τˆ = 1− µ1(Pn)
µ0(Pn)
= 1− µ1(P )
µ0(P )
− 1
µ0(P )
{µ1(Pn)− µ1(P )}
+
µ1(P )
µ0(P )2
{µ0(Pn)− µ0(P )}+ op
(
1/
√
n
)
= τ − 1
µ0(P )
(Pn − P)ϕ∗1(P∞)(O) +
µ1(P )
µ0(P )2
(Pn − P)ϕ∗0(P∞)(O) + op(1/
√
n) . (5.42)
The op(1/
√
n) comes from the second order remainder term of the expansion. Using the
expansion in (5.42) along with the fact that ϕ∗z(P∞)(O)− Pϕ∗z(P∞)(O) are mean zero i.i.d.
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random variables we can write the scaled asymptotic variance of τˆ , n · var(τˆ), as
EP
[
µ1(P )
µ0(P )2
(ϕ∗0{P∞)(O)− Pϕ∗0(P∞)(O)} −
1
µ0(P )
{ϕ∗1(P∞)(O)− Pϕ∗1(P∞)(O)}
]2
. (5.43)
5.6.5. Additional Simulation Study Details for TMLE-based Estimators
Below are the simulation settings for the individual-specific vaccine and protective effica-
cies (τi and νi), the baseline covariates and how they are transformed when they enter the
condition mean of the distribution of fever counts (Xi, X˜
m
i , and X˜
nm
i ), and unobserved
heterogeneity in the distribution of fever counts between individuals (mi and 
nm
i ).
Generative Distributions:
(1− νi) ∼ (1− ν) exp{−0.052/2} · Lognormal(0, 0.052)
(1− τi) ∼ (1− τ) exp{−0.052/2} · Lognormal(0, 0.052) ,
X˜mi ∼ exp{0.05Xi − 0.052/2} ,
X˜nmi ∼ exp{0.075Xi − 0.0752/2} ,
Xi ∼ Normal(0, 1) ,
mi ∼ exp{−0.052/2} · Lognormal(0, 0.052) ,
nmi ∼ exp{−0.052/2} · Lognormal(0, 0.052) .
We assume that the spillover efficacy η is equal to zero. Based on empirical evidence and
the negative dependence between malaria-attributable fevers and non-malaria fevers as de-
fined in (5.1), we simulate the number of malaria-attributable and non-malaria fevers from
negatively dependent negative binomial distributions (Olotu et al., 2013). We use a overdis-
persion parameter of r = 10
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Count of malaria-attributable Fevers per child-year:
On the margin, the count of malaria-attributable fevers per child-year follows a negative
binomial distribution with mean µm,i and variance σ
2
m,i,
1TY mi (z, g) ∼ NB(µm,i, σ2m,i) (5.44)
where µm,i = κ · (1− νi)g · (1− τi)z · X˜mi · mi and σ2m,i = µ2m,i/r + µm,i.
Count of non-malaria fevers per child-year:
On the margin, the count of non-malaria fevers per child-year follows a negative binomial
distribution with mean µnm,i and variance σ
2
nm,i,
1TY nmi (z, g) ∼ NB(µnm,i, σ2nm,i) (5.45)
where µnm,i = φ · X˜nmi · nmi and σ2nm,i = µ2nm,i/r + µnm,i.
Count of fevers of any-cause per child-year:
The joint distribution of the counts of non-malaria and malaria-attributable fevers per child-
year are simulated using a Gaussian copula with a negative dependence parameter ρ = −0.1
(Genest and Neslehova´, 2007).
Specificity and Mendelian Gene Prevalence Settings:
We calibrated κ and φ to achieve different levels of case specificity (s = 0.5 and 0.8).
For example, for a case specificity of 0.8 we set κ and φ so that the expected number of
malaria-attributable fevers is 80% of the expected number of total fevers of any-cause. The
prevalence of the Mendelian gene was set to 20% based on existing estimates of HbAS
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prevalence in sub-Saharan Africa (Ter Kuile et al., 2003; Elguero et al., 2015).
Initial and Updated Working Model Estimates:
For both the MFD and naive estimators, we used the R function glm.fit from the package
stats to fit the initial estimator µˆ0 in step 1 of Algorithm 1 using Poisson regression. The
regression included main terms for Z, G, and X as well as all interactions.
153
Bibliography
Aalen, O. O., Cook, R. J., and Røysland, K. (2015). Does cox analysis of a randomized
survival study yield a causal treatment effect? Lifetime data analysis, 21(4):579–593.
Abadie, A., Diamond, A., and Hainmueller, J. (2010). Synthetic control methods for com-
parative case studies: Estimating the effect of California’s tobacco control program. Jour-
nal of the American Statistical Association, 105(490):493–505.
Ashenfelter, O. and Rouse, C. (1998). Income, schooling, and ability: Evidence from a new
sample of identical twins. The Quarterly Journal of Economics, 113(1):253–284.
Athey, S., Eckles, D., and Imbens, G. W. (2018). Exact p-values for network interference.
Journal of the American Statistical Association, 113(521):230–240.
Athey, S. and Imbens, G. W. (2006). Identification and inference in nonlinear difference-in-
differences models. Econometrica, 74(2):431–497.
Becker, G. S. (2009). Human Capital: A Theoretical and Empirical Analysis, with Special
Reference to Education. University of Chicago Press.
Bejon, P., Berkley, J. A., Mwangi, T., Ogada, E., Mwangi, I., Maitland, K., Williams,
T., Scott, J. A. G., English, M., Lowe, B. S., et al. (2007). Defining childhood severe
falciparum malaria for intervention studies. PLoS medicine, 4(8):e251.
Bejon, P., White, M. T., Olotu, A., Bojang, K., Lusingu, J. P., Salim, N., Otsyula, N. N.,
Agnandji, S. T., Asante, K. P., Owusu-Agyei, S., et al. (2013). Efficacy of rts, s malaria
vaccines: individual-participant pooled analysis of phase 2 data. The Lancet infectious
diseases, 13(4):319–327.
Berger, R. L. (1982). Multiparameter hypothesis testing and acceptance sampling. Tech-
nometrics, 24(4):295–300.
Berger, R. L. and Boos, D. D. (1994). P values maximized over a confidence set for the
nuisance parameter. Journal of the American Statistical Association, 89(427):1012–1016.
Bernal, J. L., Cummins, S., and Gasparrini, A. (2017). Interrupted time series regression
for the evaluation of public health interventions: a tutorial. International journal of
epidemiology, 46(1):348–355.
Bertrand, M., Duflo, E., and Mullainathan, S. (2004). How much should we trust differences-
in-differences estimates? The Quarterly Journal of Economics, 119(1):249–275.
Bhatia, R. and Davis, C. (2000). A better bound on the variance. The American Mathe-
matical Monthly, 107(4):353–357.
Blitstein, J. L., Hannan, P. J., Murray, D. M., and Shadish, W. R. (2005). Increasing the
degrees of freedom in existing group randomized trials: The df* approach. Evaluation
Review, 29(3):241–267.
154
Brillinger, D. R. (1986). A biometrics invited paper with discussion: the natural variability
of vital rates and associated statistics. Biometrics, 42:693–734.
Burgess, S., Small, D. S., and Thompson, S. G. (2017). A review of instrumental vari-
able estimators for mendelian randomization. Statistical methods in medical research,
26(5):2333–2355.
Burstein, A. and Vogel, J. (2017). International trade, technology, and the skill premium.
Journal of Political Economy, 125(5):1356–1412.
Campbell, D. T. (1969). Prospective: Artifact and control. In Rosenthal, R. and Rosnow,
R. L., editors, Artifacts in Behavioral Research: Robert Rosenthal and Ralph L. Rosnow’s
Classic Books, pages 351–382. Academic Press, New York, NY.
Campbell, D. T. and Stanley, J. C. (1963). Experimental and quasi-experimental designs
for research. In Gage, N., editor, Handbook of research on teaching, pages 171–246. Rand
McNally, Chicago, IL.
Card, D. (1999). The causal effect of education on earnings. volume 3 of Handbook of Labor
Economics, pages 1801 – 1863. Elsevier.
Card, D. and Krueger, A. B. (1992). Does school quality matter? Returns to education and
the characteristics of public schools in the United States. Journal of Political Economy,
100(1):1–40.
Conley, T. G. and Taber, C. R. (2011). Inference with “difference in differences” with a
small number of policy changes. The Review of Economics and Statistics, 93(1):113–125.
Cook, T. D. and Campbell, D. T. (1979). Quasi-experimentation: Design and analysis
issues for field settings. Rand McNally, Chicago, IL.
Cook, T. D., Campbell, D. T., and Shadish, W. (2002). Experimental and quasi-
experimental designs for generalized causal inference. Houghton Miﬄin, Boston, MA.
Cornfield, J., Haenszel, W., Hammond, E. C., Lilienfeld, A. M., Shimkin, M. B., and
Wynder, E. L. (1959). Smoking and lung cancer: Recent evidence and a discussion of
some questions. Journal of the National Cancer Institute, 22(1):173–203.
Cox, D. R. (1975). Partial likelihood. Biometrika, 62(2):269–276.
Crifasi, C. K., Merrill-Francis, M., McCourt, A., Vernick, J. S., Wintemute, G. J., and
Webster, D. W. (2018). Association between firearm laws and homicide in urban counties.
Journal of urban health, 95(3):383–390.
De Neve, J. and Gerds, T. A. (2019). On the interpretation of the hazard ratio in cox
regression. Biometrical Journal.
Dix-Carneiro, R. and Kovak, B. K. (2017). Trade liberalization and regional dynamics.
American Economic Review, 107(10):2908–46.
155
Donald, S. G. and Lang, K. (2007). Inference with difference-in-differences and other panel
data. The Review of Economics and Statistics, 89(2):221–233.
Donovan, S. J. and Susser, E. (2011). Commentary: Advent of sibling designs. International
Journal of Epidemiology, 40(2):345.
Egleston, B. L., Scharfstein, D. O., and MacKenzie, E. (2009). On estimation of the survivor
average causal effect in observational studies when important confounders are missing due
to death. Biometrics, 65(2):497–504.
Elguero, E., De´licat-Loembet, L. M., Rougeron, V., Arnathau, C., Roche, B., Becquart,
P., Gonzalez, J.-P., Nkoghe, D., Sica, L., Leroy, E. M., et al. (2015). Malaria continues
to select for sickle cell trait in central africa. Proceedings of the National Academy of
Sciences, 112(22):7051–7054.
Ferreira, A., Marguti, I., Bechmann, I., Jeney, V., Chora, Aˆ., Palha, N. R., Rebelo, S.,
Henri, A., Beuzard, Y., and Soares, M. P. (2011). Sickle hemoglobin confers tolerance to
plasmodium infection. Cell, 145(3):398–409.
Fine, J. P. and Gray, R. J. (1999). A proportional hazards model for the subdistribution of
a competing risk. Journal of the American statistical association, 94(446):496–509.
Fisher, R. A. (1935). The Design of Experiments. Oliver & Boyd.
Fogarty, C. B. and Hasegawa, R. B. (2019). Extended sensitivity analysis for heterogeneous
unmeasured confounding with an application to sibling studies of returns to education.
to appear.
Fogarty, C. B. and Small, D. S. (2016). Sensitivity analysis for multiple comparisons in
matched observational studies through quadratically constrained linear programming.
Journal of the American Statistical Association, 111(516):1820–1830.
Frisell, T., O¨berg, S., Kuja-Halkola, R., and Sjo¨lander, A. (2012). Sibling compari-
son designs: Bias from non-shared confounders and measurement error. Epidemiology,
23(5):713–720.
Gastwirth, J. L., Krieger, A. M., and Rosenbaum, P. R. (1998). Dual and simultaneous
sensitivity analysis for matched pairs. Biometrika, 85(4):pp. 907–920.
Gastwirth, J. L., Krieger, A. M., and Rosenbaum, P. R. (2000). Asymptotic separability
in sensitivity analysis. Journal of the Royal Statistical Society: Series B (Statistical
Methodology), 62(3):545–555.
Genest, C. and Neslehova´, J. (2007). A primer on copulas for count data. ASTIN Bulletin:
The Journal of the IAA, 37(2):475–515.
Gleser, L. J. (1975). On the distribution of the number of successes in independent trials.
Ann. Probab., 3(1):182–188.
156
Gong, L., Parikh, S., Rosenthal, P. J., and Greenhouse, B. (2013). Biochemical and immuno-
logical mechanisms by which sickle cell trait protects against malaria. Malaria Journal,
12(1):317.
Gravenor, M. and Kwiatkowski, D. (1998). An analysis of the temperature effects of fever on
the intra-host population dynamics of plasmodium falciparum. Parasitology, 117(2):97–
105.
Griliches, Z. (1970). Notes on the role of education in production functions and growth
accounting. In Education, Income, and Human Capital, NBER Chapters, pages 71–127.
National Bureau of Economic Research, Inc.
Griliches, Z. (1979). Sibling models and data in economics: Beginnings of a survey. Journal
of Political Economy, 87(5):S37–S64.
Ha´jek, J., S˘ida´k, Z., and Sen, P. K. (1999). Theory of Rank Tests. Academic Press, San
Diego.
Hammond, E. C. (1964). Smoking in relation to mortality and morbidity. findings in first
thirty-four months of follow-up in a prospective study started in 1959. Journal of the
National Cancer Institute, 32(5):1161–1188.
Hansen, B. B. and Klopfer, S. O. (2006). Optimal full matching and related designs via
network flows. Journal of Computational and Graphical Statistics, 15(3):609–627.
Hansen, C. B. (2007). Generalized least squares inference in panel and multilevel models
with serial correlation and fixed effects. Journal of Econometrics, 140(2):670–694.
Hansen, L. P. (1982). Large sample properties of generalized method of moments estimators.
Econometrica: Journal of the Econometric Society, pages 1029–1054.
Hasegawa, R. and Small, D. (2017). Sensitivity analysis for matched pair analysis of binary
data: From worst case to average case analysis. Biometrics, 73(4):1424–1432.
Hasegawa, R. B., Webster, D. W., and Small, D. S. (2019). Evaluating missouri’s handgun
purchaser law. Epidemiology, 30(3):371–379.
Hauser, R. M., Sheridan, J. T., and Warren, J. R. (1999). Socioeconomic achievements of
siblings in the life course. Research on Aging, 21(2):338–378.
Herd, P., Carr, D., and Roan, C. (2014). Cohort profile: Wisconsin longitudinal study
(WLS). International Journal of Epidemiology, 43(1):34–41.
Herna´n, M. A. (2010). The hazards of hazard ratios. Epidemiology, 21(1):13–15.
Hoeffding, W. (1956). On the distribution of the number of successes in independent trials.
Ann. Math. Statist., 27(3):713–721.
Hosman, C. A., Hansen, B. B., and Holland, P. W. (2010). The sensitivity of linear regression
coefficients’ confidence limits to the omission of a confounder. Annals of Applied Statistics,
4(2):849–870.
157
Hsu, J. Y., Roy, J. A., Xie, D., Yang, W., Shou, H., Anderson, A. H., Landis, J. R., Jepson,
C., Wolf, M., Isakova, T., et al. (2017). Statistical methods for cohort studies of ckd:
survival analysis in the setting of competing risks. Clinical Journal of the American
Society of Nephrology, 12(7):1181–1189.
Hsu, J. Y. and Small, D. S. (2013). Calibrating sensitivity analyses to observed covariates
in observational studies. Biometrics, 69(4):803–811.
http://wonder.cdc.gov (2018). Centers for Disease Control and Prevention, National Center
for Health Statistics. Compressed Mortality File on CDC WONDER Online Database,
released December 2017. Data are from the Compressed Mortality File 1999-2016 Series
20 No. 2V, 2017, as compiled from data provided by the 57 vital statistics jurisdictions
through the Vital Statistics Cooperative Program. Accessed at http://wonder.cdc.gov on
Mar 19, 2018.
Hudgens, M. G. and Halloran, M. E. (2008). Toward causal inference with interference.
Journal of the American Statistical Association, 103(482):832–842.
Imbens, G. W. (2003). Sensitivity to exogeneity assumptions in program evaluation. Amer-
ican Economic Review, 93(2):126–132.
Imbens, G. W. and Rosenbaum, P. R. (2005). Robust, accurate confidence intervals with a
weak instrument: Quarter of birth and education. Journal of the Royal Statistical Society.
Series A (Statistics in Society), 168(1):109–126.
Imbens, G. W. and Wooldridge, J. M. (2009). Recent developments in the econometrics of
program evaluation. Journal of Economic Literature, 47(1):5–86.
Kang, H., Kreuels, B., Adjei, O., Krumkamp, R., May, J., and Small, D. S. (2013). The
causal effect of malaria on stunting: a mendelian randomization and matching approach.
International Journal of Epidemiology, 42(5):1390–1398.
Kang, H., Zhang, A., Cai, T. T., and Small, D. S. (2016). Instrumental variables estimation
with some invalid instruments and its application to mendelian randomization. Journal
of the American Statistical Association, 111(513):132–144.
Kennedy, E. H. (2016). Semiparametric theory and empirical processes in causal inference.
In Statistical Causal Inferences and Their Applications in Public Health Research, pages
141–167. Springer.
Keyfitz, N. (1966). Sampling variance of standardized mortality rates. Human Biology,
38(3):309–317.
Klein, J. P. (1992). Semiparametric estimation of random effects using the cox model based
on the em algorithm. Biometrics, 48(3):795–806.
Lachenbruch, P. A. (1998). Sensitivity, specificity, and vaccine efficacy. Controlled clinical
trials, 19(6):569–574.
158
Lee, K. and Small, D. S. (2018). Estimating the malaria attributable fever fraction account-
ing for parasites being killed by fever and measurement error. Journal of the American
Statistical Association, (just-accepted):1–38.
Lehmann, E. (1952). Testing multiparameter hypotheses. The Annals of Mathematical
Statistics, pages 541–552.
Liu, W., Kuramoto, S. J., and Stuart, E. A. (2013). An introduction to sensitivity analysis
for unobserved confounding in nonexperimental prevention research. Prevention Science,
14(6):570–580.
Mabunda, S., Aponte, J. J., Tiago, A., and Alonso, P. (2009). A country-wide malaria
survey in mozambique. ii. malaria attributable proportion of fever and establishment
of malaria case definition in children across different epidemiological settings. Malaria
Journal, 8(1):74.
Mahmoudi, S. and Keshavarz, H. (2017). Efficacy of phase 3 trial of rts, s/as01 malaria
vaccine: the need for an alternative development plan. Human vaccines & immunother-
apeutics, 13(9):2098–2101.
Marcus, S. M. (1997). Using omitted variable bias to assess uncertainty in the estimation
of an aids education treatment effect. Journal of Educational and Behavioral Statistics,
22(2):193–201.
Marsaglia, G. et al. (2006). Ratios of normal variables. Journal of Statistical Software,
16(4):1–10.
Martens, E. P., Pestman, W. R., de Boer, A., Belitser, S. V., and Klungel, O. H. (2006).
Instrumental variables: application and limitations. Epidemiology, pages 260–267.
Martinussen, T., Vansteelandt, S., and Andersen, P. K. (2018). Subtleties in the interpre-
tation of hazard ratios. arXiv preprint arXiv:1810.09192.
Matthews, K., Shepherd, J., and Sivarajasingham, V. (2006). Violence-related injury and
the price of beer in england and wales. Applied Economics, 38(6):661–670.
McCandless, L. C., Gustafson, P., and Levy, A. (2007). Bayesian sensitivity analysis for
unmeasured confounding in observational studies. Statistics in medicine, 26(11):2331–
2347.
Meyer, B. D. (1995). Natural and quasi-experiments in economics. Journal of Business &
Economic Statistics, 13(2):151–161.
Moorthy, V., Reed, Z., and Smith, P. G. (2007). Measurement of malaria vaccine efficacy
in phase iii trials: Report of a who consultation. Vaccine, 25(28):5115 – 5123.
Moorthy, V. S. and Ballou, W. R. (2009). Immunological mechanisms underlying protection
mediated by rts, s: a review of the available data. Malaria journal, 8(1):312.
Morton, N. (2001). Linkage disequilibrium. In Brenner, S. and Miller, J. H., editors,
Encyclopedia of Genetics, page 1105. Academic Press, New York.
159
Ndila, C. M., Uyoga, S., Macharia, A. W., Nyutu, G., Peshu, N., Ojal, J., Shebe, M.,
Awuondo, K. O., Mturi, N., Tsofa, B., et al. (2018). Human candidate gene polymor-
phisms and risk of severe malaria in children in kilifi, kenya: a case-control association
study. The Lancet Haematology, 5(8):e333–e345.
Neuwald, A. F. and Green, P. (1994). Detecting patterns in protein sequences. Journal of
molecular biology, 239(5):698–712.
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens,
M., Leboulleux, D., Njuguna, P., Peshu, N., and et al. (2013). Four-year efficacy of
rts,s/as01e and its interaction with malaria exposure. New England Journal of Medicine,
368(12):1111–1120.
Penny, M. A., Galactionova, K., Tarantino, M., Tanner, M., and Smith, T. A. (2015).
The public health impact of malaria vaccine rts, s in malaria endemic africa: country-
specific predictions using 18 month follow-up phase iii data and simulation models. BMC
medicine, 13(1):170.
Penny, M. A., Maire, N., Studer, A., Schapira, A., and Smith, T. A. (2008). What should
vaccine developers ask? simulation of the effectiveness of malaria vaccines. PLoS One,
3(9):e3193.
Rassen, J. A., Brookhart, M. A., Glynn, R. J., Mittleman, M. A., and Schneeweiss, S.
(2009). Instrumental variables i: instrumental variables exploit natural variation in non-
experimental data to estimate causal relationships. Journal of clinical epidemiology,
62(12):1226–1232.
Regules, J. A., Cummings, J. F., and Ockenhouse, C. F. (2011). The rts, s vaccine candidate
for malaria. Expert review of vaccines, 10(5):589–599.
Reynolds, K. D. and West, S. G. (1987). A multiplist strategy for strengthening nonequiv-
alent control group designs. Evaluation Review, 11(6):691–714.
Rosenbaum, P. R. (1984). Conditional permutation tests and the propensity score in ob-
servational studies. Journal of the American Statistical Association, 79(387):565–574.
Rosenbaum, P. R. (1987). Sensitivity analysis for certain permutation inferences in matched
observational studies. Biometrika, 74(1):13–26.
Rosenbaum, P. R. (1992). Detecting bias with confidence in observational studies.
Biometrika, 79(2):367–374.
Rosenbaum, P. R. (1999). Choice as an alternative to control in observational studies.
Statistical Science, 14(3):259–278.
Rosenbaum, P. R. (2002a). Attributing effects to treatment in matched observational stud-
ies. Journal of the American Statistical Association, 97(457):183–192.
Rosenbaum, P. R. (2002b). Covariance adjustment in randomized experiments and obser-
vational studies. Statistical Science, 17(3):286–327.
160
Rosenbaum, P. R. (2002c). Observational studies. Springer.
Rosenbaum, P. R. (2010). Design of Observational Studies. Springer, New York.
Rosenbaum, P. R. (2011). Some approximate evidence factors in observational studies.
Journal of the American Statistical Association, 106(493):285–295.
Rosenbaum, P. R. and Rubin, D. B. (1983). The central role of the propensity score in
observational studies for causal effects. Biometrika, 70(1):41.
Rosenbaum, P. R. and Silber, J. H. (2009). Amplification of sensitivity analysis in matched
observational studies. Journal of the American Statistical Association, 104(488).
Rosenblum, M. and van der Laan, M. J. (2009). Using regression models to analyze ran-
domized trials: Asymptotically valid hypothesis tests despite incorrectly specified models.
Biometrics, 65(3):937–945.
Rosenblum, M. and van der Laan, M. J. (2010). Simple, efficient estimators of treatment
effects in randomized trials using generalized linear models to leverage baseline variables.
The International Journal of Biostatistics, 6(1).
Rubin, D. B. (1980). Comment (on d. basu, randomization analysis of experimental
data: The fisher randomization test). Journal of the American Statistical Association,
75(371):591–593.
Rubin, D. B. (2005). Causal inference using potential outcomes. Journal of the American
Statistical Association, 100(469):322–331.
Rudolph, K. E., Stuart, E. A., Vernick, J. S., and Webster, D. W. (2015). Association
between connecticut’s permit-to-purchase handgun law and homicides. American journal
of public health, 105(8):e49–e54.
Shaked, M. and Shanthikumar, J. G. (1994). Stochastic Orders and Their Applications.
Academic Press, New York.
Shepherd, J. and Page, N. (2015). The economic downturn probably reduced violence far
more than licensing restrictions. Addiction, 110(10):1583–1584.
Small, D. S., Cheng, J., and Ten Have, T. R. (2010). Evaluating the efficacy of a malaria
vaccine. The international journal of biostatistics, 6(2).
Smith, G. D. and Ebrahim, S. (2008). Mendelian randomization: genetic variants as instru-
ments for strengthening causal inference in observational studies. In Biosocial Surveys.
National Academies Press (US).
Smith, T., Schellenberg, J. A., and Hayes, R. (1994). Attributable fraction estimates and
case definitions for malaria in endemic. Statistics in medicine, 13(22):2345–2358.
Stanek, K. C., Iacono, W. G., and McGue, M. (2011). Returns to education: What do twin
studies control? Twin Research and Human Genetics, 14(6):509–515.
161
Stensrud, M. J., Valberg, M., Røysland, K., and Aalen, O. O. (2017). Exploring selection
bias by causal frailty models. Epidemiology, 28(3):379–386.
Stuart, E. A. (2010). Matching methods for causal inference: A review and a look forward.
Statist. Sci., 25(1):1–21.
Taylor, S. M., Parobek, C. M., and Fairhurst, R. M. (2012). Haemoglobinopathies and
the clinical epidemiology of malaria: a systematic review and meta-analysis. The Lancet
infectious diseases, 12(6):457–468.
Ter Kuile, F. O., Lal, A. A., Kariuki, S. K., Shi, Y. P., Mirel, L. B., Vulule, J. M., A.,
P.-H. P., Kolczak, M. S., Hawley, W. A., Nahlen, B. L., and et al. (2003). Impact
of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area
of intense perennial malaria transmission in western kenya. The American Journal of
Tropical Medicine and Hygiene, 68(4):68–77.
The RTS,S Clinical Trials Partnership (2011). First results of phase 3 trial of rts,s/as01
malaria vaccine in african children. New England Journal of Medicine, 365(20):1863–1875.
Therneau, T. M., Grambsch, P. M., and Pankratz, V. S. (2003). Penalized survival models
and frailty. Journal of computational and graphical statistics, 12(1):156–175.
Tibshirani, R. and Redelmeier, D. A. (1997). Cellular telephones and motor-vehicle col-
lisions: Some variations on matched-pairs analysis. Canadian Journal of Statistics,
25(4):581–591.
US Department of Health and Human Services (2004). Vital statistics of the united states:
mortality, 1999 technical appendix. Technical report, CDC National Center for Health
Statistics, Hyattsville, MD.
Van der Laan, M. J. and Rose, S. (2011). Targeted learning: causal inference for observa-
tional and experimental data. Springer Science & Business Media, New York, NY.
van der Laan, M. J. and Rubin, D. (2006). Targeted maximum likelihood learning. The
International Journal of Biostatistics, 2(1).
VanderWeele, T. J. and Ding, P. (2017). Sensitivity analysis in observational research:
introducing the E-value. Annals of Internal Medicine, 167(4):268–274.
VanderWeele, T. J. and Hernan, M. A. (2013). Causal inference under multiple versions of
treatment. Journal of Causal Inference, 1(1):1–20.
Volpp, K. G., Rosen, A. K., Rosenbaum, P. R., Romano, P. S., Even-Shoshan, O., Wang,
Y., Bellini, L., Behringer, T., and Silber, J. H. (2007). Mortality among hospitalized
medicare beneficiaries in the first 2 years following ACGME resident duty hour reform.
Journal of the American Medical Association, 298(9):975–983.
Wald, A. (1940). The fitting of straight lines if both variables are subject to error. The
Annals of Mathematical Statistics, 11(3):284–300.
162
Wang, L. and Krieger, A. M. (2006). Causal conclusions are most sensitive to unobserved
binary covariates. Statistics in medicine, 25(13):2257–2271.
Webster, D., Crifasi, C. K., and Vernick, J. S. (2014). Effects of the repeal of missouris
handgun purchaser licensing law on homicides. Journal of Urban Health, 91(2):293–302.
Wienke, A. (2010). Frailty models in survival analysis. Chapman & Hall/CRC Biostatistics
Series.
Williams, T. N. (2011). How do hemoglobins s and c result in malaria protection? Journal
of Infectious Diseases, 204(11):1651–1653.
Williams, T. N., Mwangi, T. W., Wambua, S., Alexander, N. D., Kortok, M., Snow, R. W.,
and Marsh, K. (2005). Sickle cell trait and the risk of plasmodium falciparum malaria
and other childhood diseases. The Journal of infectious diseases, 192(1):178–186.
Wing, C., Simon, K., and Bello-Gomez, R. A. (2018). Designing difference in difference
studies: Best practices for public health policy research. Annual Review of Public Health,
39:453–469.
Wolf, A., Gray, R., and Fazel, S. (2014). Violence as a public health problem: An ecological
study of 169 countries. Social Science & Medicine, 104:220–227.
Wolfe, D. A. (1974). A characterization of population weighted-symmetry and related
results. Journal of the American Statistical Association, 69(347):819–822.
World Health Organization (2018). Who world malaria report 2018. World Health Organi-
zation, Luxembourg.
Wu, Y., Sinden, R. E., Churcher, T. S., Tsuboi, T., and Yusibov, V. (2015). Development
of malaria transmission-blocking vaccines: from concept to product. In Advances in
parasitology, volume 89, pages 109–152. Elsevier.
Yu, B. and Gastwirth, J. L. (2005). Sensitivity analysis for trend tests: application to the
risk of radiation exposure. Biostatistics, 6(2):201–209.
Zubizarreta, J. R., Cerda´, M., and Rosenbaum, P. R. (2013). Effect of the 2010 Chilean
earthquake on posttraumatic stress: Reducing sensitivity to unmeasured bias through
study design. Epidemiology, 24(1):79–87.
163
